Page last updated: 2024-12-11

gentamicin sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID9855350
CHEMBL ID3039594
MeSH IDM0009170
PubMed CID9898639
CHEMBL ID3039597
MeSH IDM0009170

Synonyms (22)

Synonym
gentamicin sulfate (salt)
gentibioptal
gentamicin sulphate (salt)
gent-ak
CHEMBL3039594
gentamicin (gentamycin sulfate)
gentamicin (as sulfate)
ophtagram
gentamicini sulfas
gentamicin (as sulphate)
pangram
gentalyn
gentogram
gentacin
gent-ophtal
RDEIXVOBVLKYNT-VQBXQJRRSA-N
sch-9724
CHEMBL3039597
G-2419
gentamycin, antibiotic for culture media use only
bdbm50476074
gentamicinsulfate salt

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However, severe toxic side effects along with the reduced suppression efficiency at subtoxic doses limit the use of gentamicin for suppression therapy."( Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
Baasov, T; Belakhov, V; Ben-Yosef, T; Chen, F; Cherniavsky, M; Hainrichson, M; Nudelman, I; Pilch, DS; Rebibo-Sabbah, A; Schacht, J, 2009
)
0.35
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36

Pharmacokinetics

ExcerptReferenceRelevance
"Using an in vitro pharmacodynamic model, a multidrug-resistant strain of Acinetobacter baumannii was exposed to colistin methanesulfonate alone and in combination with ceftazidime."( Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Hovde, LB; Kroeger, LA; Mitropoulos, IF; Rotschafer, JC; Schafer, J, 2007
)
0.34
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
"To facilitate optimal dosing regimen design, we previously developed a mathematical model using time-kill study data to predict the responses of Pseudomonas aeruginosa to various pharmacokinetic profiles of meropenem and levofloxacin."( Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
Kabbara, S; Ledesma, KR; Lim, TP; Nikolaou, M; Tam, VH; Vo, G, 2008
)
0.35
"The objective of the present prospective pharmacokinetic study was to describe the variability of plasma gentamicin concentrations in critically ill patients with acute kidney injury (AKI) necessitating extended daily diafiltration (EDD-f) using a population pharmacokinetic model and to subsequently perform Monte Carlo dosing simulations to determine which dose regimen achieves the pharmacodynamic targets the most consistently."( Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
Field, J; Kirkpatrick, CM; Lipman, J; Roberts, JA; Tallot, M; Visser, A; Whitbread, R, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
" Daptomycin sub-MICs combined with gentamicin concentrations lower than the MIC yielded synergy in 34 (68%) of the 50 strains."( Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
Appelbaum, PC; Credito, K; Lin, G, 2007
)
0.34
"A total of 30 chalcone analogues was synthesized via a base catalyzed Claisen Schmidt condensation and screened for their in vitro antibacterial activity against Methicillin-sensitive Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) alone or in combination with non beta-lactam antibiotics namely ciprofloxacin, chloramphenicol, erythromycin, vancomycin, doxycycline and gentamicin."( Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
"Oral bioavailability (F) is a product of fraction absorbed (Fa), fraction escaping gut-wall elimination (Fg), and fraction escaping hepatic elimination (Fh)."( Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" Depending on the intended indication and dosing regimen, PPL can delay or stop development of a compound in the drug discovery process."( Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.
Gehlhaar, D; Greene, N; Johnson, TO; Pelletier, DJ; Tilloy-Ellul, A,
)
0.13
"To facilitate optimal dosing regimen design, we previously developed a mathematical model using time-kill study data to predict the responses of Pseudomonas aeruginosa to various pharmacokinetic profiles of meropenem and levofloxacin."( Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
Kabbara, S; Ledesma, KR; Lim, TP; Nikolaou, M; Tam, VH; Vo, G, 2008
)
0.35
"The objective of the present prospective pharmacokinetic study was to describe the variability of plasma gentamicin concentrations in critically ill patients with acute kidney injury (AKI) necessitating extended daily diafiltration (EDD-f) using a population pharmacokinetic model and to subsequently perform Monte Carlo dosing simulations to determine which dose regimen achieves the pharmacodynamic targets the most consistently."( Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
Field, J; Kirkpatrick, CM; Lipman, J; Roberts, JA; Tallot, M; Visser, A; Whitbread, R, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (136)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
60S acidic ribosomal protein P1Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S acidic ribosomal protein P0Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S17Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein SAHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S2Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L35aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L7Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L17Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S4, Y isoform 1Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S3Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S12Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L13Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L10Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L12Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L9Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L22Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L4Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S19Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L3Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L13aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S27Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L35Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L27aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L5Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L21Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L28Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S9Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S5Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S10Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L29Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L34Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L14Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S20Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S3aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L26Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L15Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L27Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L37aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L37Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S7Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S8Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S15aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S16Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S14Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S23Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S18Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S29Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S13Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S11Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L7aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S4, X isoformHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L23aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S6Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L23Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S15Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S24Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S25Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S26Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S28Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S30Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L30Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L39Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L31Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L10aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L32Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L11Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L8Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L41Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
Ubiquitin-40S ribosomal protein S27aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L38Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
40S ribosomal protein S21Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L24Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L36aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L19Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L18aHomo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L6Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L18Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
60S ribosomal protein L36Homo sapiens (human)IC50 (µMol)26.00000.30002.12507.0000AID717551
Dihydrofolate reductaseHomo sapiens (human)IC50 (µMol)18.00000.00060.87267.3000AID472620
Dihydrofolate reductase Bos taurus (cattle)IC50 (µMol)25.00000.00170.04350.1007AID472619
30S ribosomal protein S6Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S7Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L15Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L10Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L11Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L7/L12Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L19Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L1Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L20Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L27Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L28Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L29Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L31Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L31 type BEscherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L32Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L33Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L34Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L35Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L36Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S10Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S11Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S12Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S13Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S16Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S18Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S19Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S20Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S2Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S3Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S4Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S5Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S8Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S9Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L13Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L14Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L16Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L23Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S15Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L17Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L21Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L30Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L6Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S14Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S17Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S1Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L18Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L2Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L3Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L24Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L4Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L22Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L5Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
30S ribosomal protein S21Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L25Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
50S ribosomal protein L36 2Escherichia coli K-12IC50 (µMol)0.02800.00891.20355.0000AID488044
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (180)

Processvia Protein(s)Taxonomy
cytoplasmic translation60S acidic ribosomal protein P1Homo sapiens (human)
translation60S acidic ribosomal protein P1Homo sapiens (human)
translational elongation60S acidic ribosomal protein P1Homo sapiens (human)
cytoplasmic translation60S acidic ribosomal protein P0Homo sapiens (human)
translation60S acidic ribosomal protein P0Homo sapiens (human)
ribosome biogenesis60S acidic ribosomal protein P0Homo sapiens (human)
ribosomal large subunit assembly60S acidic ribosomal protein P0Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S17Homo sapiens (human)
rRNA processing40S ribosomal protein S17Homo sapiens (human)
translation40S ribosomal protein S17Homo sapiens (human)
translational initiation40S ribosomal protein S17Homo sapiens (human)
erythrocyte homeostasis40S ribosomal protein S17Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S17Homo sapiens (human)
cytoplasmic translation40S ribosomal protein SAHomo sapiens (human)
translation40S ribosomal protein SAHomo sapiens (human)
cell adhesion40S ribosomal protein SAHomo sapiens (human)
symbiont entry into host cell40S ribosomal protein SAHomo sapiens (human)
antiviral innate immune response40S ribosomal protein SAHomo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein SAHomo sapiens (human)
cytoplasmic translation40S ribosomal protein S2Homo sapiens (human)
translation40S ribosomal protein S2Homo sapiens (human)
positive regulation of ubiquitin-protein transferase activity40S ribosomal protein S2Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L35aHomo sapiens (human)
rRNA processing60S ribosomal protein L35aHomo sapiens (human)
translation60S ribosomal protein L35aHomo sapiens (human)
ribosomal large subunit biogenesis60S ribosomal protein L35aHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L7Homo sapiens (human)
rRNA processing60S ribosomal protein L7Homo sapiens (human)
translation60S ribosomal protein L7Homo sapiens (human)
ribosomal large subunit biogenesis60S ribosomal protein L7Homo sapiens (human)
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)60S ribosomal protein L7Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L17Homo sapiens (human)
translation60S ribosomal protein L17Homo sapiens (human)
translation40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S3Homo sapiens (human)
DNA repair40S ribosomal protein S3Homo sapiens (human)
base-excision repair40S ribosomal protein S3Homo sapiens (human)
translation40S ribosomal protein S3Homo sapiens (human)
translational initiation40S ribosomal protein S3Homo sapiens (human)
apoptotic process40S ribosomal protein S3Homo sapiens (human)
DNA damage response40S ribosomal protein S3Homo sapiens (human)
chromosome segregation40S ribosomal protein S3Homo sapiens (human)
positive regulation of gene expression40S ribosomal protein S3Homo sapiens (human)
negative regulation of translation40S ribosomal protein S3Homo sapiens (human)
positive regulation of microtubule polymerization40S ribosomal protein S3Homo sapiens (human)
positive regulation of protein-containing complex assembly40S ribosomal protein S3Homo sapiens (human)
negative regulation of protein ubiquitination40S ribosomal protein S3Homo sapiens (human)
positive regulation of endodeoxyribonuclease activity40S ribosomal protein S3Homo sapiens (human)
positive regulation of interleukin-2 production40S ribosomal protein S3Homo sapiens (human)
cellular response to reactive oxygen species40S ribosomal protein S3Homo sapiens (human)
positive regulation of activated T cell proliferation40S ribosomal protein S3Homo sapiens (human)
regulation of apoptotic process40S ribosomal protein S3Homo sapiens (human)
positive regulation of JUN kinase activity40S ribosomal protein S3Homo sapiens (human)
negative regulation of DNA repair40S ribosomal protein S3Homo sapiens (human)
positive regulation of DNA repair40S ribosomal protein S3Homo sapiens (human)
positive regulation of T cell receptor signaling pathway40S ribosomal protein S3Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activity40S ribosomal protein S3Homo sapiens (human)
spindle assembly40S ribosomal protein S3Homo sapiens (human)
cell division40S ribosomal protein S3Homo sapiens (human)
response to TNF agonist40S ribosomal protein S3Homo sapiens (human)
cellular response to hydrogen peroxide40S ribosomal protein S3Homo sapiens (human)
cellular response to tumor necrosis factor40S ribosomal protein S3Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transduction40S ribosomal protein S3Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage40S ribosomal protein S3Homo sapiens (human)
positive regulation of base-excision repair40S ribosomal protein S3Homo sapiens (human)
positive regulation of apoptotic signaling pathway40S ribosomal protein S3Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis40S ribosomal protein S3Homo sapiens (human)
positive regulation of canonical Wnt signaling pathway40S ribosomal protein S12Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S12Homo sapiens (human)
translation40S ribosomal protein S12Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S12Homo sapiens (human)
maintenance of translational fidelity40S ribosomal protein S12Homo sapiens (human)
blastocyst development60S ribosomal protein L13Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L13Homo sapiens (human)
translation60S ribosomal protein L13Homo sapiens (human)
bone development60S ribosomal protein L13Homo sapiens (human)
translation60S ribosomal protein L10Homo sapiens (human)
negative regulation of transcription by RNA polymerase II60S ribosomal protein L10Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L10Homo sapiens (human)
translation60S ribosomal protein L10Homo sapiens (human)
regulation of translation60S ribosomal protein L10Homo sapiens (human)
negative regulation of apoptotic process60S ribosomal protein L10Homo sapiens (human)
embryonic brain development60S ribosomal protein L10Homo sapiens (human)
ribosomal large subunit assembly60S ribosomal protein L10Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L12Homo sapiens (human)
translation60S ribosomal protein L12Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L9Homo sapiens (human)
translation60S ribosomal protein L9Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L22Homo sapiens (human)
translation60S ribosomal protein L22Homo sapiens (human)
alpha-beta T cell differentiation60S ribosomal protein L22Homo sapiens (human)
translation at presynapse60S ribosomal protein L22Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L4Homo sapiens (human)
translation60S ribosomal protein L4Homo sapiens (human)
erythrocyte differentiation40S ribosomal protein S19Homo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein S19Homo sapiens (human)
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)40S ribosomal protein S19Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S19Homo sapiens (human)
monocyte chemotaxis40S ribosomal protein S19Homo sapiens (human)
rRNA processing40S ribosomal protein S19Homo sapiens (human)
translation40S ribosomal protein S19Homo sapiens (human)
nucleolus organization40S ribosomal protein S19Homo sapiens (human)
maturation of SSU-rRNA40S ribosomal protein S19Homo sapiens (human)
killing of cells of another organism40S ribosomal protein S19Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S19Homo sapiens (human)
defense response to Gram-negative bacterium40S ribosomal protein S19Homo sapiens (human)
positive regulation of respiratory burst involved in inflammatory response40S ribosomal protein S19Homo sapiens (human)
negative regulation of respiratory burst involved in inflammatory response40S ribosomal protein S19Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptide40S ribosomal protein S19Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L3Homo sapiens (human)
translation60S ribosomal protein L3Homo sapiens (human)
cellular response to interleukin-460S ribosomal protein L3Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L13aHomo sapiens (human)
translation60S ribosomal protein L13aHomo sapiens (human)
negative regulation of translation60S ribosomal protein L13aHomo sapiens (human)
response to lipopolysaccharide60S ribosomal protein L13aHomo sapiens (human)
homeostatic process60S ribosomal protein L13aHomo sapiens (human)
macrophage chemotaxis60S ribosomal protein L13aHomo sapiens (human)
lung morphogenesis60S ribosomal protein L13aHomo sapiens (human)
cellular response to type II interferon60S ribosomal protein L13aHomo sapiens (human)
negative regulation of formation of translation preinitiation complex60S ribosomal protein L13aHomo sapiens (human)
cytoplasmic translation40S ribosomal protein S27Homo sapiens (human)
rRNA processing40S ribosomal protein S27Homo sapiens (human)
translation40S ribosomal protein S27Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S27Homo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein S27Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L35Homo sapiens (human)
translation60S ribosomal protein L35Homo sapiens (human)
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)60S ribosomal protein L35Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L27aHomo sapiens (human)
translation60S ribosomal protein L27aHomo sapiens (human)
ribosomal large subunit assembly60S ribosomal protein L5Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L5Homo sapiens (human)
rRNA processing60S ribosomal protein L5Homo sapiens (human)
translation60S ribosomal protein L5Homo sapiens (human)
positive regulation of gene expression60S ribosomal protein L5Homo sapiens (human)
ribosomal large subunit biogenesis60S ribosomal protein L5Homo sapiens (human)
positive regulation of translation60S ribosomal protein L5Homo sapiens (human)
protein stabilization60S ribosomal protein L5Homo sapiens (human)
regulation of signal transduction by p53 class mediator60S ribosomal protein L5Homo sapiens (human)
negative regulation of ubiquitin protein ligase activity60S ribosomal protein L5Homo sapiens (human)
negative regulation of ubiquitin-dependent protein catabolic process60S ribosomal protein L5Homo sapiens (human)
negative regulation of protein neddylation60S ribosomal protein L5Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L21Homo sapiens (human)
translation60S ribosomal protein L21Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L28Homo sapiens (human)
translation60S ribosomal protein L28Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S9Homo sapiens (human)
translation40S ribosomal protein S9Homo sapiens (human)
regulation of translation40S ribosomal protein S9Homo sapiens (human)
positive regulation of cell population proliferation40S ribosomal protein S9Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S9Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S5Homo sapiens (human)
translation40S ribosomal protein S5Homo sapiens (human)
translational initiation40S ribosomal protein S5Homo sapiens (human)
regulation of translational fidelity40S ribosomal protein S5Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S5Homo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein S5Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S10Homo sapiens (human)
translation40S ribosomal protein S10Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L29Homo sapiens (human)
translation60S ribosomal protein L29Homo sapiens (human)
embryo implantation60S ribosomal protein L29Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L34Homo sapiens (human)
translation60S ribosomal protein L34Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L14Homo sapiens (human)
rRNA processing60S ribosomal protein L14Homo sapiens (human)
translation60S ribosomal protein L14Homo sapiens (human)
ribosomal large subunit biogenesis60S ribosomal protein L14Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S20Homo sapiens (human)
translation40S ribosomal protein S20Homo sapiens (human)
positive regulation of signal transduction by p53 class mediator40S ribosomal protein S20Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S3aHomo sapiens (human)
translation40S ribosomal protein S3aHomo sapiens (human)
translational initiation40S ribosomal protein S3aHomo sapiens (human)
cell differentiation40S ribosomal protein S3aHomo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S3aHomo sapiens (human)
negative regulation of apoptotic process40S ribosomal protein S3aHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L26Homo sapiens (human)
rRNA processing60S ribosomal protein L26Homo sapiens (human)
translation60S ribosomal protein L26Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest60S ribosomal protein L26Homo sapiens (human)
cellular response to UV60S ribosomal protein L26Homo sapiens (human)
ribosomal large subunit biogenesis60S ribosomal protein L26Homo sapiens (human)
positive regulation of translation60S ribosomal protein L26Homo sapiens (human)
cellular response to gamma radiation60S ribosomal protein L26Homo sapiens (human)
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator60S ribosomal protein L26Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator60S ribosomal protein L26Homo sapiens (human)
regulation of translation involved in cellular response to UV60S ribosomal protein L26Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L15Homo sapiens (human)
translation60S ribosomal protein L15Homo sapiens (human)
response to ethanol60S ribosomal protein L15Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L27Homo sapiens (human)
rRNA processing60S ribosomal protein L27Homo sapiens (human)
translation60S ribosomal protein L27Homo sapiens (human)
response to aldosterone60S ribosomal protein L27Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L37aHomo sapiens (human)
translation60S ribosomal protein L37aHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L37Homo sapiens (human)
translation60S ribosomal protein L37Homo sapiens (human)
positive regulation of signal transduction by p53 class mediator60S ribosomal protein L37Homo sapiens (human)
neural tube closure40S ribosomal protein S7Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S7Homo sapiens (human)
rRNA processing40S ribosomal protein S7Homo sapiens (human)
translation40S ribosomal protein S7Homo sapiens (human)
positive regulation of gene expression40S ribosomal protein S7Homo sapiens (human)
neural crest cell differentiation40S ribosomal protein S7Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S7Homo sapiens (human)
protein stabilization40S ribosomal protein S7Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator40S ribosomal protein S7Homo sapiens (human)
negative regulation of ubiquitin protein ligase activity40S ribosomal protein S7Homo sapiens (human)
negative regulation of ubiquitin-dependent protein catabolic process40S ribosomal protein S7Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S8Homo sapiens (human)
translation40S ribosomal protein S8Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S8Homo sapiens (human)
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)40S ribosomal protein S8Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S15aHomo sapiens (human)
translation40S ribosomal protein S15aHomo sapiens (human)
positive regulation of cell population proliferation40S ribosomal protein S15aHomo sapiens (human)
response to virus40S ribosomal protein S15aHomo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S15aHomo sapiens (human)
positive regulation of cell cycle40S ribosomal protein S15aHomo sapiens (human)
cytoplasmic translation40S ribosomal protein S16Homo sapiens (human)
rRNA processing40S ribosomal protein S16Homo sapiens (human)
translation40S ribosomal protein S16Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S16Homo sapiens (human)
cellular response to leukemia inhibitory factor40S ribosomal protein S16Homo sapiens (human)
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)40S ribosomal protein S16Homo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein S14Homo sapiens (human)
negative regulation of transcription by RNA polymerase II40S ribosomal protein S14Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S14Homo sapiens (human)
translation40S ribosomal protein S14Homo sapiens (human)
regulation of translation40S ribosomal protein S14Homo sapiens (human)
erythrocyte differentiation40S ribosomal protein S14Homo sapiens (human)
maturation of SSU-rRNA40S ribosomal protein S14Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S14Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S23Homo sapiens (human)
translation40S ribosomal protein S23Homo sapiens (human)
stress granule assembly40S ribosomal protein S23Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S23Homo sapiens (human)
maintenance of translational fidelity40S ribosomal protein S23Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S18Homo sapiens (human)
translation40S ribosomal protein S18Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S29Homo sapiens (human)
translation40S ribosomal protein S29Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S13Homo sapiens (human)
translation40S ribosomal protein S13Homo sapiens (human)
negative regulation of RNA splicing40S ribosomal protein S13Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S13Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S11Homo sapiens (human)
translation40S ribosomal protein S11Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S11Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L7aHomo sapiens (human)
translation60S ribosomal protein L7aHomo sapiens (human)
maturation of LSU-rRNA60S ribosomal protein L7aHomo sapiens (human)
cytoplasmic translation40S ribosomal protein S4, X isoformHomo sapiens (human)
translation40S ribosomal protein S4, X isoformHomo sapiens (human)
positive regulation of cell population proliferation40S ribosomal protein S4, X isoformHomo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S4, X isoformHomo sapiens (human)
positive regulation of translation40S ribosomal protein S4, X isoformHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L23aHomo sapiens (human)
translation60S ribosomal protein L23aHomo sapiens (human)
ribosomal large subunit assembly60S ribosomal protein L23aHomo sapiens (human)
G1/S transition of mitotic cell cycle40S ribosomal protein S6Homo sapiens (human)
placenta development40S ribosomal protein S6Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S6Homo sapiens (human)
T cell proliferation involved in immune response40S ribosomal protein S6Homo sapiens (human)
rRNA processing40S ribosomal protein S6Homo sapiens (human)
translation40S ribosomal protein S6Homo sapiens (human)
activation-induced cell death of T cells40S ribosomal protein S6Homo sapiens (human)
gastrulation40S ribosomal protein S6Homo sapiens (human)
positive regulation of cell population proliferation40S ribosomal protein S6Homo sapiens (human)
mammalian oogenesis stage40S ribosomal protein S6Homo sapiens (human)
TOR signaling40S ribosomal protein S6Homo sapiens (human)
T cell differentiation in thymus40S ribosomal protein S6Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S6Homo sapiens (human)
glucose homeostasis40S ribosomal protein S6Homo sapiens (human)
positive regulation of apoptotic process40S ribosomal protein S6Homo sapiens (human)
negative regulation of apoptotic process40S ribosomal protein S6Homo sapiens (human)
erythrocyte development40S ribosomal protein S6Homo sapiens (human)
G1 to G0 transition60S ribosomal protein L23Homo sapiens (human)
regulation of G1 to G0 transition60S ribosomal protein L23Homo sapiens (human)
negative regulation of transcription by RNA polymerase II60S ribosomal protein L23Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L23Homo sapiens (human)
translation60S ribosomal protein L23Homo sapiens (human)
ribosomal protein import into nucleus60S ribosomal protein L23Homo sapiens (human)
positive regulation of cell population proliferation60S ribosomal protein L23Homo sapiens (human)
positive regulation of gene expression60S ribosomal protein L23Homo sapiens (human)
protein-DNA complex disassembly60S ribosomal protein L23Homo sapiens (human)
protein stabilization60S ribosomal protein L23Homo sapiens (human)
cellular response to actinomycin D60S ribosomal protein L23Homo sapiens (human)
positive regulation of signal transduction by p53 class mediator60S ribosomal protein L23Homo sapiens (human)
negative regulation of ubiquitin protein ligase activity60S ribosomal protein L23Homo sapiens (human)
negative regulation of ubiquitin-dependent protein catabolic process60S ribosomal protein L23Homo sapiens (human)
ribosomal small subunit export from nucleus40S ribosomal protein S15Homo sapiens (human)
osteoblast differentiation40S ribosomal protein S15Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S15Homo sapiens (human)
rRNA processing40S ribosomal protein S15Homo sapiens (human)
translation40S ribosomal protein S15Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S15Homo sapiens (human)
liver regeneration40S ribosomal protein S15Homo sapiens (human)
positive regulation of signal transduction by p53 class mediator40S ribosomal protein S15Homo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein S15Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S24Homo sapiens (human)
rRNA processing40S ribosomal protein S24Homo sapiens (human)
translation40S ribosomal protein S24Homo sapiens (human)
erythrocyte homeostasis40S ribosomal protein S24Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S24Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S25Homo sapiens (human)
rRNA processing40S ribosomal protein S25Homo sapiens (human)
translation40S ribosomal protein S25Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S25Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S26Homo sapiens (human)
translation40S ribosomal protein S26Homo sapiens (human)
negative regulation of RNA splicing40S ribosomal protein S26Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S28Homo sapiens (human)
rRNA processing40S ribosomal protein S28Homo sapiens (human)
translation40S ribosomal protein S28Homo sapiens (human)
ribosome biogenesis40S ribosomal protein S28Homo sapiens (human)
ribosomal small subunit biogenesis40S ribosomal protein S28Homo sapiens (human)
ribosomal small subunit assembly40S ribosomal protein S28Homo sapiens (human)
maturation of SSU-rRNA40S ribosomal protein S28Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S30Homo sapiens (human)
innate immune response in mucosa40S ribosomal protein S30Homo sapiens (human)
translation40S ribosomal protein S30Homo sapiens (human)
antibacterial humoral response40S ribosomal protein S30Homo sapiens (human)
defense response to Gram-positive bacterium40S ribosomal protein S30Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptide40S ribosomal protein S30Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L30Homo sapiens (human)
translation60S ribosomal protein L30Homo sapiens (human)
killing of cells of another organism60S ribosomal protein L30Homo sapiens (human)
defense response to Gram-negative bacterium60S ribosomal protein L30Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptide60S ribosomal protein L30Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L39Homo sapiens (human)
innate immune response in mucosa60S ribosomal protein L39Homo sapiens (human)
translation60S ribosomal protein L39Homo sapiens (human)
antibacterial humoral response60S ribosomal protein L39Homo sapiens (human)
defense response to Gram-positive bacterium60S ribosomal protein L39Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptide60S ribosomal protein L39Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L31Homo sapiens (human)
translation60S ribosomal protein L31Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L10aHomo sapiens (human)
translation60S ribosomal protein L10aHomo sapiens (human)
response to ethanol60S ribosomal protein L10aHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L32Homo sapiens (human)
translation60S ribosomal protein L32Homo sapiens (human)
ribosomal large subunit assembly60S ribosomal protein L11Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L11Homo sapiens (human)
rRNA processing60S ribosomal protein L11Homo sapiens (human)
translation60S ribosomal protein L11Homo sapiens (human)
protein targeting60S ribosomal protein L11Homo sapiens (human)
positive regulation of gene expression60S ribosomal protein L11Homo sapiens (human)
positive regulation of protein binding60S ribosomal protein L11Homo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic process60S ribosomal protein L11Homo sapiens (human)
protein localization to nucleus60S ribosomal protein L11Homo sapiens (human)
ribosomal large subunit biogenesis60S ribosomal protein L11Homo sapiens (human)
protein stabilization60S ribosomal protein L11Homo sapiens (human)
regulation of signal transduction by p53 class mediator60S ribosomal protein L11Homo sapiens (human)
positive regulation of signal transduction by p53 class mediator60S ribosomal protein L11Homo sapiens (human)
negative regulation of ubiquitin protein ligase activity60S ribosomal protein L11Homo sapiens (human)
negative regulation of ubiquitin-dependent protein catabolic process60S ribosomal protein L11Homo sapiens (human)
negative regulation of protein neddylation60S ribosomal protein L11Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L8Homo sapiens (human)
translation60S ribosomal protein L8Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L41Homo sapiens (human)
translation60S ribosomal protein L41Homo sapiens (human)
cytoplasmic translationUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
translationUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
protein ubiquitinationUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
modification-dependent protein catabolic processUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
skeletal system development60S ribosomal protein L38Homo sapiens (human)
ossification60S ribosomal protein L38Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L38Homo sapiens (human)
translation60S ribosomal protein L38Homo sapiens (human)
regulation of translation60S ribosomal protein L38Homo sapiens (human)
sensory perception of sound60S ribosomal protein L38Homo sapiens (human)
90S preribosome assembly60S ribosomal protein L38Homo sapiens (human)
middle ear morphogenesis60S ribosomal protein L38Homo sapiens (human)
axial mesoderm development60S ribosomal protein L38Homo sapiens (human)
protein-RNA complex assembly60S ribosomal protein L38Homo sapiens (human)
cytoplasmic translation40S ribosomal protein S21Homo sapiens (human)
translation40S ribosomal protein S21Homo sapiens (human)
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)40S ribosomal protein S21Homo sapiens (human)
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)40S ribosomal protein S21Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L24Homo sapiens (human)
translation60S ribosomal protein L24Homo sapiens (human)
exit from mitosis60S ribosomal protein L24Homo sapiens (human)
optic nerve development60S ribosomal protein L24Homo sapiens (human)
retinal ganglion cell axon guidance60S ribosomal protein L24Homo sapiens (human)
retina development in camera-type eye60S ribosomal protein L24Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L36aHomo sapiens (human)
translation60S ribosomal protein L36aHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L19Homo sapiens (human)
translation60S ribosomal protein L19Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L18aHomo sapiens (human)
translation60S ribosomal protein L18aHomo sapiens (human)
cytoplasmic translation60S ribosomal protein L6Homo sapiens (human)
regulation of DNA-templated transcription60S ribosomal protein L6Homo sapiens (human)
translation60S ribosomal protein L6Homo sapiens (human)
ribosomal large subunit assembly60S ribosomal protein L6Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L18Homo sapiens (human)
translation60S ribosomal protein L18Homo sapiens (human)
cytoplasmic translation60S ribosomal protein L36Homo sapiens (human)
translation60S ribosomal protein L36Homo sapiens (human)
tetrahydrobiopterin biosynthetic processDihydrofolate reductaseHomo sapiens (human)
one-carbon metabolic processDihydrofolate reductaseHomo sapiens (human)
negative regulation of translationDihydrofolate reductaseHomo sapiens (human)
axon regenerationDihydrofolate reductaseHomo sapiens (human)
response to methotrexateDihydrofolate reductaseHomo sapiens (human)
dihydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate biosynthetic processDihydrofolate reductaseHomo sapiens (human)
folic acid metabolic processDihydrofolate reductaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityDihydrofolate reductaseHomo sapiens (human)
regulation of removal of superoxide radicalsDihydrofolate reductaseHomo sapiens (human)
one-carbon metabolic processDihydrofolate reductase Bos taurus (cattle)
response to methotrexateDihydrofolate reductase Bos taurus (cattle)
tetrahydrofolate metabolic processDihydrofolate reductase Bos taurus (cattle)
tetrahydrofolate biosynthetic processDihydrofolate reductase Bos taurus (cattle)
cytoplasmic translation30S ribosomal protein S6Escherichia coli K-12
translation30S ribosomal protein S6Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S7Escherichia coli K-12
negative regulation of translation30S ribosomal protein S7Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S7Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S7Escherichia coli K-12
translation30S ribosomal protein S7Escherichia coli K-12
negative regulation of translation30S ribosomal protein S7Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L15Escherichia coli K-12
translation50S ribosomal protein L15Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L10Escherichia coli K-12
translation50S ribosomal protein L10Escherichia coli K-12
regulation of translation50S ribosomal protein L10Escherichia coli K-12
negative regulation of translation50S ribosomal protein L10Escherichia coli K-12
translation50S ribosomal protein L11Escherichia coli K-12
translational termination50S ribosomal protein L11Escherichia coli K-12
stringent response50S ribosomal protein L11Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L11Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L11Escherichia coli K-12
translation50S ribosomal protein L11Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L7/L12Escherichia coli K-12
translation50S ribosomal protein L7/L12Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L19Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L19Escherichia coli K-12
translation50S ribosomal protein L19Escherichia coli K-12
negative regulation of translational initiation50S ribosomal protein L1Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L1Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L1Escherichia coli K-12
translation50S ribosomal protein L1Escherichia coli K-12
regulation of translation50S ribosomal protein L1Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L20Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L20Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L20Escherichia coli K-12
translation50S ribosomal protein L20Escherichia coli K-12
negative regulation of translation50S ribosomal protein L20Escherichia coli K-12
cytosolic ribosome assembly50S ribosomal protein L27Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L27Escherichia coli K-12
regulation of cell growth50S ribosomal protein L27Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L27Escherichia coli K-12
translation50S ribosomal protein L27Escherichia coli K-12
positive regulation of ribosome biogenesis50S ribosomal protein L27Escherichia coli K-12
assembly of large subunit precursor of preribosome50S ribosomal protein L27Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L28Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L28Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L28Escherichia coli K-12
translation50S ribosomal protein L28Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L29Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L29Escherichia coli K-12
translation50S ribosomal protein L29Escherichia coli K-12
translation50S ribosomal protein L31Escherichia coli K-12
translational initiation50S ribosomal protein L31Escherichia coli K-12
negative regulation of cytoplasmic translational initiation50S ribosomal protein L31Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L31Escherichia coli K-12
translation50S ribosomal protein L31Escherichia coli K-12
cellular response to zinc ion starvation50S ribosomal protein L31 type BEscherichia coli K-12
cytoplasmic translation50S ribosomal protein L31 type BEscherichia coli K-12
translation50S ribosomal protein L31 type BEscherichia coli K-12
response to reactive oxygen species50S ribosomal protein L32Escherichia coli K-12
response to radiation50S ribosomal protein L32Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L32Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L32Escherichia coli K-12
translation50S ribosomal protein L32Escherichia coli K-12
response to antibiotic50S ribosomal protein L33Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L33Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L33Escherichia coli K-12
translation50S ribosomal protein L33Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L34Escherichia coli K-12
translation50S ribosomal protein L34Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L35Escherichia coli K-12
translation50S ribosomal protein L35Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L36Escherichia coli K-12
translation50S ribosomal protein L36Escherichia coli K-12
transcription antitermination30S ribosomal protein S10Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S10Escherichia coli K-12
translation30S ribosomal protein S10Escherichia coli K-12
transcription antitermination30S ribosomal protein S10Escherichia coli K-12
regulation of DNA-templated transcription elongation30S ribosomal protein S10Escherichia coli K-12
ribosome biogenesis30S ribosomal protein S10Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S11Escherichia coli K-12
translation30S ribosomal protein S11Escherichia coli K-12
Group I intron splicing30S ribosomal protein S12Escherichia coli K-12
positive regulation of RNA splicing30S ribosomal protein S12Escherichia coli K-12
RNA folding30S ribosomal protein S12Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S12Escherichia coli K-12
translation30S ribosomal protein S12Escherichia coli K-12
response to antibiotic30S ribosomal protein S12Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S12Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S13Escherichia coli K-12
translation30S ribosomal protein S13Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S16Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S16Escherichia coli K-12
DNA metabolic process30S ribosomal protein S16Escherichia coli K-12
translation30S ribosomal protein S16Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S18Escherichia coli K-12
translation30S ribosomal protein S18Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S19Escherichia coli K-12
translation30S ribosomal protein S19Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S19Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S20Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S20Escherichia coli K-12
translation30S ribosomal protein S20Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S2Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S2Escherichia coli K-12
translation30S ribosomal protein S2Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S3Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S3Escherichia coli K-12
translation30S ribosomal protein S3Escherichia coli K-12
transcription antitermination30S ribosomal protein S4Escherichia coli K-12
negative regulation of translational initiation30S ribosomal protein S4Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S4Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S4Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S4Escherichia coli K-12
DNA-templated transcription termination30S ribosomal protein S4Escherichia coli K-12
translation30S ribosomal protein S4Escherichia coli K-12
regulation of translation30S ribosomal protein S4Escherichia coli K-12
transcription antitermination30S ribosomal protein S4Escherichia coli K-12
ribosome biogenesis30S ribosomal protein S4Escherichia coli K-12
response to antibiotic30S ribosomal protein S4Escherichia coli K-12
ribosomal small subunit biogenesis30S ribosomal protein S4Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S5Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S5Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S5Escherichia coli K-12
translation30S ribosomal protein S5Escherichia coli K-12
response to antibiotic30S ribosomal protein S5Escherichia coli K-12
regulation of mRNA stability30S ribosomal protein S8Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S8Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S8Escherichia coli K-12
translation30S ribosomal protein S8Escherichia coli K-12
regulation of translation30S ribosomal protein S8Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S9Escherichia coli K-12
translation30S ribosomal protein S9Escherichia coli K-12
negative regulation of translation50S ribosomal protein L13Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L13Escherichia coli K-12
translation50S ribosomal protein L13Escherichia coli K-12
negative regulation of translation50S ribosomal protein L13Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L14Escherichia coli K-12
translation50S ribosomal protein L14Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L16Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L16Escherichia coli K-12
translation50S ribosomal protein L16Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L23Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L23Escherichia coli K-12
translation50S ribosomal protein L23Escherichia coli K-12
translation30S ribosomal protein S15Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S15Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S15Escherichia coli K-12
translation30S ribosomal protein S15Escherichia coli K-12
regulation of translation30S ribosomal protein S15Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L17Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L17Escherichia coli K-12
translation50S ribosomal protein L17Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L21Escherichia coli K-12
translation50S ribosomal protein L21Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L30Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L30Escherichia coli K-12
translation50S ribosomal protein L30Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L6Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L6Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L6Escherichia coli K-12
translation50S ribosomal protein L6Escherichia coli K-12
response to antibiotic50S ribosomal protein L6Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S14Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S14Escherichia coli K-12
translation30S ribosomal protein S14Escherichia coli K-12
response to antibiotic30S ribosomal protein S17Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S17Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S17Escherichia coli K-12
translation30S ribosomal protein S17Escherichia coli K-12
response to antibiotic30S ribosomal protein S17Escherichia coli K-12
translation30S ribosomal protein S1Escherichia coli K-12
RNA secondary structure unwinding30S ribosomal protein S1Escherichia coli K-12
negative regulation of cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
positive regulation of cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S1Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
translation30S ribosomal protein S1Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L18Escherichia coli K-12
translation50S ribosomal protein L18Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L2Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L2Escherichia coli K-12
translation50S ribosomal protein L2Escherichia coli K-12
negative regulation of DNA-templated DNA replication initiation50S ribosomal protein L2Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L3Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L3Escherichia coli K-12
translation50S ribosomal protein L3Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L24Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L24Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L24Escherichia coli K-12
translation50S ribosomal protein L24Escherichia coli K-12
transcriptional attenuation50S ribosomal protein L4Escherichia coli K-12
negative regulation of cytoplasmic translation50S ribosomal protein L4Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L4Escherichia coli K-12
DNA-templated transcription termination50S ribosomal protein L4Escherichia coli K-12
translation50S ribosomal protein L4Escherichia coli K-12
regulation of translation50S ribosomal protein L4Escherichia coli K-12
negative regulation of translation50S ribosomal protein L4Escherichia coli K-12
ribosome assembly50S ribosomal protein L4Escherichia coli K-12
negative regulation of DNA-templated transcription50S ribosomal protein L4Escherichia coli K-12
response to antibiotic50S ribosomal protein L4Escherichia coli K-12
translation50S ribosomal protein L22Escherichia coli K-12
cytosolic ribosome assembly50S ribosomal protein L22Escherichia coli K-12
assembly of large subunit precursor of preribosome50S ribosomal protein L22Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L22Escherichia coli K-12
translation50S ribosomal protein L22Escherichia coli K-12
ribosome assembly50S ribosomal protein L22Escherichia coli K-12
response to antibiotic50S ribosomal protein L22Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L5Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L5Escherichia coli K-12
translation50S ribosomal protein L5Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S21Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S21Escherichia coli K-12
translation30S ribosomal protein S21Escherichia coli K-12
translation50S ribosomal protein L25Escherichia coli K-12
response to radiation50S ribosomal protein L25Escherichia coli K-12
negative regulation of translation50S ribosomal protein L25Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L25Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L25Escherichia coli K-12
translation50S ribosomal protein L25Escherichia coli K-12
translation50S ribosomal protein L36 2Escherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (72)

Processvia Protein(s)Taxonomy
structural constituent of ribosome60S acidic ribosomal protein P1Homo sapiens (human)
protein binding60S acidic ribosomal protein P1Homo sapiens (human)
ribonucleoprotein complex binding60S acidic ribosomal protein P1Homo sapiens (human)
protein kinase activator activity60S acidic ribosomal protein P1Homo sapiens (human)
RNA binding60S acidic ribosomal protein P0Homo sapiens (human)
structural constituent of ribosome60S acidic ribosomal protein P0Homo sapiens (human)
protein binding60S acidic ribosomal protein P0Homo sapiens (human)
large ribosomal subunit rRNA binding60S acidic ribosomal protein P0Homo sapiens (human)
RNA binding40S ribosomal protein S17Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S17Homo sapiens (human)
virus receptor activity40S ribosomal protein SAHomo sapiens (human)
DNA binding40S ribosomal protein SAHomo sapiens (human)
RNA binding40S ribosomal protein SAHomo sapiens (human)
structural constituent of ribosome40S ribosomal protein SAHomo sapiens (human)
laminin receptor activity40S ribosomal protein SAHomo sapiens (human)
protein binding40S ribosomal protein SAHomo sapiens (human)
ribosome binding40S ribosomal protein SAHomo sapiens (human)
laminin binding40S ribosomal protein SAHomo sapiens (human)
RNA binding40S ribosomal protein S2Homo sapiens (human)
mRNA binding40S ribosomal protein S2Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S2Homo sapiens (human)
protein binding40S ribosomal protein S2Homo sapiens (human)
fibroblast growth factor binding40S ribosomal protein S2Homo sapiens (human)
enzyme binding40S ribosomal protein S2Homo sapiens (human)
cadherin binding40S ribosomal protein S2Homo sapiens (human)
tRNA binding60S ribosomal protein L35aHomo sapiens (human)
RNA binding60S ribosomal protein L35aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L35aHomo sapiens (human)
protein binding60S ribosomal protein L35aHomo sapiens (human)
DNA binding60S ribosomal protein L7Homo sapiens (human)
RNA binding60S ribosomal protein L7Homo sapiens (human)
mRNA binding60S ribosomal protein L7Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L7Homo sapiens (human)
protein binding60S ribosomal protein L7Homo sapiens (human)
identical protein binding60S ribosomal protein L7Homo sapiens (human)
RNA binding60S ribosomal protein L17Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L17Homo sapiens (human)
protein binding60S ribosomal protein L17Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
rRNA binding40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
RNA binding40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
DNA N-glycosylase activity40S ribosomal protein S3Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA binding40S ribosomal protein S3Homo sapiens (human)
DNA binding40S ribosomal protein S3Homo sapiens (human)
damaged DNA binding40S ribosomal protein S3Homo sapiens (human)
RNA binding40S ribosomal protein S3Homo sapiens (human)
mRNA binding40S ribosomal protein S3Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S3Homo sapiens (human)
DNA-(apurinic or apyrimidinic site) endonuclease activity40S ribosomal protein S3Homo sapiens (human)
DNA endonuclease activity40S ribosomal protein S3Homo sapiens (human)
protein binding40S ribosomal protein S3Homo sapiens (human)
microtubule binding40S ribosomal protein S3Homo sapiens (human)
tubulin binding40S ribosomal protein S3Homo sapiens (human)
enzyme binding40S ribosomal protein S3Homo sapiens (human)
kinase binding40S ribosomal protein S3Homo sapiens (human)
protein kinase binding40S ribosomal protein S3Homo sapiens (human)
Hsp70 protein binding40S ribosomal protein S3Homo sapiens (human)
oxidized purine DNA binding40S ribosomal protein S3Homo sapiens (human)
oxidized pyrimidine DNA binding40S ribosomal protein S3Homo sapiens (human)
ubiquitin-like protein conjugating enzyme binding40S ribosomal protein S3Homo sapiens (human)
protein-containing complex binding40S ribosomal protein S3Homo sapiens (human)
protein kinase A binding40S ribosomal protein S3Homo sapiens (human)
iron-sulfur cluster binding40S ribosomal protein S3Homo sapiens (human)
Hsp90 protein binding40S ribosomal protein S3Homo sapiens (human)
small ribosomal subunit rRNA binding40S ribosomal protein S3Homo sapiens (human)
supercoiled DNA binding40S ribosomal protein S3Homo sapiens (human)
class I DNA-(apurinic or apyrimidinic site) endonuclease activity40S ribosomal protein S3Homo sapiens (human)
DNA-binding transcription factor binding40S ribosomal protein S3Homo sapiens (human)
RNA binding40S ribosomal protein S12Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S12Homo sapiens (human)
protein binding40S ribosomal protein S12Homo sapiens (human)
RNA binding60S ribosomal protein L13Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L13Homo sapiens (human)
protein binding60S ribosomal protein L13Homo sapiens (human)
RNA binding60S ribosomal protein L10Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L10Homo sapiens (human)
protein binding60S ribosomal protein L10Homo sapiens (human)
translation regulator activity60S ribosomal protein L10Homo sapiens (human)
RNA binding60S ribosomal protein L12Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L12Homo sapiens (human)
protein binding60S ribosomal protein L12Homo sapiens (human)
large ribosomal subunit rRNA binding60S ribosomal protein L12Homo sapiens (human)
RNA binding60S ribosomal protein L9Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L9Homo sapiens (human)
protein binding60S ribosomal protein L9Homo sapiens (human)
rRNA binding60S ribosomal protein L9Homo sapiens (human)
RNA binding60S ribosomal protein L22Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L22Homo sapiens (human)
protein binding60S ribosomal protein L22Homo sapiens (human)
heparin binding60S ribosomal protein L22Homo sapiens (human)
identical protein binding60S ribosomal protein L22Homo sapiens (human)
RNA binding60S ribosomal protein L4Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L4Homo sapiens (human)
protein binding60S ribosomal protein L4Homo sapiens (human)
RNA binding40S ribosomal protein S19Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S19Homo sapiens (human)
protein binding40S ribosomal protein S19Homo sapiens (human)
fibroblast growth factor binding40S ribosomal protein S19Homo sapiens (human)
protein kinase binding40S ribosomal protein S19Homo sapiens (human)
identical protein binding40S ribosomal protein S19Homo sapiens (human)
RNA binding60S ribosomal protein L3Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L3Homo sapiens (human)
protein binding60S ribosomal protein L3Homo sapiens (human)
RNA binding60S ribosomal protein L13aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L13aHomo sapiens (human)
mRNA binding60S ribosomal protein L13aHomo sapiens (human)
DNA binding40S ribosomal protein S27Homo sapiens (human)
RNA binding40S ribosomal protein S27Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S27Homo sapiens (human)
protein binding40S ribosomal protein S27Homo sapiens (human)
zinc ion binding40S ribosomal protein S27Homo sapiens (human)
RNA binding60S ribosomal protein L35Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L35Homo sapiens (human)
mRNA binding60S ribosomal protein L35Homo sapiens (human)
RNA binding60S ribosomal protein L27aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L27aHomo sapiens (human)
protein binding60S ribosomal protein L27aHomo sapiens (human)
RNA binding60S ribosomal protein L5Homo sapiens (human)
mRNA 3'-UTR binding60S ribosomal protein L5Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L5Homo sapiens (human)
protein binding60S ribosomal protein L5Homo sapiens (human)
5S rRNA binding60S ribosomal protein L5Homo sapiens (human)
ubiquitin protein ligase binding60S ribosomal protein L5Homo sapiens (human)
mRNA 5'-UTR binding60S ribosomal protein L5Homo sapiens (human)
ubiquitin ligase inhibitor activity60S ribosomal protein L5Homo sapiens (human)
RNA binding60S ribosomal protein L21Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L21Homo sapiens (human)
protein binding60S ribosomal protein L21Homo sapiens (human)
RNA binding60S ribosomal protein L28Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L28Homo sapiens (human)
protein binding60S ribosomal protein L28Homo sapiens (human)
RNA binding40S ribosomal protein S9Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S9Homo sapiens (human)
protein binding40S ribosomal protein S9Homo sapiens (human)
translation regulator activity40S ribosomal protein S9Homo sapiens (human)
rRNA binding40S ribosomal protein S9Homo sapiens (human)
RNA binding40S ribosomal protein S5Homo sapiens (human)
mRNA binding40S ribosomal protein S5Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S5Homo sapiens (human)
protein binding40S ribosomal protein S5Homo sapiens (human)
rRNA binding40S ribosomal protein S5Homo sapiens (human)
RNA binding40S ribosomal protein S10Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S10Homo sapiens (human)
protein binding40S ribosomal protein S10Homo sapiens (human)
RNA binding60S ribosomal protein L29Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L29Homo sapiens (human)
heparin binding60S ribosomal protein L29Homo sapiens (human)
cadherin binding60S ribosomal protein L29Homo sapiens (human)
RNA binding60S ribosomal protein L34Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L34Homo sapiens (human)
protein binding60S ribosomal protein L34Homo sapiens (human)
cadherin binding60S ribosomal protein L34Homo sapiens (human)
RNA binding60S ribosomal protein L14Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L14Homo sapiens (human)
protein binding60S ribosomal protein L14Homo sapiens (human)
cadherin binding60S ribosomal protein L14Homo sapiens (human)
RNA binding40S ribosomal protein S20Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S20Homo sapiens (human)
protein binding40S ribosomal protein S20Homo sapiens (human)
MDM2/MDM4 family protein binding40S ribosomal protein S20Homo sapiens (human)
ubiquitin ligase inhibitor activity40S ribosomal protein S20Homo sapiens (human)
RNA binding40S ribosomal protein S3aHomo sapiens (human)
structural constituent of ribosome40S ribosomal protein S3aHomo sapiens (human)
protein binding40S ribosomal protein S3aHomo sapiens (human)
mRNA 5'-UTR binding40S ribosomal protein S3aHomo sapiens (human)
RNA binding60S ribosomal protein L26Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L26Homo sapiens (human)
protein binding60S ribosomal protein L26Homo sapiens (human)
mRNA 5'-UTR binding60S ribosomal protein L26Homo sapiens (human)
RNA binding60S ribosomal protein L15Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L15Homo sapiens (human)
protein binding60S ribosomal protein L15Homo sapiens (human)
cadherin binding60S ribosomal protein L15Homo sapiens (human)
RNA binding60S ribosomal protein L27Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L27Homo sapiens (human)
protein binding60S ribosomal protein L27Homo sapiens (human)
RNA binding60S ribosomal protein L37aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L37aHomo sapiens (human)
protein binding60S ribosomal protein L37aHomo sapiens (human)
metal ion binding60S ribosomal protein L37aHomo sapiens (human)
RNA binding60S ribosomal protein L37Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L37Homo sapiens (human)
rRNA binding60S ribosomal protein L37Homo sapiens (human)
metal ion binding60S ribosomal protein L37Homo sapiens (human)
MDM2/MDM4 family protein binding60S ribosomal protein L37Homo sapiens (human)
ubiquitin ligase inhibitor activity60S ribosomal protein L37Homo sapiens (human)
RNA binding40S ribosomal protein S7Homo sapiens (human)
mRNA 3'-UTR binding40S ribosomal protein S7Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S7Homo sapiens (human)
protein binding40S ribosomal protein S7Homo sapiens (human)
protein kinase binding40S ribosomal protein S7Homo sapiens (human)
mRNA 5'-UTR binding40S ribosomal protein S7Homo sapiens (human)
ubiquitin ligase inhibitor activity40S ribosomal protein S7Homo sapiens (human)
RNA binding40S ribosomal protein S8Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S8Homo sapiens (human)
protein binding40S ribosomal protein S8Homo sapiens (human)
RNA binding40S ribosomal protein S15aHomo sapiens (human)
structural constituent of ribosome40S ribosomal protein S15aHomo sapiens (human)
protein binding40S ribosomal protein S15aHomo sapiens (human)
RNA binding40S ribosomal protein S16Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S16Homo sapiens (human)
protein binding40S ribosomal protein S16Homo sapiens (human)
RNA binding40S ribosomal protein S14Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S14Homo sapiens (human)
protein binding40S ribosomal protein S14Homo sapiens (human)
translation regulator activity40S ribosomal protein S14Homo sapiens (human)
mRNA 5'-UTR binding40S ribosomal protein S14Homo sapiens (human)
RNA binding40S ribosomal protein S23Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S23Homo sapiens (human)
protein binding40S ribosomal protein S23Homo sapiens (human)
RNA binding40S ribosomal protein S18Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S18Homo sapiens (human)
protein binding40S ribosomal protein S18Homo sapiens (human)
rRNA binding40S ribosomal protein S18Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S29Homo sapiens (human)
zinc ion binding40S ribosomal protein S29Homo sapiens (human)
RNA binding40S ribosomal protein S13Homo sapiens (human)
mRNA binding40S ribosomal protein S13Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S13Homo sapiens (human)
protein binding40S ribosomal protein S13Homo sapiens (human)
mRNA 5'-UTR binding40S ribosomal protein S13Homo sapiens (human)
small ribosomal subunit rRNA binding40S ribosomal protein S13Homo sapiens (human)
RNA binding40S ribosomal protein S11Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S11Homo sapiens (human)
protein binding40S ribosomal protein S11Homo sapiens (human)
rRNA binding40S ribosomal protein S11Homo sapiens (human)
RNA binding60S ribosomal protein L7aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L7aHomo sapiens (human)
protein binding60S ribosomal protein L7aHomo sapiens (human)
cadherin binding60S ribosomal protein L7aHomo sapiens (human)
RNA binding40S ribosomal protein S4, X isoformHomo sapiens (human)
structural constituent of ribosome40S ribosomal protein S4, X isoformHomo sapiens (human)
protein binding40S ribosomal protein S4, X isoformHomo sapiens (human)
rRNA binding40S ribosomal protein S4, X isoformHomo sapiens (human)
RNA binding60S ribosomal protein L23aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L23aHomo sapiens (human)
protein binding60S ribosomal protein L23aHomo sapiens (human)
rRNA binding60S ribosomal protein L23aHomo sapiens (human)
cadherin binding60S ribosomal protein L23aHomo sapiens (human)
TORC2 complex binding60S ribosomal protein L23aHomo sapiens (human)
RNA binding40S ribosomal protein S6Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S6Homo sapiens (human)
protein binding40S ribosomal protein S6Homo sapiens (human)
protein kinase binding40S ribosomal protein S6Homo sapiens (human)
transcription coactivator binding60S ribosomal protein L23Homo sapiens (human)
RNA binding60S ribosomal protein L23Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L23Homo sapiens (human)
protein binding60S ribosomal protein L23Homo sapiens (human)
ubiquitin protein ligase binding60S ribosomal protein L23Homo sapiens (human)
ubiquitin ligase inhibitor activity60S ribosomal protein L23Homo sapiens (human)
large ribosomal subunit rRNA binding60S ribosomal protein L23Homo sapiens (human)
DNA binding40S ribosomal protein S15Homo sapiens (human)
RNA binding40S ribosomal protein S15Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S15Homo sapiens (human)
protein binding40S ribosomal protein S15Homo sapiens (human)
MDM2/MDM4 family protein binding40S ribosomal protein S15Homo sapiens (human)
ubiquitin ligase inhibitor activity40S ribosomal protein S15Homo sapiens (human)
RNA binding40S ribosomal protein S24Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S24Homo sapiens (human)
translation initiation factor binding40S ribosomal protein S24Homo sapiens (human)
RNA binding40S ribosomal protein S25Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S25Homo sapiens (human)
protein binding40S ribosomal protein S25Homo sapiens (human)
RNA binding40S ribosomal protein S26Homo sapiens (human)
mRNA binding40S ribosomal protein S26Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S26Homo sapiens (human)
protein binding40S ribosomal protein S26Homo sapiens (human)
cadherin binding40S ribosomal protein S26Homo sapiens (human)
RNA binding40S ribosomal protein S28Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S28Homo sapiens (human)
protein binding40S ribosomal protein S28Homo sapiens (human)
RNA binding40S ribosomal protein S30Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S30Homo sapiens (human)
protein binding40S ribosomal protein S30Homo sapiens (human)
RNA binding60S ribosomal protein L30Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L30Homo sapiens (human)
protein binding60S ribosomal protein L30Homo sapiens (human)
RNA binding60S ribosomal protein L39Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L39Homo sapiens (human)
RNA binding60S ribosomal protein L31Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L31Homo sapiens (human)
protein binding60S ribosomal protein L31Homo sapiens (human)
RNA binding60S ribosomal protein L10aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L10aHomo sapiens (human)
protein binding60S ribosomal protein L10aHomo sapiens (human)
RNA binding60S ribosomal protein L32Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L32Homo sapiens (human)
RNA binding60S ribosomal protein L11Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L11Homo sapiens (human)
protein binding60S ribosomal protein L11Homo sapiens (human)
5S rRNA binding60S ribosomal protein L11Homo sapiens (human)
ubiquitin protein ligase binding60S ribosomal protein L11Homo sapiens (human)
ubiquitin ligase inhibitor activity60S ribosomal protein L11Homo sapiens (human)
RNA binding60S ribosomal protein L8Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L8Homo sapiens (human)
protein binding60S ribosomal protein L8Homo sapiens (human)
rRNA binding60S ribosomal protein L8Homo sapiens (human)
RNA binding60S ribosomal protein L41Homo sapiens (human)
mRNA 3'-UTR binding60S ribosomal protein L41Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L41Homo sapiens (human)
protein binding60S ribosomal protein L41Homo sapiens (human)
mRNA 5'-UTR binding60S ribosomal protein L41Homo sapiens (human)
RNA bindingUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
structural constituent of ribosomeUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
protein bindingUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
metal ion bindingUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
protein tag activityUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
ubiquitin protein ligase bindingUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
RNA binding60S ribosomal protein L38Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L38Homo sapiens (human)
protein binding60S ribosomal protein L38Homo sapiens (human)
RNA binding40S ribosomal protein S21Homo sapiens (human)
structural constituent of ribosome40S ribosomal protein S21Homo sapiens (human)
protein binding40S ribosomal protein S21Homo sapiens (human)
RNA binding60S ribosomal protein L24Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L24Homo sapiens (human)
protein binding60S ribosomal protein L24Homo sapiens (human)
cadherin binding60S ribosomal protein L24Homo sapiens (human)
mRNA binding60S ribosomal protein L24Homo sapiens (human)
RNA binding60S ribosomal protein L36aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L36aHomo sapiens (human)
protein binding60S ribosomal protein L36aHomo sapiens (human)
RNA binding60S ribosomal protein L19Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L19Homo sapiens (human)
protein binding60S ribosomal protein L19Homo sapiens (human)
RNA binding60S ribosomal protein L18aHomo sapiens (human)
structural constituent of ribosome60S ribosomal protein L18aHomo sapiens (human)
protein binding60S ribosomal protein L18aHomo sapiens (human)
DNA binding60S ribosomal protein L6Homo sapiens (human)
RNA binding60S ribosomal protein L6Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L6Homo sapiens (human)
protein binding60S ribosomal protein L6Homo sapiens (human)
cadherin binding60S ribosomal protein L6Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L18Homo sapiens (human)
protein binding60S ribosomal protein L18Homo sapiens (human)
RNA binding60S ribosomal protein L18Homo sapiens (human)
RNA binding60S ribosomal protein L36Homo sapiens (human)
structural constituent of ribosome60S ribosomal protein L36Homo sapiens (human)
mRNA regulatory element binding translation repressor activityDihydrofolate reductaseHomo sapiens (human)
mRNA bindingDihydrofolate reductaseHomo sapiens (human)
dihydrofolate reductase activityDihydrofolate reductaseHomo sapiens (human)
folic acid bindingDihydrofolate reductaseHomo sapiens (human)
NADPH bindingDihydrofolate reductaseHomo sapiens (human)
sequence-specific mRNA bindingDihydrofolate reductaseHomo sapiens (human)
NADP bindingDihydrofolate reductaseHomo sapiens (human)
mRNA bindingDihydrofolate reductase Bos taurus (cattle)
dihydrofolate reductase activityDihydrofolate reductase Bos taurus (cattle)
structural constituent of ribosome30S ribosomal protein S6Escherichia coli K-12
protein binding30S ribosomal protein S6Escherichia coli K-12
rRNA binding30S ribosomal protein S6Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S6Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S6Escherichia coli K-12
tRNA binding30S ribosomal protein S7Escherichia coli K-12
RNA binding30S ribosomal protein S7Escherichia coli K-12
mRNA binding30S ribosomal protein S7Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S7Escherichia coli K-12
protein binding30S ribosomal protein S7Escherichia coli K-12
rRNA binding30S ribosomal protein S7Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L15Escherichia coli K-12
protein binding50S ribosomal protein L15Escherichia coli K-12
rRNA binding50S ribosomal protein L15Escherichia coli K-12
GTPase activity50S ribosomal protein L10Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L10Escherichia coli K-12
protein binding50S ribosomal protein L10Escherichia coli K-12
rRNA binding50S ribosomal protein L10Escherichia coli K-12
ribosome binding50S ribosomal protein L10Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L10Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L11Escherichia coli K-12
protein binding50S ribosomal protein L11Escherichia coli K-12
rRNA binding50S ribosomal protein L11Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L11Escherichia coli K-12
GTPase activity50S ribosomal protein L7/L12Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L7/L12Escherichia coli K-12
protein binding50S ribosomal protein L7/L12Escherichia coli K-12
protein homodimerization activity50S ribosomal protein L7/L12Escherichia coli K-12
ribosome binding50S ribosomal protein L7/L12Escherichia coli K-12
mRNA binding50S ribosomal protein L7/L12Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L19Escherichia coli K-12
rRNA binding50S ribosomal protein L19Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L19Escherichia coli K-12
tRNA binding50S ribosomal protein L1Escherichia coli K-12
RNA binding50S ribosomal protein L1Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L1Escherichia coli K-12
protein binding50S ribosomal protein L1Escherichia coli K-12
rRNA binding50S ribosomal protein L1Escherichia coli K-12
mRNA regulatory element binding translation repressor activity50S ribosomal protein L20Escherichia coli K-12
mRNA binding50S ribosomal protein L20Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L20Escherichia coli K-12
rRNA binding50S ribosomal protein L20Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L20Escherichia coli K-12
tRNA binding50S ribosomal protein L27Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L27Escherichia coli K-12
protein binding50S ribosomal protein L27Escherichia coli K-12
rRNA binding50S ribosomal protein L27Escherichia coli K-12
ribosome binding50S ribosomal protein L27Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L28Escherichia coli K-12
protein binding50S ribosomal protein L28Escherichia coli K-12
rRNA binding50S ribosomal protein L28Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L29Escherichia coli K-12
rRNA binding50S ribosomal protein L29Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L31Escherichia coli K-12
zinc ion binding50S ribosomal protein L31Escherichia coli K-12
rRNA binding50S ribosomal protein L31Escherichia coli K-12
metal ion binding50S ribosomal protein L31Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L31 type BEscherichia coli K-12
structural constituent of ribosome50S ribosomal protein L32Escherichia coli K-12
protein binding50S ribosomal protein L32Escherichia coli K-12
tRNA binding50S ribosomal protein L33Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L33Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L34Escherichia coli K-12
protein binding50S ribosomal protein L34Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L35Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L36Escherichia coli K-12
tRNA binding30S ribosomal protein S10Escherichia coli K-12
transcription antitermination factor activity, RNA binding30S ribosomal protein S10Escherichia coli K-12
RNA binding30S ribosomal protein S10Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S10Escherichia coli K-12
protein binding30S ribosomal protein S10Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S11Escherichia coli K-12
protein binding30S ribosomal protein S11Escherichia coli K-12
rRNA binding30S ribosomal protein S11Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S11Escherichia coli K-12
tRNA binding30S ribosomal protein S12Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S12Escherichia coli K-12
protein binding30S ribosomal protein S12Escherichia coli K-12
rRNA binding30S ribosomal protein S12Escherichia coli K-12
misfolded RNA binding30S ribosomal protein S12Escherichia coli K-12
tRNA binding30S ribosomal protein S13Escherichia coli K-12
RNA binding30S ribosomal protein S13Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S13Escherichia coli K-12
protein binding30S ribosomal protein S13Escherichia coli K-12
rRNA binding30S ribosomal protein S13Escherichia coli K-12
four-way junction DNA binding30S ribosomal protein S16Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S16Escherichia coli K-12
endonuclease activity30S ribosomal protein S16Escherichia coli K-12
DNA endonuclease activity30S ribosomal protein S16Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S18Escherichia coli K-12
protein binding30S ribosomal protein S18Escherichia coli K-12
rRNA binding30S ribosomal protein S18Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S18Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S18Escherichia coli K-12
tRNA binding30S ribosomal protein S19Escherichia coli K-12
RNA binding30S ribosomal protein S19Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S19Escherichia coli K-12
rRNA binding30S ribosomal protein S19Escherichia coli K-12
RNA binding30S ribosomal protein S20Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S20Escherichia coli K-12
ornithine decarboxylase inhibitor activity30S ribosomal protein S20Escherichia coli K-12
rRNA binding30S ribosomal protein S20Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S20Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S2Escherichia coli K-12
protein binding30S ribosomal protein S2Escherichia coli K-12
zinc ion binding30S ribosomal protein S2Escherichia coli K-12
RNA binding30S ribosomal protein S3Escherichia coli K-12
mRNA binding30S ribosomal protein S3Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S3Escherichia coli K-12
rRNA binding30S ribosomal protein S3Escherichia coli K-12
mRNA regulatory element binding translation repressor activity30S ribosomal protein S4Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S4Escherichia coli K-12
protein binding30S ribosomal protein S4Escherichia coli K-12
rRNA binding30S ribosomal protein S4Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S4Escherichia coli K-12
RNA binding30S ribosomal protein S5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S5Escherichia coli K-12
protein binding30S ribosomal protein S5Escherichia coli K-12
rRNA binding30S ribosomal protein S5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S8Escherichia coli K-12
rRNA binding30S ribosomal protein S8Escherichia coli K-12
tRNA binding30S ribosomal protein S9Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S9Escherichia coli K-12
RNA binding30S ribosomal protein S9Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L13Escherichia coli K-12
zinc ion binding50S ribosomal protein L13Escherichia coli K-12
mRNA 5'-UTR binding50S ribosomal protein L13Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L13Escherichia coli K-12
mRNA binding50S ribosomal protein L13Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L14Escherichia coli K-12
protein binding50S ribosomal protein L14Escherichia coli K-12
rRNA binding50S ribosomal protein L14Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L14Escherichia coli K-12
tRNA binding50S ribosomal protein L16Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L16Escherichia coli K-12
rRNA binding50S ribosomal protein L16Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L23Escherichia coli K-12
protein binding50S ribosomal protein L23Escherichia coli K-12
rRNA binding50S ribosomal protein L23Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S15Escherichia coli K-12
rRNA binding30S ribosomal protein S15Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S15Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L17Escherichia coli K-12
protein binding50S ribosomal protein L17Escherichia coli K-12
RNA binding50S ribosomal protein L21Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L21Escherichia coli K-12
rRNA binding50S ribosomal protein L21Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L30Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L6Escherichia coli K-12
rRNA binding50S ribosomal protein L6Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L6Escherichia coli K-12
tRNA binding30S ribosomal protein S14Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S14Escherichia coli K-12
rRNA binding30S ribosomal protein S14Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S17Escherichia coli K-12
zinc ion binding30S ribosomal protein S17Escherichia coli K-12
rRNA binding30S ribosomal protein S17Escherichia coli K-12
molecular adaptor activity30S ribosomal protein S17Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S17Escherichia coli K-12
RNA binding30S ribosomal protein S1Escherichia coli K-12
single-stranded RNA binding30S ribosomal protein S1Escherichia coli K-12
mRNA binding30S ribosomal protein S1Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S1Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L18Escherichia coli K-12
5S rRNA binding50S ribosomal protein L18Escherichia coli K-12
rRNA binding50S ribosomal protein L18Escherichia coli K-12
RNA binding50S ribosomal protein L2Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L2Escherichia coli K-12
protein binding50S ribosomal protein L2Escherichia coli K-12
zinc ion binding50S ribosomal protein L2Escherichia coli K-12
transferase activity50S ribosomal protein L2Escherichia coli K-12
rRNA binding50S ribosomal protein L2Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L3Escherichia coli K-12
protein binding50S ribosomal protein L3Escherichia coli K-12
rRNA binding50S ribosomal protein L3Escherichia coli K-12
RNA binding50S ribosomal protein L24Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L24Escherichia coli K-12
protein binding50S ribosomal protein L24Escherichia coli K-12
rRNA binding50S ribosomal protein L24Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L24Escherichia coli K-12
RNA-binding transcription regulator activity50S ribosomal protein L4Escherichia coli K-12
DNA binding50S ribosomal protein L4Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L4Escherichia coli K-12
protein binding50S ribosomal protein L4Escherichia coli K-12
rRNA binding50S ribosomal protein L4Escherichia coli K-12
translation repressor activity50S ribosomal protein L4Escherichia coli K-12
mRNA 5'-UTR binding50S ribosomal protein L4Escherichia coli K-12
endoribonuclease inhibitor activity50S ribosomal protein L4Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L22Escherichia coli K-12
protein binding50S ribosomal protein L22Escherichia coli K-12
rRNA binding50S ribosomal protein L22Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L22Escherichia coli K-12
tRNA binding50S ribosomal protein L5Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L5Escherichia coli K-12
5S rRNA binding50S ribosomal protein L5Escherichia coli K-12
rRNA binding50S ribosomal protein L5Escherichia coli K-12
RNA binding50S ribosomal protein L5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S21Escherichia coli K-12
rRNA binding30S ribosomal protein S21Escherichia coli K-12
RNA binding50S ribosomal protein L25Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L25Escherichia coli K-12
5S rRNA binding50S ribosomal protein L25Escherichia coli K-12
rRNA binding50S ribosomal protein L25Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L36 2Escherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (51)

Processvia Protein(s)Taxonomy
cytoplasm60S acidic ribosomal protein P1Homo sapiens (human)
cytosol60S acidic ribosomal protein P1Homo sapiens (human)
focal adhesion60S acidic ribosomal protein P1Homo sapiens (human)
cytosolic large ribosomal subunit60S acidic ribosomal protein P1Homo sapiens (human)
cytosolic ribosome60S acidic ribosomal protein P1Homo sapiens (human)
postsynaptic density60S acidic ribosomal protein P0Homo sapiens (human)
postsynapse60S acidic ribosomal protein P0Homo sapiens (human)
nucleus60S acidic ribosomal protein P0Homo sapiens (human)
cytoplasm60S acidic ribosomal protein P0Homo sapiens (human)
endoplasmic reticulum60S acidic ribosomal protein P0Homo sapiens (human)
cytosol60S acidic ribosomal protein P0Homo sapiens (human)
focal adhesion60S acidic ribosomal protein P0Homo sapiens (human)
membrane60S acidic ribosomal protein P0Homo sapiens (human)
cytosolic large ribosomal subunit60S acidic ribosomal protein P0Homo sapiens (human)
cytoplasmic ribonucleoprotein granule60S acidic ribosomal protein P0Homo sapiens (human)
extracellular exosome60S acidic ribosomal protein P0Homo sapiens (human)
cytosolic ribosome60S acidic ribosomal protein P0Homo sapiens (human)
ribonucleoprotein complex60S acidic ribosomal protein P0Homo sapiens (human)
nucleoplasm40S ribosomal protein S17Homo sapiens (human)
nucleolus40S ribosomal protein S17Homo sapiens (human)
cytoplasm40S ribosomal protein S17Homo sapiens (human)
cytosol40S ribosomal protein S17Homo sapiens (human)
ribosome40S ribosomal protein S17Homo sapiens (human)
focal adhesion40S ribosomal protein S17Homo sapiens (human)
membrane40S ribosomal protein S17Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S17Homo sapiens (human)
synapse40S ribosomal protein S17Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S17Homo sapiens (human)
small-subunit processome40S ribosomal protein S17Homo sapiens (human)
nucleus40S ribosomal protein SAHomo sapiens (human)
nucleus40S ribosomal protein SAHomo sapiens (human)
nucleoplasm40S ribosomal protein SAHomo sapiens (human)
cytoplasm40S ribosomal protein SAHomo sapiens (human)
cytosol40S ribosomal protein SAHomo sapiens (human)
plasma membrane40S ribosomal protein SAHomo sapiens (human)
membrane40S ribosomal protein SAHomo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein SAHomo sapiens (human)
extracellular exosome40S ribosomal protein SAHomo sapiens (human)
cytosolic ribosome40S ribosomal protein SAHomo sapiens (human)
nucleolus40S ribosomal protein S2Homo sapiens (human)
nucleus40S ribosomal protein S2Homo sapiens (human)
nucleoplasm40S ribosomal protein S2Homo sapiens (human)
cytoplasm40S ribosomal protein S2Homo sapiens (human)
cytosol40S ribosomal protein S2Homo sapiens (human)
focal adhesion40S ribosomal protein S2Homo sapiens (human)
membrane40S ribosomal protein S2Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S2Homo sapiens (human)
extracellular exosome40S ribosomal protein S2Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S2Homo sapiens (human)
cytoplasm60S ribosomal protein L35aHomo sapiens (human)
cytosol60S ribosomal protein L35aHomo sapiens (human)
membrane60S ribosomal protein L35aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L35aHomo sapiens (human)
extracellular exosome60S ribosomal protein L35aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L35aHomo sapiens (human)
postsynaptic density60S ribosomal protein L7Homo sapiens (human)
nucleus60S ribosomal protein L7Homo sapiens (human)
nucleolus60S ribosomal protein L7Homo sapiens (human)
cytoplasm60S ribosomal protein L7Homo sapiens (human)
cytosol60S ribosomal protein L7Homo sapiens (human)
focal adhesion60S ribosomal protein L7Homo sapiens (human)
membrane60S ribosomal protein L7Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L7Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L7Homo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L7Homo sapiens (human)
nucleus60S ribosomal protein L17Homo sapiens (human)
cytoplasm60S ribosomal protein L17Homo sapiens (human)
cytosol60S ribosomal protein L17Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L17Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L17Homo sapiens (human)
nucleus40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
nucleoplasm40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
cytosol40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
membrane40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
ribosome40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S4, Y isoform 1Homo sapiens (human)
postsynaptic density40S ribosomal protein S3Homo sapiens (human)
nucleus40S ribosomal protein S3Homo sapiens (human)
nucleoplasm40S ribosomal protein S3Homo sapiens (human)
nucleolus40S ribosomal protein S3Homo sapiens (human)
cytoplasm40S ribosomal protein S3Homo sapiens (human)
mitochondrial inner membrane40S ribosomal protein S3Homo sapiens (human)
mitochondrial matrix40S ribosomal protein S3Homo sapiens (human)
endoplasmic reticulum40S ribosomal protein S3Homo sapiens (human)
cytosol40S ribosomal protein S3Homo sapiens (human)
ribosome40S ribosomal protein S3Homo sapiens (human)
plasma membrane40S ribosomal protein S3Homo sapiens (human)
focal adhesion40S ribosomal protein S3Homo sapiens (human)
membrane40S ribosomal protein S3Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S3Homo sapiens (human)
ruffle membrane40S ribosomal protein S3Homo sapiens (human)
extracellular exosome40S ribosomal protein S3Homo sapiens (human)
mitotic spindle40S ribosomal protein S3Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S3Homo sapiens (human)
NF-kappaB complex40S ribosomal protein S3Homo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S3Homo sapiens (human)
nucleus40S ribosomal protein S3Homo sapiens (human)
nucleoplasm40S ribosomal protein S12Homo sapiens (human)
nucleolus40S ribosomal protein S12Homo sapiens (human)
cytoplasm40S ribosomal protein S12Homo sapiens (human)
Golgi apparatus40S ribosomal protein S12Homo sapiens (human)
cytosol40S ribosomal protein S12Homo sapiens (human)
membrane40S ribosomal protein S12Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S12Homo sapiens (human)
intracellular membrane-bounded organelle40S ribosomal protein S12Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S12Homo sapiens (human)
small-subunit processome40S ribosomal protein S12Homo sapiens (human)
nucleus60S ribosomal protein L13Homo sapiens (human)
nucleolus60S ribosomal protein L13Homo sapiens (human)
cytoplasm60S ribosomal protein L13Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L13Homo sapiens (human)
cytosol60S ribosomal protein L13Homo sapiens (human)
membrane60S ribosomal protein L13Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L13Homo sapiens (human)
synapse60S ribosomal protein L13Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L13Homo sapiens (human)
smooth endoplasmic reticulum60S ribosomal protein L10Homo sapiens (human)
nucleus60S ribosomal protein L10Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L10Homo sapiens (human)
cytosol60S ribosomal protein L10Homo sapiens (human)
membrane60S ribosomal protein L10Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L10Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L10Homo sapiens (human)
protein-containing complex60S ribosomal protein L10Homo sapiens (human)
postsynaptic density60S ribosomal protein L12Homo sapiens (human)
nucleolus60S ribosomal protein L12Homo sapiens (human)
cytoplasm60S ribosomal protein L12Homo sapiens (human)
cytosol60S ribosomal protein L12Homo sapiens (human)
focal adhesion60S ribosomal protein L12Homo sapiens (human)
membrane60S ribosomal protein L12Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L12Homo sapiens (human)
extracellular exosome60S ribosomal protein L12Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L12Homo sapiens (human)
nucleus60S ribosomal protein L9Homo sapiens (human)
cytoplasm60S ribosomal protein L9Homo sapiens (human)
cytosol60S ribosomal protein L9Homo sapiens (human)
ribosome60S ribosomal protein L9Homo sapiens (human)
focal adhesion60S ribosomal protein L9Homo sapiens (human)
membrane60S ribosomal protein L9Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L9Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L9Homo sapiens (human)
nucleus60S ribosomal protein L22Homo sapiens (human)
cytoplasm60S ribosomal protein L22Homo sapiens (human)
cytosol60S ribosomal protein L22Homo sapiens (human)
focal adhesion60S ribosomal protein L22Homo sapiens (human)
extracellular exosome60S ribosomal protein L22Homo sapiens (human)
presynapse60S ribosomal protein L22Homo sapiens (human)
glutamatergic synapse60S ribosomal protein L22Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L22Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L22Homo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L22Homo sapiens (human)
nucleus60S ribosomal protein L4Homo sapiens (human)
nucleolus60S ribosomal protein L4Homo sapiens (human)
cytoplasm60S ribosomal protein L4Homo sapiens (human)
rough endoplasmic reticulum60S ribosomal protein L4Homo sapiens (human)
cytosol60S ribosomal protein L4Homo sapiens (human)
focal adhesion60S ribosomal protein L4Homo sapiens (human)
membrane60S ribosomal protein L4Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L4Homo sapiens (human)
extracellular exosome60S ribosomal protein L4Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L4Homo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L4Homo sapiens (human)
postsynaptic density40S ribosomal protein S19Homo sapiens (human)
nucleoplasm40S ribosomal protein S19Homo sapiens (human)
nucleolus40S ribosomal protein S19Homo sapiens (human)
cytoplasm40S ribosomal protein S19Homo sapiens (human)
cytosol40S ribosomal protein S19Homo sapiens (human)
ribosome40S ribosomal protein S19Homo sapiens (human)
focal adhesion40S ribosomal protein S19Homo sapiens (human)
membrane40S ribosomal protein S19Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S19Homo sapiens (human)
extracellular exosome40S ribosomal protein S19Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S19Homo sapiens (human)
small-subunit processome40S ribosomal protein S19Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L3Homo sapiens (human)
nucleus60S ribosomal protein L3Homo sapiens (human)
nucleolus60S ribosomal protein L3Homo sapiens (human)
cytoplasm60S ribosomal protein L3Homo sapiens (human)
cytosol60S ribosomal protein L3Homo sapiens (human)
focal adhesion60S ribosomal protein L3Homo sapiens (human)
extracellular exosome60S ribosomal protein L3Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L3Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L3Homo sapiens (human)
protein-containing complex60S ribosomal protein L3Homo sapiens (human)
nucleus60S ribosomal protein L13aHomo sapiens (human)
nucleolus60S ribosomal protein L13aHomo sapiens (human)
cytoplasm60S ribosomal protein L13aHomo sapiens (human)
cytosol60S ribosomal protein L13aHomo sapiens (human)
focal adhesion60S ribosomal protein L13aHomo sapiens (human)
membrane60S ribosomal protein L13aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L13aHomo sapiens (human)
synapse60S ribosomal protein L13aHomo sapiens (human)
large ribosomal subunit60S ribosomal protein L13aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L13aHomo sapiens (human)
GAIT complex60S ribosomal protein L13aHomo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L13aHomo sapiens (human)
ribosome60S ribosomal protein L13aHomo sapiens (human)
postsynaptic density40S ribosomal protein S27Homo sapiens (human)
nucleus40S ribosomal protein S27Homo sapiens (human)
nucleoplasm40S ribosomal protein S27Homo sapiens (human)
nucleolus40S ribosomal protein S27Homo sapiens (human)
cytosol40S ribosomal protein S27Homo sapiens (human)
ribosome40S ribosomal protein S27Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S27Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S27Homo sapiens (human)
small-subunit processome40S ribosomal protein S27Homo sapiens (human)
nucleolus60S ribosomal protein L35Homo sapiens (human)
cytoplasm60S ribosomal protein L35Homo sapiens (human)
cytosol60S ribosomal protein L35Homo sapiens (human)
membrane60S ribosomal protein L35Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L35Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L35Homo sapiens (human)
nucleoplasm60S ribosomal protein L27aHomo sapiens (human)
cytoplasm60S ribosomal protein L27aHomo sapiens (human)
endoplasmic reticulum60S ribosomal protein L27aHomo sapiens (human)
cytosol60S ribosomal protein L27aHomo sapiens (human)
membrane60S ribosomal protein L27aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L27aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L27aHomo sapiens (human)
nucleus60S ribosomal protein L5Homo sapiens (human)
nucleoplasm60S ribosomal protein L5Homo sapiens (human)
nucleolus60S ribosomal protein L5Homo sapiens (human)
cytoplasm60S ribosomal protein L5Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L5Homo sapiens (human)
cytosol60S ribosomal protein L5Homo sapiens (human)
focal adhesion60S ribosomal protein L5Homo sapiens (human)
membrane60S ribosomal protein L5Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L5Homo sapiens (human)
extracellular exosome60S ribosomal protein L5Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L5Homo sapiens (human)
protein-containing complex60S ribosomal protein L5Homo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L5Homo sapiens (human)
cytoplasm60S ribosomal protein L21Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L21Homo sapiens (human)
cytosol60S ribosomal protein L21Homo sapiens (human)
membrane60S ribosomal protein L21Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L21Homo sapiens (human)
synapse60S ribosomal protein L21Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L21Homo sapiens (human)
cytoplasm60S ribosomal protein L28Homo sapiens (human)
cytosol60S ribosomal protein L28Homo sapiens (human)
membrane60S ribosomal protein L28Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L28Homo sapiens (human)
dendrite60S ribosomal protein L28Homo sapiens (human)
cytoplasmic ribonucleoprotein granule60S ribosomal protein L28Homo sapiens (human)
cell body60S ribosomal protein L28Homo sapiens (human)
synapse60S ribosomal protein L28Homo sapiens (human)
extracellular exosome60S ribosomal protein L28Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L28Homo sapiens (human)
nucleus40S ribosomal protein S9Homo sapiens (human)
nucleoplasm40S ribosomal protein S9Homo sapiens (human)
nucleolus40S ribosomal protein S9Homo sapiens (human)
cytoplasm40S ribosomal protein S9Homo sapiens (human)
cytosol40S ribosomal protein S9Homo sapiens (human)
ribosome40S ribosomal protein S9Homo sapiens (human)
focal adhesion40S ribosomal protein S9Homo sapiens (human)
membrane40S ribosomal protein S9Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S9Homo sapiens (human)
synapse40S ribosomal protein S9Homo sapiens (human)
extracellular exosome40S ribosomal protein S9Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S9Homo sapiens (human)
small-subunit processome40S ribosomal protein S9Homo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S9Homo sapiens (human)
nucleoplasm40S ribosomal protein S5Homo sapiens (human)
nucleolus40S ribosomal protein S5Homo sapiens (human)
cytoplasm40S ribosomal protein S5Homo sapiens (human)
cytosol40S ribosomal protein S5Homo sapiens (human)
focal adhesion40S ribosomal protein S5Homo sapiens (human)
membrane40S ribosomal protein S5Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S5Homo sapiens (human)
synapse40S ribosomal protein S5Homo sapiens (human)
extracellular exosome40S ribosomal protein S5Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S5Homo sapiens (human)
small-subunit processome40S ribosomal protein S5Homo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S5Homo sapiens (human)
ribosome40S ribosomal protein S5Homo sapiens (human)
nucleoplasm40S ribosomal protein S10Homo sapiens (human)
nucleolus40S ribosomal protein S10Homo sapiens (human)
cytoplasm40S ribosomal protein S10Homo sapiens (human)
cytosol40S ribosomal protein S10Homo sapiens (human)
ribosome40S ribosomal protein S10Homo sapiens (human)
focal adhesion40S ribosomal protein S10Homo sapiens (human)
membrane40S ribosomal protein S10Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S10Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S10Homo sapiens (human)
cytoplasm60S ribosomal protein L29Homo sapiens (human)
cytosol60S ribosomal protein L29Homo sapiens (human)
membrane60S ribosomal protein L29Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L29Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L29Homo sapiens (human)
nucleolus60S ribosomal protein L34Homo sapiens (human)
cytoplasm60S ribosomal protein L34Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L34Homo sapiens (human)
cytosol60S ribosomal protein L34Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L34Homo sapiens (human)
synapse60S ribosomal protein L34Homo sapiens (human)
extracellular exosome60S ribosomal protein L34Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L34Homo sapiens (human)
postsynaptic density60S ribosomal protein L14Homo sapiens (human)
cytoplasm60S ribosomal protein L14Homo sapiens (human)
cytosol60S ribosomal protein L14Homo sapiens (human)
membrane60S ribosomal protein L14Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L14Homo sapiens (human)
extracellular exosome60S ribosomal protein L14Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L14Homo sapiens (human)
nucleoplasm40S ribosomal protein S20Homo sapiens (human)
cytoplasm40S ribosomal protein S20Homo sapiens (human)
cytosol40S ribosomal protein S20Homo sapiens (human)
membrane40S ribosomal protein S20Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S20Homo sapiens (human)
synapse40S ribosomal protein S20Homo sapiens (human)
extracellular exosome40S ribosomal protein S20Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S20Homo sapiens (human)
nucleus40S ribosomal protein S3aHomo sapiens (human)
nucleoplasm40S ribosomal protein S3aHomo sapiens (human)
nucleolus40S ribosomal protein S3aHomo sapiens (human)
cytoplasm40S ribosomal protein S3aHomo sapiens (human)
endoplasmic reticulum40S ribosomal protein S3aHomo sapiens (human)
cytosol40S ribosomal protein S3aHomo sapiens (human)
focal adhesion40S ribosomal protein S3aHomo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S3aHomo sapiens (human)
synapse40S ribosomal protein S3aHomo sapiens (human)
extracellular exosome40S ribosomal protein S3aHomo sapiens (human)
cytosolic ribosome40S ribosomal protein S3aHomo sapiens (human)
small-subunit processome40S ribosomal protein S3aHomo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S3aHomo sapiens (human)
cytosol40S ribosomal protein S3aHomo sapiens (human)
nucleoplasm60S ribosomal protein L26Homo sapiens (human)
nucleolus60S ribosomal protein L26Homo sapiens (human)
cytoplasm60S ribosomal protein L26Homo sapiens (human)
cytosol60S ribosomal protein L26Homo sapiens (human)
membrane60S ribosomal protein L26Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L26Homo sapiens (human)
synapse60S ribosomal protein L26Homo sapiens (human)
extracellular exosome60S ribosomal protein L26Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L26Homo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L26Homo sapiens (human)
nucleus60S ribosomal protein L15Homo sapiens (human)
cytoplasm60S ribosomal protein L15Homo sapiens (human)
cytosol60S ribosomal protein L15Homo sapiens (human)
ribosome60S ribosomal protein L15Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L15Homo sapiens (human)
A band60S ribosomal protein L15Homo sapiens (human)
synapse60S ribosomal protein L15Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L15Homo sapiens (human)
nucleus60S ribosomal protein L27Homo sapiens (human)
nucleoplasm60S ribosomal protein L27Homo sapiens (human)
nucleolus60S ribosomal protein L27Homo sapiens (human)
cytoplasm60S ribosomal protein L27Homo sapiens (human)
cytosol60S ribosomal protein L27Homo sapiens (human)
ribosome60S ribosomal protein L27Homo sapiens (human)
focal adhesion60S ribosomal protein L27Homo sapiens (human)
membrane60S ribosomal protein L27Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L27Homo sapiens (human)
synapse60S ribosomal protein L27Homo sapiens (human)
extracellular exosome60S ribosomal protein L27Homo sapiens (human)
cytoplasmic side of rough endoplasmic reticulum membrane60S ribosomal protein L27Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L27Homo sapiens (human)
ribonucleoprotein complex60S ribosomal protein L27Homo sapiens (human)
nucleus60S ribosomal protein L37aHomo sapiens (human)
cytoplasm60S ribosomal protein L37aHomo sapiens (human)
cytosol60S ribosomal protein L37aHomo sapiens (human)
focal adhesion60S ribosomal protein L37aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L37aHomo sapiens (human)
extracellular exosome60S ribosomal protein L37aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L37aHomo sapiens (human)
cytoplasm60S ribosomal protein L37Homo sapiens (human)
cytosol60S ribosomal protein L37Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L37Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L37Homo sapiens (human)
centrosome40S ribosomal protein S7Homo sapiens (human)
nucleus40S ribosomal protein S7Homo sapiens (human)
nucleoplasm40S ribosomal protein S7Homo sapiens (human)
nucleolus40S ribosomal protein S7Homo sapiens (human)
cytoplasm40S ribosomal protein S7Homo sapiens (human)
endoplasmic reticulum40S ribosomal protein S7Homo sapiens (human)
cytosol40S ribosomal protein S7Homo sapiens (human)
ribosome40S ribosomal protein S7Homo sapiens (human)
focal adhesion40S ribosomal protein S7Homo sapiens (human)
membrane40S ribosomal protein S7Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S7Homo sapiens (human)
synapse40S ribosomal protein S7Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S7Homo sapiens (human)
small-subunit processome40S ribosomal protein S7Homo sapiens (human)
protein-containing complex40S ribosomal protein S7Homo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S7Homo sapiens (human)
nucleus40S ribosomal protein S8Homo sapiens (human)
nucleoplasm40S ribosomal protein S8Homo sapiens (human)
nucleolus40S ribosomal protein S8Homo sapiens (human)
cytoplasm40S ribosomal protein S8Homo sapiens (human)
endoplasmic reticulum40S ribosomal protein S8Homo sapiens (human)
cytosol40S ribosomal protein S8Homo sapiens (human)
focal adhesion40S ribosomal protein S8Homo sapiens (human)
membrane40S ribosomal protein S8Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S8Homo sapiens (human)
extracellular exosome40S ribosomal protein S8Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S8Homo sapiens (human)
small-subunit processome40S ribosomal protein S8Homo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S8Homo sapiens (human)
nucleoplasm40S ribosomal protein S15aHomo sapiens (human)
nucleolus40S ribosomal protein S15aHomo sapiens (human)
cytoplasm40S ribosomal protein S15aHomo sapiens (human)
cytosol40S ribosomal protein S15aHomo sapiens (human)
membrane40S ribosomal protein S15aHomo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S15aHomo sapiens (human)
synapse40S ribosomal protein S15aHomo sapiens (human)
extracellular exosome40S ribosomal protein S15aHomo sapiens (human)
cytosolic ribosome40S ribosomal protein S15aHomo sapiens (human)
small-subunit processome40S ribosomal protein S15aHomo sapiens (human)
nucleoplasm40S ribosomal protein S16Homo sapiens (human)
nucleolus40S ribosomal protein S16Homo sapiens (human)
cytoplasm40S ribosomal protein S16Homo sapiens (human)
cytosol40S ribosomal protein S16Homo sapiens (human)
focal adhesion40S ribosomal protein S16Homo sapiens (human)
membrane40S ribosomal protein S16Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S16Homo sapiens (human)
synapse40S ribosomal protein S16Homo sapiens (human)
extracellular exosome40S ribosomal protein S16Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S16Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S16Homo sapiens (human)
small-subunit processome40S ribosomal protein S16Homo sapiens (human)
postsynaptic density40S ribosomal protein S14Homo sapiens (human)
nucleoplasm40S ribosomal protein S14Homo sapiens (human)
nucleolus40S ribosomal protein S14Homo sapiens (human)
cytoplasm40S ribosomal protein S14Homo sapiens (human)
cytosol40S ribosomal protein S14Homo sapiens (human)
focal adhesion40S ribosomal protein S14Homo sapiens (human)
membrane40S ribosomal protein S14Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S14Homo sapiens (human)
extracellular exosome40S ribosomal protein S14Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S14Homo sapiens (human)
small-subunit processome40S ribosomal protein S14Homo sapiens (human)
nucleoplasm40S ribosomal protein S23Homo sapiens (human)
nucleolus40S ribosomal protein S23Homo sapiens (human)
cytoplasm40S ribosomal protein S23Homo sapiens (human)
endoplasmic reticulum40S ribosomal protein S23Homo sapiens (human)
rough endoplasmic reticulum40S ribosomal protein S23Homo sapiens (human)
cytosol40S ribosomal protein S23Homo sapiens (human)
ribosome40S ribosomal protein S23Homo sapiens (human)
membrane40S ribosomal protein S23Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S23Homo sapiens (human)
synapse40S ribosomal protein S23Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S23Homo sapiens (human)
small-subunit processome40S ribosomal protein S23Homo sapiens (human)
ribosome40S ribosomal protein S23Homo sapiens (human)
postsynaptic density40S ribosomal protein S18Homo sapiens (human)
nucleus40S ribosomal protein S18Homo sapiens (human)
nucleoplasm40S ribosomal protein S18Homo sapiens (human)
cytoplasm40S ribosomal protein S18Homo sapiens (human)
cytosol40S ribosomal protein S18Homo sapiens (human)
ribosome40S ribosomal protein S18Homo sapiens (human)
focal adhesion40S ribosomal protein S18Homo sapiens (human)
membrane40S ribosomal protein S18Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S18Homo sapiens (human)
extracellular exosome40S ribosomal protein S18Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S18Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S18Homo sapiens (human)
cytosol40S ribosomal protein S18Homo sapiens (human)
nucleoplasm40S ribosomal protein S29Homo sapiens (human)
cytoplasm40S ribosomal protein S29Homo sapiens (human)
cytosol40S ribosomal protein S29Homo sapiens (human)
focal adhesion40S ribosomal protein S29Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S29Homo sapiens (human)
extracellular exosome40S ribosomal protein S29Homo sapiens (human)
cytoplasmic side of rough endoplasmic reticulum membrane40S ribosomal protein S29Homo sapiens (human)
ribosome40S ribosomal protein S29Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S29Homo sapiens (human)
postsynaptic density40S ribosomal protein S13Homo sapiens (human)
nucleus40S ribosomal protein S13Homo sapiens (human)
nucleoplasm40S ribosomal protein S13Homo sapiens (human)
nucleolus40S ribosomal protein S13Homo sapiens (human)
cytoplasm40S ribosomal protein S13Homo sapiens (human)
cytosol40S ribosomal protein S13Homo sapiens (human)
ribosome40S ribosomal protein S13Homo sapiens (human)
focal adhesion40S ribosomal protein S13Homo sapiens (human)
membrane40S ribosomal protein S13Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S13Homo sapiens (human)
extracellular exosome40S ribosomal protein S13Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S13Homo sapiens (human)
small-subunit processome40S ribosomal protein S13Homo sapiens (human)
nucleolus40S ribosomal protein S13Homo sapiens (human)
nucleoplasm40S ribosomal protein S11Homo sapiens (human)
nucleolus40S ribosomal protein S11Homo sapiens (human)
cytoplasm40S ribosomal protein S11Homo sapiens (human)
cytosol40S ribosomal protein S11Homo sapiens (human)
ribosome40S ribosomal protein S11Homo sapiens (human)
focal adhesion40S ribosomal protein S11Homo sapiens (human)
membrane40S ribosomal protein S11Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S11Homo sapiens (human)
synapse40S ribosomal protein S11Homo sapiens (human)
extracellular exosome40S ribosomal protein S11Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S11Homo sapiens (human)
small-subunit processome40S ribosomal protein S11Homo sapiens (human)
nucleus60S ribosomal protein L7aHomo sapiens (human)
nucleolus60S ribosomal protein L7aHomo sapiens (human)
cytoplasm60S ribosomal protein L7aHomo sapiens (human)
cytosol60S ribosomal protein L7aHomo sapiens (human)
ribosome60S ribosomal protein L7aHomo sapiens (human)
focal adhesion60S ribosomal protein L7aHomo sapiens (human)
membrane60S ribosomal protein L7aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L7aHomo sapiens (human)
synapse60S ribosomal protein L7aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L7aHomo sapiens (human)
nucleoplasm40S ribosomal protein S4, X isoformHomo sapiens (human)
nucleolus40S ribosomal protein S4, X isoformHomo sapiens (human)
cytosol40S ribosomal protein S4, X isoformHomo sapiens (human)
ribosome40S ribosomal protein S4, X isoformHomo sapiens (human)
focal adhesion40S ribosomal protein S4, X isoformHomo sapiens (human)
membrane40S ribosomal protein S4, X isoformHomo sapiens (human)
cytoplasmic ribonucleoprotein granule40S ribosomal protein S4, X isoformHomo sapiens (human)
synapse40S ribosomal protein S4, X isoformHomo sapiens (human)
extracellular exosome40S ribosomal protein S4, X isoformHomo sapiens (human)
small ribosomal subunit40S ribosomal protein S4, X isoformHomo sapiens (human)
cytosolic ribosome40S ribosomal protein S4, X isoformHomo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S4, X isoformHomo sapiens (human)
small-subunit processome40S ribosomal protein S4, X isoformHomo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S4, X isoformHomo sapiens (human)
nucleus60S ribosomal protein L23aHomo sapiens (human)
nucleolus60S ribosomal protein L23aHomo sapiens (human)
cytoplasm60S ribosomal protein L23aHomo sapiens (human)
cytosol60S ribosomal protein L23aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L23aHomo sapiens (human)
extracellular exosome60S ribosomal protein L23aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L23aHomo sapiens (human)
cytosolic ribosome40S ribosomal protein S6Homo sapiens (human)
nucleus40S ribosomal protein S6Homo sapiens (human)
nucleoplasm40S ribosomal protein S6Homo sapiens (human)
nucleolus40S ribosomal protein S6Homo sapiens (human)
cytoplasm40S ribosomal protein S6Homo sapiens (human)
endoplasmic reticulum40S ribosomal protein S6Homo sapiens (human)
cytosol40S ribosomal protein S6Homo sapiens (human)
membrane40S ribosomal protein S6Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S6Homo sapiens (human)
dendrite40S ribosomal protein S6Homo sapiens (human)
cytoplasmic ribonucleoprotein granule40S ribosomal protein S6Homo sapiens (human)
cell body40S ribosomal protein S6Homo sapiens (human)
perinuclear region of cytoplasm40S ribosomal protein S6Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S6Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S6Homo sapiens (human)
small-subunit processome40S ribosomal protein S6Homo sapiens (human)
ribonucleoprotein complex40S ribosomal protein S6Homo sapiens (human)
nucleoplasm60S ribosomal protein L23Homo sapiens (human)
nucleolus60S ribosomal protein L23Homo sapiens (human)
cytoplasm60S ribosomal protein L23Homo sapiens (human)
cytosol60S ribosomal protein L23Homo sapiens (human)
ribosome60S ribosomal protein L23Homo sapiens (human)
focal adhesion60S ribosomal protein L23Homo sapiens (human)
membrane60S ribosomal protein L23Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L23Homo sapiens (human)
synapse60S ribosomal protein L23Homo sapiens (human)
extracellular exosome60S ribosomal protein L23Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L23Homo sapiens (human)
protein-containing complex60S ribosomal protein L23Homo sapiens (human)
nucleus40S ribosomal protein S15Homo sapiens (human)
nucleoplasm40S ribosomal protein S15Homo sapiens (human)
cytoplasm40S ribosomal protein S15Homo sapiens (human)
cytosol40S ribosomal protein S15Homo sapiens (human)
focal adhesion40S ribosomal protein S15Homo sapiens (human)
membrane40S ribosomal protein S15Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S15Homo sapiens (human)
synapse40S ribosomal protein S15Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S15Homo sapiens (human)
nucleus40S ribosomal protein S24Homo sapiens (human)
nucleoplasm40S ribosomal protein S24Homo sapiens (human)
nucleolus40S ribosomal protein S24Homo sapiens (human)
cytoplasm40S ribosomal protein S24Homo sapiens (human)
endoplasmic reticulum40S ribosomal protein S24Homo sapiens (human)
cytosol40S ribosomal protein S24Homo sapiens (human)
membrane40S ribosomal protein S24Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S24Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S24Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S24Homo sapiens (human)
small-subunit processome40S ribosomal protein S24Homo sapiens (human)
postsynaptic density40S ribosomal protein S25Homo sapiens (human)
nucleus40S ribosomal protein S25Homo sapiens (human)
nucleoplasm40S ribosomal protein S25Homo sapiens (human)
nucleolus40S ribosomal protein S25Homo sapiens (human)
cytoplasm40S ribosomal protein S25Homo sapiens (human)
cytosol40S ribosomal protein S25Homo sapiens (human)
ribosome40S ribosomal protein S25Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S25Homo sapiens (human)
extracellular exosome40S ribosomal protein S25Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S25Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S25Homo sapiens (human)
nucleoplasm40S ribosomal protein S26Homo sapiens (human)
cytoplasm40S ribosomal protein S26Homo sapiens (human)
cytosol40S ribosomal protein S26Homo sapiens (human)
membrane40S ribosomal protein S26Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S26Homo sapiens (human)
synapse40S ribosomal protein S26Homo sapiens (human)
extracellular exosome40S ribosomal protein S26Homo sapiens (human)
cytoplasmic side of rough endoplasmic reticulum membrane40S ribosomal protein S26Homo sapiens (human)
ribosome40S ribosomal protein S26Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S26Homo sapiens (human)
nucleoplasm40S ribosomal protein S28Homo sapiens (human)
nucleolus40S ribosomal protein S28Homo sapiens (human)
cytoplasm40S ribosomal protein S28Homo sapiens (human)
cytosol40S ribosomal protein S28Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S28Homo sapiens (human)
synapse40S ribosomal protein S28Homo sapiens (human)
extracellular exosome40S ribosomal protein S28Homo sapiens (human)
cytoplasmic side of rough endoplasmic reticulum membrane40S ribosomal protein S28Homo sapiens (human)
ribosome40S ribosomal protein S28Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S28Homo sapiens (human)
small-subunit processome40S ribosomal protein S28Homo sapiens (human)
extracellular space40S ribosomal protein S30Homo sapiens (human)
nucleoplasm40S ribosomal protein S30Homo sapiens (human)
cytoplasm40S ribosomal protein S30Homo sapiens (human)
cytosol40S ribosomal protein S30Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S30Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S30Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S30Homo sapiens (human)
postsynaptic density60S ribosomal protein L30Homo sapiens (human)
nucleus60S ribosomal protein L30Homo sapiens (human)
cytoplasm60S ribosomal protein L30Homo sapiens (human)
cytosol60S ribosomal protein L30Homo sapiens (human)
focal adhesion60S ribosomal protein L30Homo sapiens (human)
membrane60S ribosomal protein L30Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L30Homo sapiens (human)
extracellular exosome60S ribosomal protein L30Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L30Homo sapiens (human)
extracellular space60S ribosomal protein L39Homo sapiens (human)
cytosol60S ribosomal protein L39Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L39Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L39Homo sapiens (human)
cytoplasm60S ribosomal protein L31Homo sapiens (human)
cytosol60S ribosomal protein L31Homo sapiens (human)
focal adhesion60S ribosomal protein L31Homo sapiens (human)
membrane60S ribosomal protein L31Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L31Homo sapiens (human)
extracellular exosome60S ribosomal protein L31Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L31Homo sapiens (human)
nucleus60S ribosomal protein L10aHomo sapiens (human)
cytoplasm60S ribosomal protein L10aHomo sapiens (human)
cytosol60S ribosomal protein L10aHomo sapiens (human)
focal adhesion60S ribosomal protein L10aHomo sapiens (human)
postsynaptic density60S ribosomal protein L10aHomo sapiens (human)
membrane60S ribosomal protein L10aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L10aHomo sapiens (human)
extracellular exosome60S ribosomal protein L10aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L10aHomo sapiens (human)
cytoplasm60S ribosomal protein L32Homo sapiens (human)
cytosol60S ribosomal protein L32Homo sapiens (human)
membrane60S ribosomal protein L32Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L32Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L32Homo sapiens (human)
nucleoplasm60S ribosomal protein L11Homo sapiens (human)
nucleolus60S ribosomal protein L11Homo sapiens (human)
cytoplasm60S ribosomal protein L11Homo sapiens (human)
cytosol60S ribosomal protein L11Homo sapiens (human)
membrane60S ribosomal protein L11Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L11Homo sapiens (human)
extracellular exosome60S ribosomal protein L11Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L11Homo sapiens (human)
protein-containing complex60S ribosomal protein L11Homo sapiens (human)
postsynaptic density60S ribosomal protein L8Homo sapiens (human)
postsynapse60S ribosomal protein L8Homo sapiens (human)
nucleoplasm60S ribosomal protein L8Homo sapiens (human)
cytoplasm60S ribosomal protein L8Homo sapiens (human)
cytosol60S ribosomal protein L8Homo sapiens (human)
focal adhesion60S ribosomal protein L8Homo sapiens (human)
membrane60S ribosomal protein L8Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L8Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L8Homo sapiens (human)
cytoplasm60S ribosomal protein L41Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L41Homo sapiens (human)
cytosol60S ribosomal protein L41Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L41Homo sapiens (human)
extracellular spaceUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
nucleusUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
nucleoplasmUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
nucleolusUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
cytoplasmUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
mitochondrial outer membraneUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
endoplasmic reticulum membraneUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
cytosolUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
plasma membraneUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
endosome membraneUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
membraneUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
cytosolic small ribosomal subunitUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
endocytic vesicle membraneUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
vesicleUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
synapseUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
extracellular exosomeUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
cytosolic ribosomeUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
small-subunit processomeUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
nucleusUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
cytoplasmUbiquitin-40S ribosomal protein S27aHomo sapiens (human)
postsynaptic density60S ribosomal protein L38Homo sapiens (human)
cytoplasm60S ribosomal protein L38Homo sapiens (human)
cytosol60S ribosomal protein L38Homo sapiens (human)
focal adhesion60S ribosomal protein L38Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L38Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L38Homo sapiens (human)
eukaryotic 80S initiation complex60S ribosomal protein L38Homo sapiens (human)
nucleoplasm40S ribosomal protein S21Homo sapiens (human)
cytoplasm40S ribosomal protein S21Homo sapiens (human)
rough endoplasmic reticulum40S ribosomal protein S21Homo sapiens (human)
cytosol40S ribosomal protein S21Homo sapiens (human)
cytosolic small ribosomal subunit40S ribosomal protein S21Homo sapiens (human)
synapse40S ribosomal protein S21Homo sapiens (human)
small ribosomal subunit40S ribosomal protein S21Homo sapiens (human)
cytosolic ribosome40S ribosomal protein S21Homo sapiens (human)
cytoplasm60S ribosomal protein L24Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L24Homo sapiens (human)
cytosol60S ribosomal protein L24Homo sapiens (human)
membrane60S ribosomal protein L24Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L24Homo sapiens (human)
synapse60S ribosomal protein L24Homo sapiens (human)
extracellular exosome60S ribosomal protein L24Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L24Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L36aHomo sapiens (human)
cytosol60S ribosomal protein L36aHomo sapiens (human)
ribosome60S ribosomal protein L36aHomo sapiens (human)
plasma membrane60S ribosomal protein L36aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L36aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L36aHomo sapiens (human)
nucleolus60S ribosomal protein L19Homo sapiens (human)
cytoplasm60S ribosomal protein L19Homo sapiens (human)
cytosol60S ribosomal protein L19Homo sapiens (human)
focal adhesion60S ribosomal protein L19Homo sapiens (human)
membrane60S ribosomal protein L19Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L19Homo sapiens (human)
synapse60S ribosomal protein L19Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L19Homo sapiens (human)
cytoplasm60S ribosomal protein L18aHomo sapiens (human)
cytosol60S ribosomal protein L18aHomo sapiens (human)
membrane60S ribosomal protein L18aHomo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L18aHomo sapiens (human)
cytosolic ribosome60S ribosomal protein L18aHomo sapiens (human)
nucleus60S ribosomal protein L6Homo sapiens (human)
cytoplasm60S ribosomal protein L6Homo sapiens (human)
rough endoplasmic reticulum60S ribosomal protein L6Homo sapiens (human)
cytosol60S ribosomal protein L6Homo sapiens (human)
focal adhesion60S ribosomal protein L6Homo sapiens (human)
postsynaptic density60S ribosomal protein L6Homo sapiens (human)
membrane60S ribosomal protein L6Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L6Homo sapiens (human)
cytoplasmic ribonucleoprotein granule60S ribosomal protein L6Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L6Homo sapiens (human)
nucleus60S ribosomal protein L18Homo sapiens (human)
nucleolus60S ribosomal protein L18Homo sapiens (human)
cytoplasm60S ribosomal protein L18Homo sapiens (human)
endoplasmic reticulum60S ribosomal protein L18Homo sapiens (human)
rough endoplasmic reticulum60S ribosomal protein L18Homo sapiens (human)
cytosol60S ribosomal protein L18Homo sapiens (human)
focal adhesion60S ribosomal protein L18Homo sapiens (human)
membrane60S ribosomal protein L18Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L18Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L18Homo sapiens (human)
nucleolus60S ribosomal protein L36Homo sapiens (human)
cytoplasm60S ribosomal protein L36Homo sapiens (human)
cytosol60S ribosomal protein L36Homo sapiens (human)
membrane60S ribosomal protein L36Homo sapiens (human)
cytosolic large ribosomal subunit60S ribosomal protein L36Homo sapiens (human)
synapse60S ribosomal protein L36Homo sapiens (human)
cytosolic ribosome60S ribosomal protein L36Homo sapiens (human)
mitochondrionDihydrofolate reductaseHomo sapiens (human)
cytosolDihydrofolate reductaseHomo sapiens (human)
mitochondrionDihydrofolate reductaseHomo sapiens (human)
cytoplasmDihydrofolate reductase Bos taurus (cattle)
mitochondrionDihydrofolate reductase Bos taurus (cattle)
cytoplasm30S ribosomal protein S6Escherichia coli K-12
cytosol30S ribosomal protein S6Escherichia coli K-12
ribosome30S ribosomal protein S6Escherichia coli K-12
intracellular organelle30S ribosomal protein S6Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S6Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S6Escherichia coli K-12
cytosol30S ribosomal protein S7Escherichia coli K-12
ribosome30S ribosomal protein S7Escherichia coli K-12
membrane30S ribosomal protein S7Escherichia coli K-12
cytoplasm30S ribosomal protein S7Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S7Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S7Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S7Escherichia coli K-12
ribosome30S ribosomal protein S7Escherichia coli K-12
ribosome50S ribosomal protein L15Escherichia coli K-12
cytoplasm50S ribosomal protein L15Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L15Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L15Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L15Escherichia coli K-12
cytosol50S ribosomal protein L10Escherichia coli K-12
ribosome50S ribosomal protein L10Escherichia coli K-12
cytoplasm50S ribosomal protein L10Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L10Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L10Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L10Escherichia coli K-12
cytosol50S ribosomal protein L11Escherichia coli K-12
ribosome50S ribosomal protein L11Escherichia coli K-12
cytoplasm50S ribosomal protein L11Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L11Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L11Escherichia coli K-12
cytoplasm50S ribosomal protein L7/L12Escherichia coli K-12
cytosol50S ribosomal protein L7/L12Escherichia coli K-12
ribosome50S ribosomal protein L7/L12Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L7/L12Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L7/L12Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L7/L12Escherichia coli K-12
cytosol50S ribosomal protein L19Escherichia coli K-12
ribosome50S ribosomal protein L19Escherichia coli K-12
cytoplasm50S ribosomal protein L19Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L19Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L19Escherichia coli K-12
cytosol50S ribosomal protein L1Escherichia coli K-12
ribosome50S ribosomal protein L1Escherichia coli K-12
cytoplasm50S ribosomal protein L1Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L1Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L1Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L1Escherichia coli K-12
cytosol50S ribosomal protein L20Escherichia coli K-12
ribosome50S ribosomal protein L20Escherichia coli K-12
cytoplasm50S ribosomal protein L20Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L20Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L20Escherichia coli K-12
ribosome50S ribosomal protein L27Escherichia coli K-12
cytoplasm50S ribosomal protein L27Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L27Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L27Escherichia coli K-12
cytosol50S ribosomal protein L28Escherichia coli K-12
ribosome50S ribosomal protein L28Escherichia coli K-12
cytoplasm50S ribosomal protein L28Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L28Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L28Escherichia coli K-12
ribosome50S ribosomal protein L29Escherichia coli K-12
cytoplasm50S ribosomal protein L29Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L29Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L29Escherichia coli K-12
cytosol50S ribosomal protein L31Escherichia coli K-12
ribosome50S ribosomal protein L31Escherichia coli K-12
cytoplasm50S ribosomal protein L31Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L31Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L31Escherichia coli K-12
ribosome50S ribosomal protein L31 type BEscherichia coli K-12
cytoplasm50S ribosomal protein L31 type BEscherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L31 type BEscherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L31 type BEscherichia coli K-12
cytosol50S ribosomal protein L32Escherichia coli K-12
ribosome50S ribosomal protein L32Escherichia coli K-12
cytoplasm50S ribosomal protein L32Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L32Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L32Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L32Escherichia coli K-12
cytoplasm50S ribosomal protein L33Escherichia coli K-12
cytosol50S ribosomal protein L33Escherichia coli K-12
ribosome50S ribosomal protein L33Escherichia coli K-12
intracellular organelle50S ribosomal protein L33Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L33Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L33Escherichia coli K-12
ribosome50S ribosomal protein L34Escherichia coli K-12
cytoplasm50S ribosomal protein L34Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L34Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L34Escherichia coli K-12
ribosome50S ribosomal protein L35Escherichia coli K-12
cytoplasm50S ribosomal protein L35Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L35Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L35Escherichia coli K-12
cytoplasm50S ribosomal protein L36Escherichia coli K-12
ribosome50S ribosomal protein L36Escherichia coli K-12
intracellular organelle50S ribosomal protein L36Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L36Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L36Escherichia coli K-12
cytosol30S ribosomal protein S10Escherichia coli K-12
ribosome30S ribosomal protein S10Escherichia coli K-12
cytoplasm30S ribosomal protein S10Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S10Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S10Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S10Escherichia coli K-12
cytosol30S ribosomal protein S11Escherichia coli K-12
ribosome30S ribosomal protein S11Escherichia coli K-12
cytoplasm30S ribosomal protein S11Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S11Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S11Escherichia coli K-12
cytosol30S ribosomal protein S12Escherichia coli K-12
ribosome30S ribosomal protein S12Escherichia coli K-12
cytoplasm30S ribosomal protein S12Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S12Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S12Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S12Escherichia coli K-12
ribosome30S ribosomal protein S12Escherichia coli K-12
cytosol30S ribosomal protein S13Escherichia coli K-12
ribosome30S ribosomal protein S13Escherichia coli K-12
cytoplasm30S ribosomal protein S13Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S13Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S13Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S13Escherichia coli K-12
cytosol30S ribosomal protein S13Escherichia coli K-12
cytoplasm30S ribosomal protein S16Escherichia coli K-12
ribosome30S ribosomal protein S16Escherichia coli K-12
intracellular organelle30S ribosomal protein S16Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S16Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S16Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S16Escherichia coli K-12
cytosol30S ribosomal protein S18Escherichia coli K-12
ribosome30S ribosomal protein S18Escherichia coli K-12
cytoplasm30S ribosomal protein S18Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S18Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S18Escherichia coli K-12
cytoplasm30S ribosomal protein S19Escherichia coli K-12
cytosol30S ribosomal protein S19Escherichia coli K-12
ribosome30S ribosomal protein S19Escherichia coli K-12
intracellular organelle30S ribosomal protein S19Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S19Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S19Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S19Escherichia coli K-12
cytosol30S ribosomal protein S20Escherichia coli K-12
ribosome30S ribosomal protein S20Escherichia coli K-12
cytoplasm30S ribosomal protein S20Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S20Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S20Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S20Escherichia coli K-12
cytosol30S ribosomal protein S20Escherichia coli K-12
ribosome30S ribosomal protein S2Escherichia coli K-12
cytoplasm30S ribosomal protein S2Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S2Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S2Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S2Escherichia coli K-12
cytosol30S ribosomal protein S3Escherichia coli K-12
ribosome30S ribosomal protein S3Escherichia coli K-12
cytoplasm30S ribosomal protein S3Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S3Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S3Escherichia coli K-12
cytosol30S ribosomal protein S4Escherichia coli K-12
ribosome30S ribosomal protein S4Escherichia coli K-12
cytoplasm30S ribosomal protein S4Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S4Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S4Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S4Escherichia coli K-12
cytoplasm30S ribosomal protein S5Escherichia coli K-12
cytosol30S ribosomal protein S5Escherichia coli K-12
ribosome30S ribosomal protein S5Escherichia coli K-12
intracellular organelle30S ribosomal protein S5Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S5Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S5Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S5Escherichia coli K-12
cytoplasm30S ribosomal protein S8Escherichia coli K-12
cytosol30S ribosomal protein S8Escherichia coli K-12
ribosome30S ribosomal protein S8Escherichia coli K-12
intracellular organelle30S ribosomal protein S8Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S8Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S8Escherichia coli K-12
cytosol30S ribosomal protein S9Escherichia coli K-12
ribosome30S ribosomal protein S9Escherichia coli K-12
intracellular organelle30S ribosomal protein S9Escherichia coli K-12
cytoplasm30S ribosomal protein S9Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S9Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S9Escherichia coli K-12
cytoplasm50S ribosomal protein L13Escherichia coli K-12
cytosol50S ribosomal protein L13Escherichia coli K-12
ribosome50S ribosomal protein L13Escherichia coli K-12
intracellular organelle50S ribosomal protein L13Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L13Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L13Escherichia coli K-12
ribosome50S ribosomal protein L13Escherichia coli K-12
cytosol50S ribosomal protein L14Escherichia coli K-12
ribosome50S ribosomal protein L14Escherichia coli K-12
cytoplasm50S ribosomal protein L14Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L14Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L14Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L14Escherichia coli K-12
ribosome50S ribosomal protein L16Escherichia coli K-12
cytoplasm50S ribosomal protein L16Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L16Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L16Escherichia coli K-12
ribosome50S ribosomal protein L23Escherichia coli K-12
cytoplasm50S ribosomal protein L23Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L23Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L23Escherichia coli K-12
cytoplasm30S ribosomal protein S15Escherichia coli K-12
cytosol30S ribosomal protein S15Escherichia coli K-12
ribosome30S ribosomal protein S15Escherichia coli K-12
intracellular organelle30S ribosomal protein S15Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S15Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S15Escherichia coli K-12
cytosol50S ribosomal protein L17Escherichia coli K-12
ribosome50S ribosomal protein L17Escherichia coli K-12
cytoplasm50S ribosomal protein L17Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L17Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L17Escherichia coli K-12
cytoplasm50S ribosomal protein L21Escherichia coli K-12
cytosol50S ribosomal protein L21Escherichia coli K-12
ribosome50S ribosomal protein L21Escherichia coli K-12
intracellular organelle50S ribosomal protein L21Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L21Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L21Escherichia coli K-12
ribosome50S ribosomal protein L30Escherichia coli K-12
cytoplasm50S ribosomal protein L30Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L30Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L30Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L30Escherichia coli K-12
cytosol50S ribosomal protein L6Escherichia coli K-12
ribosome50S ribosomal protein L6Escherichia coli K-12
cytoplasm50S ribosomal protein L6Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L6Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L6Escherichia coli K-12
cytoplasm30S ribosomal protein S14Escherichia coli K-12
ribosome30S ribosomal protein S14Escherichia coli K-12
intracellular organelle30S ribosomal protein S14Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S14Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S14Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S14Escherichia coli K-12
ribosome30S ribosomal protein S17Escherichia coli K-12
cytoplasm30S ribosomal protein S17Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S17Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S17Escherichia coli K-12
cytoplasm30S ribosomal protein S1Escherichia coli K-12
ribosome30S ribosomal protein S1Escherichia coli K-12
membrane30S ribosomal protein S1Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S1Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S1Escherichia coli K-12
cytoplasm50S ribosomal protein L18Escherichia coli K-12
cytosol50S ribosomal protein L18Escherichia coli K-12
ribosome50S ribosomal protein L18Escherichia coli K-12
intracellular organelle50S ribosomal protein L18Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L18Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L18Escherichia coli K-12
cytosol50S ribosomal protein L2Escherichia coli K-12
ribosome50S ribosomal protein L2Escherichia coli K-12
cytoplasm50S ribosomal protein L2Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L2Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L2Escherichia coli K-12
DnaA-L2 complex50S ribosomal protein L2Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L2Escherichia coli K-12
cytosol50S ribosomal protein L3Escherichia coli K-12
ribosome50S ribosomal protein L3Escherichia coli K-12
cytoplasm50S ribosomal protein L3Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L3Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L3Escherichia coli K-12
cytosol50S ribosomal protein L24Escherichia coli K-12
ribosome50S ribosomal protein L24Escherichia coli K-12
cytoplasm50S ribosomal protein L24Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L24Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L24Escherichia coli K-12
cytosol50S ribosomal protein L4Escherichia coli K-12
ribosome50S ribosomal protein L4Escherichia coli K-12
cytoplasm50S ribosomal protein L4Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L4Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L4Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L4Escherichia coli K-12
cytosol50S ribosomal protein L22Escherichia coli K-12
ribosome50S ribosomal protein L22Escherichia coli K-12
cytoplasm50S ribosomal protein L22Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L22Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L22Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L22Escherichia coli K-12
cytosol50S ribosomal protein L5Escherichia coli K-12
ribosome50S ribosomal protein L5Escherichia coli K-12
cytoplasm50S ribosomal protein L5Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L5Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L5Escherichia coli K-12
cytosol30S ribosomal protein S21Escherichia coli K-12
ribosome30S ribosomal protein S21Escherichia coli K-12
cytoplasm30S ribosomal protein S21Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S21Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S21Escherichia coli K-12
cytosol50S ribosomal protein L25Escherichia coli K-12
ribosome50S ribosomal protein L25Escherichia coli K-12
cytoplasm50S ribosomal protein L25Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L25Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L25Escherichia coli K-12
ribosome50S ribosomal protein L36 2Escherichia coli K-12
cytosolic ribosome50S ribosomal protein L36 2Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L36 2Escherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3258)

Assay IDTitleYearJournalArticle
AID620131Antimicrobial activity against Pseudomonas aeruginosa IFO 3448 at 100 ug/disc after 24 hrs by agar disc diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID266676Antibacterial activity against Escherichia coli2006Bioorganic & medicinal chemistry letters, Jul-15, Volume: 16, Issue:14
Synthesis and antibacterial evaluation of ureides of Baylis-Hillman derivatives.
AID490038Antimicrobial activity against Staphylococcus epidermidis at 100 ug/ml after 24 to 48 hrs by disk diffusion method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
One-pot multicomponent synthesis and anti-microbial evaluation of 2'-(indol-3-yl)-2-oxospiro(indoline-3,4'-pyran) derivatives.
AID1124796Antimicrobial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by standard broth microdilution method2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
AID276870Effect on human PCDH15 R3X mutation translation level at 80 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID463985Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid.
AID352090Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID717549Selectivity ratio of IC50 for ribosome-mediated protein synthesis in rabbit reticulocytes to IC50 for ribosome S30 subunit-mediated protein synthesis in Escherichia coli2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID717550Inhibition of ribosome-mediated translation of CFTR W1282X nonsense mutant gene expressed in human HEK293 cells after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID352094Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID1110803Antimicrobial activity against Corynebacterium accolens at 10 ug after 24 hr by disk diffusion method2005Phytochemistry, Jan, Volume: 66, Issue:2
Bioactive ellagitannins from Cunonia macrophylla, an endemic Cunoniaceae from New Caledonia.
AID592571Antibacterial activity against Staphylococcus aureus ATCC 29213 at 25 ug/disk by agar disk diffusion assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Phomalevones A-C: dimeric and pseudodimeric polyketides from a fungicolous Hawaiian isolate of Phoma sp. (Cucurbitariaceae).
AID371458Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID620133Antimicrobial activity against Staphylococcus aureus IFO 3060 after 24 hrs by two fold serial dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID1190605Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID1124793Antimicrobial activity against Escherichia coli ATCC 9637 after 24 hrs by standard broth microdilution method2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
AID717560Inhibition of ribosome-mediated translation of PCDH15 R3X nonsense mutant gene expressed in rabbit reticulocytes harboring p2luc plasmid after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID276869Suppression of human PCDH15 R3X mutation at 80 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID1190607Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID469840Antibacterial activity against Bacillus subtilis ATCC 6051 at 50 ug/disk by disk diffusion method2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Hymenopsins A and B and a macrophorin analogue from a fungicolous Hymenopsis sp.
AID717551Inhibition of mitochondrial ribosome-mediated protein synthesis in human HeLa cells assessed as {35S]methionine incorporation by autoradiography2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID717559Inhibition of ribosome-mediated translation of CFTR G542X nonsense mutant gene expressed in rabbit reticulocytes harboring p2luc plasmid after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID293589Antibacterial activity against Escherichia coli ATCC 25922 assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID352097Antimicrobial activity against multidrug-resistant Staphylococcus aureus after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID293584Antibacterial activity against Escherichia coli isolate assessed after 24 hrs by by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID352089Antimicrobial activity against Klebsiella pneumoniae RSHM 574 after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID592570Antibacterial activity against Bacillus subtilis ATCC 6051 at 25 ug/disk by agar disk diffusion assay2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Phomalevones A-C: dimeric and pseudodimeric polyketides from a fungicolous Hawaiian isolate of Phoma sp. (Cucurbitariaceae).
AID371459Antimicrobial activity against Staphylococcus aureus isolate after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID276867Antibacterial activity against Escherichia coli ATCC 25922 at 30 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID1190608Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID463986Antibacterial activity against Klebsiella pneumoniae after 24 hrs by broth microdilution method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid.
AID371461Antimicrobial activity against Bacillus subtilis isolate after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID717553Antibacterial activity against Bacillus subtilis ATCC-6633 by double-microdilution method2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID717565Inhibition of ribosome-mediated protein synthesis in rabbit reticulocytes after 60 mins by coupled transcription/translation assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID276866Effect on human PCDH15 R3X mutation translation level at 30 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID717556Inhibition of ribosome-mediated translation of IDUA Q70X nonsense mutant gene expressed in rabbit reticulocytes harboring p2luc plasmid after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID490040Antimicrobial activity against Aspergillus niger at 100 ug/ml after 24 to 48 hrs by disk diffusion method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
One-pot multicomponent synthesis and anti-microbial evaluation of 2'-(indol-3-yl)-2-oxospiro(indoline-3,4'-pyran) derivatives.
AID1124795Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by standard broth microdilution method2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
AID371463Antimicrobial activity against Escherichia coli isolate after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID293583Antibacterial activity against Pseudomonas aeruginosa isolate assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID371460Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID463984Antibacterial activity against Streptococcus viridans after 24 hrs by broth microdilution method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid.
AID1110804Antimicrobial activity against Staphylococcus aureus at 10 ug after 24 hr by disk diffusion method2005Phytochemistry, Jan, Volume: 66, Issue:2
Bioactive ellagitannins from Cunonia macrophylla, an endemic Cunoniaceae from New Caledonia.
AID293586Antibacterial activity against Staphylococcus aureus isolate assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID620134Antimicrobial activity against Bacillus subtilis IFO 3007 after 24 hrs by two fold serial dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID293590Antibacterial activity against Bacillus subtilis ATCC 6633 assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID293591Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID352096Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID293585Antibacterial activity against Bacillus subtilis isolate assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID1190610Antimicrobial activity against Candida tropicalis ATCC 750 assessed as inhibition of microbial growth incubated for 72 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID371464Antimicrobial activity against Klebsiella pneumoniae RSHM 574 after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID266675Antibacterial activity against Klebsiella pneumoniae2006Bioorganic & medicinal chemistry letters, Jul-15, Volume: 16, Issue:14
Synthesis and antibacterial evaluation of ureides of Baylis-Hillman derivatives.
AID490039Antimicrobial activity against Bacillus subtilis at 100 ug/ml after 24 to 48 hrs by disk diffusion method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
One-pot multicomponent synthesis and anti-microbial evaluation of 2'-(indol-3-yl)-2-oxospiro(indoline-3,4'-pyran) derivatives.
AID469841Antifungal activity against Candida albicans ATCC 14053 at 200 ug/disk by disk diffusion method2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Hymenopsins A and B and a macrophorin analogue from a fungicolous Hymenopsis sp.
AID352093Antimicrobial activity against Pseudomonas aeruginosa ATCC 25853 after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID620135Antimicrobial activity against Micrococcus luteus IFO 3232 after 24 hrs by two fold serial dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID1190609Antimicrobial activity against Candida albicans ATCC 10231 assessed as inhibition of microbial growth incubated for 72 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID371465Antimicrobial activity against Klebsiella pneumoniae after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID1190614Bactericidal activity against Pseudomonas aeruginosa ATCC 10145 assessed as microbial killing during 18 hrs post sub-culture onto drug-free solid media by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID1190604Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID620136Antimicrobial activity against Escherichia coli IFO 3301 after 24 hrs by two fold serial dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID276872Antibacterial activity against Bacillus subtilis ATCC 6633 at 80 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID293582Antibacterial activity against Klebsiella pneumoniae isolate assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID717557Inhibition of ribosome-mediated translation of DMD R3381X nonsense mutant gene expressed in rabbit reticulocytes harboring p2luc plasmid after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID717554Antibacterial activity against Escherichia coli R477/100 by microdilution method2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID1190612Bactericidal activity against Staphylococcus aureus ATCC 25923 assessed as microbial killing during 18 hrs post sub-culture onto drug-free solid media by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID276865Suppression of human PCDH15 R3X mutation at 30 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID1190606Antimicrobial activity against Escherichia coli ATCC 10536 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID266674Antibacterial activity against Streptococcus faecalis2006Bioorganic & medicinal chemistry letters, Jul-15, Volume: 16, Issue:14
Synthesis and antibacterial evaluation of ureides of Baylis-Hillman derivatives.
AID620054Antimicrobial activity against Staphylococcus aureus IFO 3060 at 100 ug/disc after 24 hrs by agar disc diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID1190613Bactericidal activity against Escherichia coli ATCC 10536 assessed as microbial killing during 18 hrs post sub-culture onto drug-free solid media by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID1190611Bactericidal activity against Bacillus subtilis ATCC 6633 assessed as microbial killing during 18 hrs post sub-culture onto drug-free solid media by broth dilution method2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Synthesis, antimicrobial activity and molecular docking of novel tetracyclic scaffolds incorporating a flavonoid framework with medium sized oxygen heterocycles.
AID717555Cytotoxicity against human HEK293 cells assessed as cell viability after 48 hrs by XTT based calorimetric assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID717558Inhibition of ribosome-mediated translation of CFTR W1282X nonsense mutant gene expressed in rabbit reticulocytes harboring p2luc plasmid after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID352092Antimicrobial activity against multidrug-resistant Escherichia coli after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID379782Antibacterial activity against Bacillus subtilis ATCC 6051 at 50 ug/disk by standard petri-plate assay1999Journal of natural products, May, Volume: 62, Issue:5
New verticillin and glisoprenin analogues from gliocladium catenulatum, a mycoparasite of aspergillus flavus sclerotia
AID717562Inhibition of ribosome-mediated translation of PCDH15 R245X nonsense mutant gene expressed in human HEK293 cells after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID620129Antimicrobial activity against Micrococcus luteus IFO 3232 at 100 ug/disc after 24 hrs by agar disc diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID717564Inhibition of ribosome-mediated translation of CFTR WG542X nonsense mutant gene expressed in human HEK293 cells after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID1124794Antimicrobial activity against Pseudomonas aeruginosa ATCC BAA-427 after 24 hrs by standard broth microdilution method2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
AID620130Antimicrobial activity against Escherichia coli IFO 3301 at 100 ug/disc after 24 hrs by agar disc diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID717566Inhibition of ribosome S30 subunit-mediated protein synthesis in Escherichia coli after 60 mins by coupled transcription/translation assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID293587Antibacterial activity against Klebsiella pneumoniae RSHM 574 assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID1110805Antimicrobial activity against Pectobacterium carotovorum at 10 ug after 24 hr by disk diffusion method2005Phytochemistry, Jan, Volume: 66, Issue:2
Bioactive ellagitannins from Cunonia macrophylla, an endemic Cunoniaceae from New Caledonia.
AID266673Antibacterial activity against Staphylococcus aureus2006Bioorganic & medicinal chemistry letters, Jul-15, Volume: 16, Issue:14
Synthesis and antibacterial evaluation of ureides of Baylis-Hillman derivatives.
AID620137Antimicrobial activity against Pseudomonas aeruginosa IFO 3448 after 24 hrs by two fold serial dilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID293588Antibacterial activity against Pseudomonas aeruginosa ATCC 25853 assessed after 24 hrs by serial dilution method2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
AID378751Antimicrobial activity against Bacillus subtilis ATCC 6051 at 50 ug/disk by standard disk assay1999Journal of natural products, Feb, Volume: 62, Issue:2
Antifungal and antibacterial metabolites from a sclerotium-colonizing isolate of Mortierella vinacea.
AID717563Inhibition of ribosome-mediated translation of PCDH15 R3X nonsense mutant gene expressed in human HEK293 cells after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID379784Antibacterial activity against Staphylococcus aureus ATCC 14053 at 50 ug/disk by standard petri-plate assay1999Journal of natural products, May, Volume: 62, Issue:5
New verticillin and glisoprenin analogues from gliocladium catenulatum, a mycoparasite of aspergillus flavus sclerotia
AID620128Antimicrobial activity against Bacillus subtilis IFO 3007 at 100 ug/disc after 24 hrs by agar disc diffusion method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents.
AID276871Antibacterial activity against Escherichia coli ATCC 25922 at 80 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID490037Antimicrobial activity against Staphylococcus aureus at 100 ug/ml after 24 to 48 hrs by disk diffusion method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
One-pot multicomponent synthesis and anti-microbial evaluation of 2'-(indol-3-yl)-2-oxospiro(indoline-3,4'-pyran) derivatives.
AID266677Antibacterial activity against Pseudomonas aeruginosa2006Bioorganic & medicinal chemistry letters, Jul-15, Volume: 16, Issue:14
Synthesis and antibacterial evaluation of ureides of Baylis-Hillman derivatives.
AID371462Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID352095Antimicrobial activity against ceftriazone-resistant Bacillus subtilis after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID717561Inhibition of ribosome-mediated translation of PCDH15 R245X nonsense mutant gene expressed in rabbit reticulocytes harboring p2luc plasmid after 16 hrs by dual luciferase reporter gene assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations.
AID378753Antimicrobial activity against Staphylococcus aureus ATCC 14053 at 50 ug/disk by standard disk assay1999Journal of natural products, Feb, Volume: 62, Issue:2
Antifungal and antibacterial metabolites from a sclerotium-colonizing isolate of Mortierella vinacea.
AID352091Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
AID371466Antimicrobial activity against Pseudomonas aeruginosa ATCC 25853 after 24 hrs by disk diffusion method2008European journal of medicinal chemistry, Jul, Volume: 43, Issue:7
Synthesis and biological activity of some new benzoxazoles.
AID463987Antibacterial activity against Proteus mirabilis after 24 hrs by broth microdilution method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid.
AID469838Antibacterial activity against Staphylococcus aureus ATCC 25923 at 50 ug/disk by disk diffusion method2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Hymenopsins A and B and a macrophorin analogue from a fungicolous Hymenopsis sp.
AID276868Antibacterial activity against Bacillus subtilis ATCC 6633 at 30 ug/ml2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
AID283539Antibacterial activity against Pseudomonas aeruginosa FE57G with inactivated rplY and nuoG genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID396000Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
AID152322Minimum inhibitory concentration was measured against Providencia stuartii 75082808 producing AAC-(2'') modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID548740Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID1188548Antimicrobial activity against Staphylococcus aureus assessed as inhibition of visible growth after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID531780Antibacterial activity against Pseudomonas aeruginosa obtained from complicated skin and skin structure infections by agar dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
AID573334Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID531737Induction of mexY in Pseudomonas aeruginosa 3308 clinical isolate harboring nfxB deltaA122-G131 mutant gene at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID533339Antibacterial activity against non-gentamicin-resistant Pseudomonas aeruginosa clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID573378Antibacterial activity against imipenem-susceptible Acinetobacter assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID545042Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ043 from patient abdominal drainage by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID429830Antibacterial activity against Escherichia coli ATCC 25922 at 10 ug2009Journal of natural products, Jun, Volume: 72, Issue:6
Phenylphenalenones from the Australian plant Haemodorum simplex.
AID446125Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID521591Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 5.7 by broth dilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID400531Antibacterial activity against Micrococcus luteus IFO 12708 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID573545Antibacterial activity against Klebsiella pneumoniae Kp3799 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID573494Antibacterial activity against Enterobacter cloacae isolate El3518 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID542721Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as resistant isolates2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
AID561478Antibacterial activity against Pseudomonas aeruginosa by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID565745Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID625836Antibacterial activity against Escherichia coli by micro-broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
AID460801Antibacterial activity against Acinetobacter baumannii 3304 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID743579Antimicrobial activity against Escherichia coli at 100 ug after 24 hrs by agar disc diffusion method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID561661Antimicrobial activity against Pseudomonas aeruginosa isolate OC17349 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID428880Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit by footprint assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID1257069Antibacterial activity against Staphylococcus aureus ATCC 29213 after 20 hrs by CLSI broth microdilution method2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis of biscoumarin and dihydropyran derivatives with promising antitumor and antibacterial activities.
AID460794Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID571694Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 3 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID565006Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1127110Antibacterial activity against Klebsiella pneumoniae by NCCLS two-fold dilution method2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID1245988Antimicrobial activity against Erwinia amylovora 1501 after 24 hrs by spectrophotometry2015Journal of medicinal chemistry, Jan-22, Volume: 58, Issue:2
Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
AID1133316Antibacterial activity against Corynebacterium acnes ATCC 11828 assessed as lowest concentration required for total inhibition by broth microdilution assay1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles.
AID394685Antibacterial activity against wild type Pseudomonas aeruginosa isolate by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID743581Antimicrobial activity against Micrococcus luteus at 100 ug after 24 hrs by agar disc diffusion method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID565015Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565749Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID422127Antimicrobial activity against Staphylococcus aureus by broth microdilution assay2009Journal of natural products, May-22, Volume: 72, Issue:5
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua.
AID1230231Antibacterial activity against Listeria monocytogenes CIP 103575 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID542044Antibacterial activity against Escherichia coli TrC B expressing Klebsiella pneumoniae B blaCTX-M beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID746787Antimicrobial activity against Escherichia coli ATCC 25922 after 18 to 20 hrs by macrobroth dilution method2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
AID533334Antibacterial activity against non-gentamicin-resistant Serratia marcescens clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID573517Antibacterial activity against Serratia marcescens isolate Sm203 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID285656Antimicrobial activity against Pseudomonas aeruginosa 19E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID565072Antibacterial activity against SHV-12 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID584121Antimicrobial activity against methicillin-resistant Staphylococcus aureus ST398 isolate 11 containing apmA, erm(B), tet(L), tet(M), tet(K), dfrK, aadD, mecA, blaZ resistance genes by CLSI M31-A3 method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.
AID559771Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy39 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID561241Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID532407Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B2 isolate VA-06X-20 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID585429Antimicrobial activity against Escherichia coli C600 ST2-T transconjugant harboring oqxAB, qnrB6 and aac(6')-Ib-cr genes by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID534343Antimicrobial activity against Burkholderia pseudomallei Bp173 harboring mini-Tn7T after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID295083Antibacterial activity against Klebsiella pneumoniae UC57 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID251737Zone of inhibition of Staphylococcus aureus after treatment with 10 ug of the compound2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones.
AID1553770Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID535879Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae JN132 harboring GyrA S83I, ParC S80I mutant, wild-type GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID540929Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor KO-347 harboring rpsl P91S mutant gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID766159Antibacterial activity against methicillin-resistant Staphylococcus aureus MW2 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID394701Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, ANT(2'')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID1167676Antibacterial activity against wild type Escherichia coli BW251132014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.
AID583429Antibacterial activity against aminoglycoside-resistant Staphylococcus epidermidis expressing APH(3')-3 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1159097Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID532202Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae WH99 harboring wild-type GyrA, ParC, GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID573363Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID599623Antibacterial activity against Micrococcus luteus AGD12011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID674907Antibacterial activity against Escherichia coli MTCC 4432012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
AID528832Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient urine assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID731203Antibacterial activity against Escherichia coli MTCC 443 after 24 hrs by broth microdilution method2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
AID560598Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID1230237Antibacterial activity against Staphylococcus aureus CIP 483 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID524825Antibacterial activity against erythromycin susceptible Campylobacter sp. by agar plate dilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID1056865Antibacterial activity against Pseudomonas aeruginosa FNSST 982 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID497694Antimicrobial activity against colistin-resistant Klebsiella pneumoniae isolated from bacteremia patient assessed as percentage of resistant isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
AID373760Antibacterial activity against imipenem-intermediate Acinetobacter baumannii ab1297 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID572147Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID573379Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID573382Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID374136Antimicrobial activity Enterobacter cloacae 91 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID481453Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID278856Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID530329Antimicrobial activity against Escherichia coli XL1-Blue harboring pGEM-T carrying aacA4 Ala108Thr mutant gene by Etest method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID565012Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID563877Antimicrobial activity against methicillin-resistant Staphylococcus aureus 9344 using 2.5 X 10'5 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID572146Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii unique clonal group isolate 40 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID573341Antibacterial activity against ceftazidime-susceptible Citrobacter freundii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID587244Antimicrobial activity against Pseudomonas aeruginosa DSM 1128 at 1 ug/ul after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID565007Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1230241Antibacterial activity against Staphylococcus aureus CIP 7625 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID573723Antibacterial activity against Klebsiella pneumoniae Kp204 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1241207Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID257550Antibacterial activity against Streptococcus faecalis2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
AID516169Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID1055476Antibacterial activity against Pseudomonas aeruginosa DSM 50071 assessed as growth inhibition2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Gymnopalynes A and B, chloropropynyl-isocoumarin antibiotics from cultures of the basidiomycete Gymnopus sp.
AID766172Antibacterial activity against Bacillus cereus NCTC 7464 after 20 to 24 hrs by two-fold broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID386863Antibacterial activity against clinical isolate resistant Proteus vulgaris after 16 hrs by microbroth dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID495511Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4665 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID583235Antibacterial activity against Enterobacter spp. by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID285646Antimicrobial activity against Pseudomonas aeruginosa 16D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID258350MIC per disc against Escherichia coli by disc diffusion method2006Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
AID1056852Antibacterial activity against CTX-15 expressing Stenotrophomonas maltophilia isolate 125 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID410023Antimicrobial activity against Staphylococcus aureus after 24 hrs by well diffusion method2008Bioorganic & medicinal chemistry letters, Dec-01, Volume: 18, Issue:23
Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
AID528717Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID1553817Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of ZnCl22019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID521573Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse Nramp deficient RAW 264.7 cells at 100 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID531765Antimicrobial activity against Pseudomonas aeruginosa blood isolate 4667 containing PFGE clone A expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID564809Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID731201Antibacterial activity against Vibrio cholerae MTCC 3906 after 24 hrs by broth microdilution method2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
AID558754Antibacterial activity against methicillin-susceptible, tetracycline-resistant and chloramphenicol-resistant Staphylococcus aureus deltaIP-KVR by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID571065Drug uptake in Wistar rat Kidney Henle's loop cells obtained after tissue digestion with 0.04% protease digestion for 15 mins to 2 hrs mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID510503Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate M2AC9-31 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID560499Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 5zjsau3 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID532418Antibacterial activity against IMP-13 producing Pseudomonas aeruginosa clone C3 isolate PG-12X-03 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID561462Antibacterial activity against Proteus mirabilis by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID565744Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID64908Minimum inhibitory concentration was measured against Escherichia coli 76070703 producing AAC-(3)-I modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID285632Antimicrobial activity against Pseudomonas aeruginosa 10A9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID276382Antibacterial activity against Staphylococcus aureus by broth microdilution technique2006Bioorganic & medicinal chemistry letters, Nov-15, Volume: 16, Issue:22
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
AID278803Antimicrobial activity against recombinant Escherichia coli DHalpha expressing pBAD [aph(3')-2]2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
AID1230208Antibacterial activity against Bacillus cereus N349 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID573722Antibacterial activity against Klebsiella oxytoca Ko238 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID446126Antibacterial activity against AAC6'-2a expressing Pseudomonas aeruginosa F03 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID575148Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID394699Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID369007Sensitivity of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 10 ug/disk after 20 hrs2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
AID583224Antibacterial activity against Acinetobacter baumannii ATCC 19606 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID516165Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates by CLSi method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID534338Antimicrobial activity against Burkholderia pseudomallei Bp250 harboring mini-Tn7T-bpeA+B+ -oprB+ after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID432092Antibacterial activity against Escherichia coli at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID519177Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 8 ug/ml of amikacin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID736480Antibacterial activity against Staphylococcus aureus RCMB 010027 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID1230222Antibacterial activity against Enterococcus faecium N490 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID561933Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate RUH134 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
AID470153Antimicrobial activity against Staphylococcus aureus ATCC 6538 by disk diffusion method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents.
AID285653Antimicrobial activity against Pseudomonas aeruginosa 19C12 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID561673Antimicrobial activity against Pseudomonas aeruginosa isolate OC14812 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID573346Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID534173Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid MEZ by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID486256Antibacterial activity against Staphylococcus aureus NCIM 2120 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID69601Minimum bacterial concentration (MBC) against Escherichia coli2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents.
AID521588Reduction in light emission by Salmonella enterica serovars virchow isolate 101591 after 5mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID516162Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID521283Antimicrobial activity against CTX-M-59 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype G by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID536092Antimicrobial activity against Candida albicans IFO 0583 after 48 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID583230Antibacterial activity against Pseudomonas aeruginosa expressing ANT(4')-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID278809Antibacterial activity against Escherichia coli BL21(DE3)2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID535832Antimicrobial activity against wild-type Pseudomonas aeruginosa GP61 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID561244Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID250297Susceptibility testing against Pseudomonas aeruginosa PAE_NUH22; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID738390Antibacterial activity against Escherichia coli ATCC 8099 after 24 hrs by NCCLS method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Efficient synthesis and antimicrobial activity of some novel S-β-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.
AID533663Antimicrobial activity against Staphylococcus aureus RN10242008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID338269Antimicrobial activity against Micrococcus luteus DSM 348 after 18 hrs by twofold serial dilution method1994Journal of natural products, Dec, Volume: 57, Issue:12
Biological effects of prenylated hydroquinones: structure-activity relationship studies in antimicrobial, brine shrimp, and fish lethality assays.
AID278857Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID253032Antimicrobial activity against Pseudomonas aeruginosa was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.
AID276386Antibacterial activity against Pseudomonas aeruginosa by broth microdilution technique2006Bioorganic & medicinal chemistry letters, Nov-15, Volume: 16, Issue:22
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
AID422455Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as growth inhibition at 0.25 ug/mL using static culture after 24 hrs2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID486414Antibacterial activity against Klebsiella pneumoniae NCIM 5082 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID481459Antibacterial activity against Streptococcus pneumoniae ATCC 13883 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID1056843Antibacterial activity against CTX-15 expressing Enterobacter cloacae isolate 51 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID581659Fraction unbound in human plasma2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID534108Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID563521Antibacterial activity against Pseudomonas aeruginosa NY217 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
AID563597Antimicrobial activity against ESBL producing Escherichia coli assessed as resistant isolates by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
AID532199Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae WH42T harboring qnrA gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID447238Antibacterial activity against Bacillus cereus ATCC 7064 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID1056856Antibacterial activity against Escherichia coli FNSST 982 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID561237Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1235643Antibacterial activity against Streptococcus pyogenes DSM 11728 incubated for 24 hrs by disk diffusion method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Endophytic Diaporthe sp. LG23 Produces a Potent Antibacterial Tetracyclic Triterpenoid.
AID523490Antimicrobial activity against Pseudomonas aeruginosa AHP Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID583251Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing AAC(3)-4 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID529494Antimicrobial activity against Enterobacter cloacae isolate 837 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID774219Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID529194Antibacterial activity against AmpC-producing Escherichia coli isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
AID278861Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID245249Minimum inhibitory concentration gainst Staphylococcus aureus by broth microdilution technique2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents.
AID583268Antibacterial activity against aminoglycoside-resistant Staphylococcus epidermidis expressing APH(2'') + AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID520958Antimicrobial activity against Corynebacterium minutissimum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID573537Antibacterial activity against Klebsiella pneumoniae Kp7564 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID207263In vitro minimum inhibitory concentration against Staphylococcus aureus (SFCO-1a)1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group.
AID285616Antimicrobial activity against Pseudomonas aeruginosa 3E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID257552Antibacterial activity against Escherichia coli2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
AID1224519Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 9449/2007 after 7 days by micromethod2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID495517Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4675 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID528821Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient wound assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID565064Antibacterial activity against SHV-12 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID444058Volume of distribution at steady state in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID564822Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID348883Antibacterial activity against Bacillus subtilis ATCC 465 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID533581Antibacterial activity against gentamicin-resistant Morganella morganii clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID534306Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA5092010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID585418Antimicrobial activity against Escherichia coli C600 by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID532401Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone D3 isolate VA-06X-65 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID533574Antibacterial activity against gentamicin-resistant Escherichia coli clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID523494Antimicrobial activity against Pseudomonas aeruginosa isolate 1530c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID560593Antimicrobial activity against rifampin-resistant Pseudomonas aeruginosa ATCC 27853 by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID770916Antibacterial activity against Bacillus subtilis IFO 3007 after 24 hrs by two fold dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID521574Antibacterial activity against Salmonella infected in mouse Nramp1 deficient RAW 264.7 cells assessed as log reduction in viable count at 100 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID603578Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID571906Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 17 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1159099Antimicrobial activity against Pseudomonas aeruginosa ATCC 35032 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID422471Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biomass of biofilm at 0.25 ug/mL after 2 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID540927Antimicrobial activity against Streptomyces coelicolor 1147 after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID561029Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as disruption of plasma membrane permeability at 4 times MIC by ethidium bromide uptake assay2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Antibacterial properties and mode of action of a short acyl-lysyl oligomer.
AID583215Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing armA methylase by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1230226Antibacterial activity against Enterococcus gallinarum CIP 105985 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID519106Antibacterial activity against Escherichia coli 10418 after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID529456Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone A expressing beta-lactamase Oxa-48, TEM-1, SHV-12 and Oxa-9 by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
AID1167359Antibacterial activity against Staphylococcus aureus ATCC 29213 expressing norA after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID532389Antibacterial activity against VIM-1 producing Enterobacter cloacae isolate TO-16X-51 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID533333Antibacterial activity against non-gentamicin-resistant Proteus mirabilis clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID529651Antimicrobial activity against Escherichia coli DH5alpha harboring beta-lactamase VIM-2 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID64906Minimum inhibitory concentration was measured against Escherichia coli 72091801 producing AAC-(3)-I modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID326501Antibacterial activity against vancomycin-susceptible Enterococcus faecalis 309 after 24 hrs by broth macrodilution method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
AID548531Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID561672Antimicrobial activity against Pseudomonas aeruginosa isolate OC16830 harboring plasmid MexZ expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID486969Antibacterial activity against Escherichia coli after 24 hrs by micro broth dilution method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
AID94293Minimum inhibitory concentration was measured against Klebsiella pneumoniae 7608271 producing AAC-(3)-II modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID422468Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biofilm formation at 8 ug/mL after 2 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID583242Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID477751Antimicrobial activity against Staphylococcus aureus after 24 hrs2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives.
AID423913Bactericidal activity against high inoculum density stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc at 100 ug/mL after 24 hrs by time kill study2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
AID1171851Antibacterial activity against Staphylococcus aureus assessed as growth inhibition after 24 hrs by broth microdilution assay2014Journal of natural products, Dec-26, Volume: 77, Issue:12
Indole alkaloid glycosides from the aerial parts of Strobilanthes cusia.
AID573355Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1127108Antibacterial activity against gentamicin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by spectrophotometric analysis2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID585426Antimicrobial activity against oqxAB positive Escherichia coli C600 X1B1-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID561482Antibacterial activity against Pseudomonas aeruginosa assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID763666Antibacterial activity against Escherichia coli after 24 hrs by microdilution susceptibility method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID326500Antibacterial activity against vancomycin-resistant Enterococcus faecalis UCN41 after 24 hrs by broth macrodilution method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
AID533620Bactericidal activity against Staphylococcus aureus ATCC 29213 at >=1 MIC up to 8 hrs by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID533332Antibacterial activity against non-gentamicin-resistant Citrobacter diversus clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID533576Antibacterial activity against gentamicin-resistant Enterobacter cloacae clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID545053Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ372 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID557785Antimicrobial activity against Escherichia coli CAN-ICU 61714 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID394708Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing AAC(6')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID520963Antimicrobial activity against Arcanobacterium haemolyticum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID562590Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID520956Antimicrobial activity against Corynebacterium amycolatum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID571922Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 25 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID532399Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone D2 isolate VA-06X-16 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID523892Antimicrobial activity against Acinetobacter baumannii ATCC 15151 harboring ISAba1-blaOXA-23 gene by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
AID560516Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 11b091 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID1224539Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID573361Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID386862Antibacterial activity against clinical isolate resistant Escherichia coli after 16 hrs by microbroth dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID731202Antibacterial activity against Salmonella typhi MTCC 98 after 24 hrs by broth microdilution method2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
AID555554Antimicrobial activity against Pseudomonas aeruginosa isolate M136074 expressing IMP-22 beta lactamase gene by Etest2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
AID1127111Antibacterial activity against Escherichia coli after 24 hrs by spectrophotometric analysis2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID575277Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID369011Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 10 ug/disk after 20 hrs2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
AID285593Antimicrobial activity against Pseudomonas aeruginosa 65.38-4 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1127106Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by spectrophotometric analysis2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID395400Antibacterial activity against Klebsiella pneumoniae TCC 109 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID573511Antibacterial activity against Morganella morganii isolate Mm1614 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID516159Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates by CLSi method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID573348Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID400532Antibacterial activity against Klebsiella pneumoniae IFO 13541 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID520965Antimicrobial activity against Listeria monocytogenes isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID64907Minimum inhibitory concentration was measured against Escherichia coli 73110901 producing AAC-(6')-I) modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID373039Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ32 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID447235Antibacterial activity against Escherichia coli ATCC 11230 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID520295Antimicrobial activity against extracellular Staphylococcus aureus 2548 after 4 hrs in MH-II broth2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID529481Antimicrobial activity against Enterobacter cloacae isolate 18 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID1553777Antibacterial activity against Staphylococcus epidermidis ATCC 12228 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID532403Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone E isolate VA-06X-29 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID528732Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID562810Antimicrobial activity against Escherichia coli J53 harboring pEK499 plasmid encoding CTX-M extended-spectrum beta-lactamases2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID1056869Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID477409Antibacterial activity against Staphylococcus aureus NCTC 8325 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID542060Antibacterial activity against Klebsiella pneumoniae expressing CTX-M group 1 beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID583271Antibacterial activity against aminoglycoside-resistant Acinetobacter baumannii expressing APH(3')-6 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1553789Bactericidal activity against Escherichia coli K88 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID597598Antibacterial activity against vancomycin intermediate Staphylococcus aureus ATCC 106414 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID244911In-vitro minimum inhibitory concentration against the growth of Pseudomonas aeruginosa2005Bioorganic & medicinal chemistry letters, Jul-01, Volume: 15, Issue:13
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
AID285626Antimicrobial activity against Pseudomonas aeruginosa 9A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID573393Antibacterial activity against ceftazidime-susceptible Providencia sp. assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID428266Antimicrobial activity against carbapenemase producing Enterobacteriaceae by CLSI broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID583217Antibacterial activity against aminoglycoside-resistant Serratia marcescens expressing ANT(2''), AAC(6') by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID523498Antimicrobial activity against Pseudomonas aeruginosa isolate 14169c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID536089Antimicrobial activity against Micrococcus luteus IFO 3232 after 24 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID395836Antimicrobial activity against Cryptococcus neoformans after 72 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID520810Antimicrobial activity against SHV-5 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype D by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID763672Antibacterial activity against Bacillus subtilis at 200 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID523516Antimicrobial activity against Pseudomonas aeruginosa isolate 13120 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID521598Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse Nramp deficient RAW 264.7 cells at 100 ug/ml after 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID521802Antimicrobial activity against Francisella tularensis subsp. tularensis after 48 hrs by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
AID1127112Antibacterial activity against Klebsiella pneumoniae after 24 hrs by spectrophotometric analysis2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID533579Antibacterial activity against gentamicin-resistant Proteus mirabilis clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1241225Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) assessed as change in total free energy by thermodynamic assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID717370Antibacterial activity against Escherichia coli MTCC 1573 at 10 ug per disk after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach.
AID532178Antimicrobial activity against aac(6')-Ib-cr-negative Klebsiella pneumoniae SY22 harboring GyrA S83I, ParC S80I mutant, wild-type GyrB and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID561454Antibacterial activity against Enterobacter cloacae by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID736481Antibacterial activity against Proteus vulgaris RCMB 010085 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID1553772Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID583244Antibacterial activity against aminoglycoside-resistant Citrobacter freundii expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID548528Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID424860Antimicrobial activity against Escherichia coli XL1-Blue by E-test2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID532027Antimicrobial activity against Kluyvera georgiana 14751 expressing beta-lactamase CTX-M-78 obtained from bloodstream of patient by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
AID637159Antibacterial activity against Sarcina lutea ATCC 9341 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID428272Antimicrobial activity against carbapenemase producing Enterobacter sp. by CLSI broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID534178Antimicrobial activity against Escherichia coli TOP10 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID534296Antimicrobial activity against Pseudomonas aeruginosa isolate PA477 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID504049Antimicrobial activity against Staphylococcus aureus MTCC 96 by broth microdilution technique2010Bioorganic & medicinal chemistry letters, Sep-15, Volume: 20, Issue:18
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
AID583225Antibacterial activity against aminoglycoside-resistant Acinetobacter calcoaceticus expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1235640Antibacterial activity against Escherichia coli DSM 682 incubated for 24 hrs by disk diffusion method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Endophytic Diaporthe sp. LG23 Produces a Potent Antibacterial Tetracyclic Triterpenoid.
AID533605Antibacterial activity against gentamicin-resistant Enterococcus faecalis clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID573349Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID558758Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant and rifampicin-resistant Staphylococcus aureus deltaIP-rifR::vraSH14 by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID561233Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID201750Minimum inhibitory concentration was measured against Serratia marcescens S20.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID278668Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 25302007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID564823Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID400281Antimicrobial activity against Bacillus subtilis Vernon after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID565748Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID563523Antibacterial activity against Pseudomonas aeruginosa NY220 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
AID532907Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 526 ST 376 expressing beta-lactamase SHV-1 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID597665Antibacterial activity against Pseudomonas aeruginosa CIP 5933 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID535894Antimicrobial activity against aac(6')-Ib-cr-negative Citrobacter freundii JN64T harboring qnrA gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID560515Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 13b16 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID583237Antibacterial activity against Proteus mirabilis by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID523004Antibacterial activity against uropathogenic Escherichia coli UTI89 assessed as degradation of preexisting biofilm after 24 hrs by microscopy2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID472622Antibacterial activity against Staphylococcus aureus after 24 hrs by microdilution susceptibility method2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID599612Antibacterial activity against Escherichia coli ATCC 259382011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID465553Antibacterial activity against Klebsiella pneumoniae by NCCLS broth microdilution method2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Stereospecific synthesis of oximes and oxime ethers of 3-azabicycles: A SAR study towards antimicrobial agents.
AID603579Antimicrobial activity against Bacillus cereus CCM 99 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID509632Antimicrobial activity against Staphylococcus aureus 25 transformant carrying plasmid pKKS25 and expressing erm(T), dfrKtet(L), tet(K), tet(M), mecA and blaZ genes by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID533344Antibacterial activity against non-gentamicin-resistant Staphylococcus epidermidis clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID534168Antimicrobial activity against Escherichia coli TOP10 harboring plasmid VOG2 expressing CTX-M-14 and AAC(6 )-Ib gene by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID548526Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID1056845Antibacterial activity against TEM-1/SHV-12 expressing Enterobacter cloacae isolate 306 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1185240Antimicrobial activity against Escherichia coli RCMB 010052 assessed as inhibition zone at 5 mg/ml after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
AID603659Antimicrobial activity against Proteus vulgaris ATCC 6897 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID599624Antibacterial activity against Salmonella Typhimurium isolate 112011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID278876Antiproliferative effect against primary human osteoblasts in presence of 10% FCS2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID637152Antibacterial activity against Bacillus subtilis ATCC 6633 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID1553782Antifungal activity against Candida parapsilosis cgmcc2.3989 measured after 48 hrs by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID534097Antibacterial activity against Acinetobacter baumannii PFGE type A isolate by microdilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
AID424337Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH194 harboring Pro404Leu mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID561660Antimicrobial activity against Pseudomonas aeruginosa isolate OC16830 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID533614Bactericidal activity against Escherichia coli ATCC 25922 assessed as log reduction in viable-cell count at 0.5 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID535697Antimicrobial activity against Azide-resistant Escherichia coli J53 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
AID520779Antibacterial activity against Escherichia coli EC600 by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
AID577223Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISphoA/haha mutation by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID533586Antibacterial activity against gentamicin-resistant Pseudomonas spp. clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID753894Bactericidal activity against Pseudomonas aeruginosa ATCC 10145 by broth dilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c][1,2,4]triazine derivatives from new 5-aminopyrazoles.
AID766180Antibacterial activity against Escherichia coli assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID373025Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU73 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID561246Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID449252Antibacterial activity against Klebsiella pneumoniae RITCC 1249 at 10 ug after overnight incubation by agar well diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, spectroscopic characterization and antibacterial activity of new cobalt(II) complexes of unsymmetrical tetradentate (OSN2) Schiff base ligands.
AID586053Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID599616Antibacterial activity against Vibrio cholerae isolate 72012011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID523502Antimicrobial activity against Pseudomonas aeruginosa isolate 1333c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID425393Antibacterial activity against mucosa-associated Escherichia coli isolates isolated from patients with Crohn's disease by disk diffusion method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID395779Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID562384Antimicrobial activity against Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID533583Antibacterial activity against gentamicin-resistant Proteus rettgeri clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID422953Antibacterial activity against heteroresistant Acinetobacter baumannii-calcoaceticus complex isolated from total cumulative patients preexposed to 325 to 900 mg of drug after 20 to 24 hrs by broth microdilution method2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.
AID534777Cmax in war-wounded patient infected with Acinetobacter baumannii-calcoacetius at 5 to 7 mg/kg/day2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
AID554438Ratio of MIC for Pseudomonas aeruginosa 2804 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID585423Antimicrobial activity against oqxAB positive Escherichia coli C600 G262-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID446136Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PA22 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID519737Antibacterial activity against Escherichia coli DH5alpha expressing Klebsiella pneumoniae beta-lactamase SHV-1 by agar dilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID584565Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID1224523Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 1 after 7 days by micromethod2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID287390Antibacterial activity against Proteus vulgaris after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID563519Antibacterial activity against Pseudomonas aeruginosa NY214 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
AID423908Antibacterial activity against exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc by broth microdilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
AID486254Antibacterial activity against Escherichia coli NCIM 2065 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID351920Suppression of Dystrophin R3381X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID774221Antibacterial activity against Acinetobacter lwoffii ATCC 17925 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID575149Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS3 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID532406Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B1 isolate SS-09X-45 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID574433Antimicrobial activity against Escherichia coli isolate 543T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID1240506Antibacterial activity against Escherichia coli DS17232 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID395406Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID519740Antibacterial activity against Escherichia coli DH5alpha expressing Klebsiella pneumoniae beta-lactamase SHV-72 by agar dilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID573504Antibacterial activity against Morganella morganii isolate Mm1229 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID731205Antibacterial activity against Clostridium tetani MTCC 449 after 24 hrs by broth microdilution method2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
AID1242644Antibacterial activity against methicillin/gentamicin-resistant Staphylococcus aureus ATCC 33592 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID509866Antibacterial activity against Acinetobacter baumannii isolate 510 isolated from human sputum2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID490930Antibacterial activity against Bacillus subtilis NCIM 2546 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents.
AID751576Antibacterial activity against Staphylococcus aureus ATCC 6638P after 4 to 24 hrs2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
Phosphonic analogues of glutamic acid as irreversible inhibitors of Staphylococcus aureus endoproteinase GluC: an efficient synthesis and inhibition of the human IgG degradation.
AID561665Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID564832Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID519107Antibacterial activity against Proteus mirabilis B2 after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID558757Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus deltaIP::vraSH14 harboring vraSH14 S329L mutant gene by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID571890Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 9 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID599620Antibacterial activity against Shigella flexneri DN132011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID607927Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth dilution method2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Phytochemical studies on Stemona aphylla: isolation of a new stemofoline alkaloid and six new stemofurans.
AID425001Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution technique2009Journal of natural products, May-22, Volume: 72, Issue:5
Alkaloids from the roots of Stemona aphylla.
AID470295Antibacterial activity against Escherichia coli ATCC 9637 after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
Design and synthesis of bile acid-based amino sterols as antimicrobial agents.
AID523518Antimicrobial activity against Pseudomonas aeruginosa isolate 17112 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285678Antimicrobial activity against Pseudomonas aeruginosa 29G6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1129351Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 700221 after 18 hrs by microdilution broth method2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
AID250300Susceptibility testing against Pseudomonas aeruginosa PAE_NUH25; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID564817Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID338247Antimicrobial activity against Staphylococcus albus Sal1091-4 at 1 ug/disk1994Journal of natural products, Nov, Volume: 57, Issue:11
Vibrindole A, a metabolite of the marine bacterium, Vibrio parahaemolyticus, isolated from the toxic mucus of the boxfish Ostracion cubicus.
AID529738Induction of apoptosis in pig LLC-PK1 cells assessed as caspase 3 activity at 2 mM after 2 days by DAPI staining2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID554390Antimicrobial activity against Pseudomonas aeruginosa isolate 615S obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID521599Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 assessed as log reduction in viable counts at 150 ug/ml after 1hr2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID567293AUC (0 to 24 hrs) in critically ill patient with acute kidney injury at 5 mg/kg, iv administered as 1 hr infusion2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID558070Half life in human eye administered as intracameral injection2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Pharmacokinetics of intracameral voriconazole injection.
AID1242641Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID356407Antibacterial activity against Escherichia coli2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID565065Antibacterial activity against CTX-M-14 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID278801Antimicrobial activity against recombinant Escherichia coli DH5alpha expressing pBAD2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
AID395407Antibacterial activity against Staphylococcus aureus MTCC 737 after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID521592Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 7.0 by broth dilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID562595Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID573370Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID535389Antibacterial activity against phenotypic revertant Staphylococcus aureus OM1b:F8 harboring 694-702 nucleotide deletion in menB gene by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID516167Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID542063Antibacterial activity against Klebsiella pneumoniae B expressing CTX-M group 1 beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID585425Antimicrobial activity against oqxAB positive Escherichia coli C600 G375-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID1167353Antibacterial activity against Escherichia coli D21 IpxC101 deletion mutant after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID285612Antimicrobial activity against Pseudomonas aeruginosa 65.68-4 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID565018Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID529198Antibacterial activity against AmpC-producing Escherichia coli assessed as sensitive isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
AID1553788Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID481458Antibacterial activity against Acinetobacter baumannii CAN-ICU 63169 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID429838Antibacterial activity against Escherichia coli by microdilution assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Pyrrolidinoindoline alkaloids from Selaginella moellendorfii.
AID557780Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis CAN-ICU 61589 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID563503Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 79 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID573540Antibacterial activity against Morganella morganii Mm38009 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID558254Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in intracellular bacterial cfu in peritoneum at 10 mg/kg, sc administered 2 hrs after infection measured after 4 hrs2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID736479Antibacterial activity against Staphylococcus epidermidis RCMB 010024 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID425612Cytotoxicity against mouse J774A1 cells assessed as release of adenylate kinase at 100 ug/ml after 3 hrs by total cell protein assay relative to control2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID465554Antibacterial activity against Pseudomonas aeruginosa by NCCLS broth microdilution method2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Stereospecific synthesis of oximes and oxime ethers of 3-azabicycles: A SAR study towards antimicrobial agents.
AID523495Antimicrobial activity against Pseudomonas aeruginosa isolate 1693c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285186Antimicrobial activity against nosocomially-acquired methicillin-resistant Staphylococcus aureus by time-kill methodology2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
AID565004Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID422467Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as inhibition biofilm formation at 0.25 ug/mL after 2 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID1230225Antibacterial activity against Enterococcus faecium N823 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID535858Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae GZ40T harboring qnrB gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID542719Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
AID585431Antimicrobial activity against oqxAB positive Escherichia coli C600 D83-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID584318Antimicrobial activity against Serratia marcescens ATCC 8100 by agar dilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
AID68043In vitro minimum inhibitory concentration against Enterococcus faecalis (STCO-19)1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" group.
AID1257072Antibacterial activity against methicillin-resistant Staphylococcus aureus USA 300 LAC after 20 hrs by CLSI broth microdilution method2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis of biscoumarin and dihydropyran derivatives with promising antitumor and antibacterial activities.
AID519112Antibacterial activity against Proteus mirabilis M 19 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID571888Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 8 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1060495Antibacterial activity against Pseudomonas aeruginosa MTCC 741 by agar streak dilution method2014European journal of medicinal chemistry, Jan, Volume: 71Access to a new class of biologically active quinoline based 1,2,4-triazoles.
AID565031Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID581654Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in absence of thymidine2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID533611Bactericidal activity against Klebsiella pneumoniae isolate 01-21 assessed as log reduction in viable-cell count at 0.25 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID586045Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID548532Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID295084Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID528714Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID528923Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-14 and CTX-M-27 gene and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID608939Antibacterial activity against Pseudomonas aeruginosa ATCC 25668 after 24 hrs by broth microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID373032Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate FW-F1 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID548530Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID531776Antimicrobial activity against Pseudomonas aeruginosa catheter isolate 4680 containing PFGE clone A2 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID565016Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID575282Antimicrobial activity against multiple dug-resistant Acinetobacter baumannii by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID531751Antibacterial activity against Pseudomonas aeruginosa 3308 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID488047Antibacterial activity against Bacillus subtilis ATCC 6633 by double-microdilution method2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
AID395839Antimicrobial activity against Aspergillus fumigatus after 72 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID504050Antimicrobial activity against Bacillus subtilis MTCC 441 by broth microdilution technique2010Bioorganic & medicinal chemistry letters, Sep-15, Volume: 20, Issue:18
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
AID533662Antimicrobial activity against Staphylococcus aureus RN4220 harboring vgaAv positive plasmid CU12008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID533664Antimicrobial activity against Staphylococcus aureus RN1024-tms2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID565019Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1230227Antibacterial activity against Enterococcus gallinarum N489 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID428269Antimicrobial activity against Klebsiella sp. by CLSI broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID575280Antimicrobial activity against Proteus mirabilis by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID523066Antibacterial activity against Escherichia coli JM83 harboring empty pHF022 vector by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID528818Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID717206Antimicrobial activity against Kocuria rhizophila ATCC 9341 incubated for 24 hrs by microtiter broth dilution method2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja.
AID422469Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biomass of biofilm at 16 ug/mL after 2 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID486394Antibacterial activity against Escherichia coli after 24 hrs by liquid growth inhibition assay2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Structures and antimicrobial activities of pyridoacridine alkaloids isolated from different chromotypes of the ascidian Cystodytes dellechiajei.
AID520960Antimicrobial activity against Corynebacterium striatum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID774213Antibacterial activity against Escherichia coli L58058.1 expressing ANT2''-1A after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID395405Antibacterial activity against Klebsiella pneumoniae TCC 109 after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID561677Antimicrobial activity against Pseudomonas aeruginosa isolate OC14551 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID1242649Antifungal activity against Trichophyton mentagrophytes after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID519993Antimicrobial activity against vancomycin-resistant Enterococcus faecium nosocomial isolate2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID583257Antibacterial activity against aminoglycoside-resistant Klebsiella oxytoca expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID573538Antibacterial activity against Citrobacter amalonaticus Ca38009 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1553826Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of NH4Cl2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID565003Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285594Antimicrobial activity against Pseudomonas aeruginosa 1A9 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID481908Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID481449Antibacterial activity against Staphylococcus epidermidis ATCC 1490 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID561484Antibacterial activity against Pseudomonas aeruginosa assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID355391Antimicrobial activity against methicillin-resistant Staphylococcus aureus SAP00017 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID549331Antimicrobial activity against Escherichia coli isolate 32 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID565747Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID585879Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID348890Antibacterial activity against Enterococcus faecalis ATCC 29737 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID1060496Antibacterial activity against Escherichia coli MTCC 739 by agar streak dilution method2014European journal of medicinal chemistry, Jan, Volume: 71Access to a new class of biologically active quinoline based 1,2,4-triazoles.
AID535852Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae FJ67T harboring qnrS gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID348888Antibacterial activity against Streptococcus mutans PTCC 1601 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID470152Antimicrobial activity against Pseudomonas aeruginosa ATCC 15442 by disk diffusion method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents.
AID521576Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 50 ug/ml after 40 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID531758Antibacterial activity against Pseudomonas aeruginosa 1956 harboring pNF225 carrying nfxB by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID257551Antibacterial activity against Klebsiella pneumoniae2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
AID285689Antimicrobial susceptibility of carbapenem-resistant Pseudomonas aeruginosa PA4012 isolate expressing carbapenemase KPC22007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
AID554436Ratio of MIC for Pseudomonas aeruginosa 2721 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID562381Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID446123Antibacterial activity against Acinetobacter lwoffii ATCC 17925 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID561932Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate N50 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
AID521285Antimicrobial activity against CTX-M-2 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype I by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID395393Antibacterial activity against Listeria monocytogenes ATCC 15313 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID372846Antibacterial activity against Acinetobacter baumannii isolate E expressing 16S rRNA methylase armA gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
AID535666Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae FJ67 harboring wild-type GyrA S83I and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID1056837Antibacterial activity against TEM-1/SHV-12 expressing Escherichia coli isolate 237 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID573532Antibacterial activity against Klebsiella pneumoniae Kp2730 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 and dfrA12-orfF-aadA2 arrays by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1224537Antibacterial activity against Escherichia coli ATCC 8739 after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID532904Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 531 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID540928Antimicrobial activity against streptomycin-resistant Streptomyces coelicolor KO-178 harboring rpsL K88E mutant gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID542742Antimicrobial activity against Citrobacter freundii D26 expressing qnrB6 and CTX-M-9G genes by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID563520Antibacterial activity against Pseudomonas aeruginosa NY215 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
AID573374Antibacterial activity against multidrug-resistant Acinetobacter assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID348887Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID532413Antibacterial activity against IMP-13 producing Pseudomonas aeruginosa clone C1 isolate AV-13X-28 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID1173800Antimicrobial activity against Bacillus subtilis NCIB 3610 by agar well diffusion method2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones.
AID573514Antibacterial activity against Klebsiella pneumoniae isolate Kp149 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID490931Antibacterial activity against Escherichia coli NCIM 2065 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents.
AID521587Reduction in light emission by Salmonella enterica serovars virchow isolate 101591 at >= 50 ug/ml after 40 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID278670Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57352007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID554422Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2858 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID738391Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by NCCLS method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Efficient synthesis and antimicrobial activity of some novel S-β-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.
AID1188545Antimicrobial activity against Escherichia coli assessed as inhibition zone at 200 ug/disk after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID1256169Antibacterial activity in Chromobacterium violaceum CV026 at 0.6 mg/ml by agar-well diffusion method2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
The quorum-sensing inhibiting effects of stilbenoids and their potential structure-activity relationship.
AID278671Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57362007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID296127Antibacterial activity against Staphylococcus aureus at 50 to 100 uM after 24 hrs by well diffusion method2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
AID531738Induction of mexY in Pseudomonas aeruginosa 3308 clinical isolate harboring pNF225 at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID572122Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 28 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID285625Antimicrobial activity against Pseudomonas aeruginosa 9A1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID560520Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID561285Antibacterial activity against Klebsiella oxytoca by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID557784Antimicrobial activity against Escherichia coli ATCC 25922 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID554393Antimicrobial activity against Pseudomonas aeruginosa isolate 3020R obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285606Antimicrobial activity against Pseudomonas aeruginosa 2A7 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID460793Antibacterial activity against methicillin-resistant Staphylococcus aureus BAA-44 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID94226Minimum inhibitory concentration was measured against Klebsiella pneumoniae ATCC 138831991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1230239Antibacterial activity against Staphylococcus aureus CIP 53156 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID576109Antimicrobial activity against mecA-deficient Staphylococcus sciuri assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID571066Drug uptake in Wistar rat kidney collecting duct cells obtained after tissue digestion with 0.04% protease digestion for 30 mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID519406Antibacterial activity against Escherichia coli DH10B harboring pBCSK expressing rmtB gene by Etest2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
AID565010Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID571918Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 23 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, aphA6 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID465551Antibacterial activity against Bacillus subtilis by NCCLS broth microdilution method2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Stereospecific synthesis of oximes and oxime ethers of 3-azabicycles: A SAR study towards antimicrobial agents.
AID529647Antimicrobial activity against Escherichia coli DH5alpha harboring beta-lactamase VIM-15 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID373758Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab1254 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID1230248Antibacterial activity against Staphylococcus saprophyticus E260 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID561242Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID585878Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID533589Antibacterial activity against gentamicin-resistant Enterococcus faecalis clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID565750Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID561474Antibacterial activity against Serratia marcescens assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID283549Antibacterial activity against Pseudomonas aeruginosa FE64 containing inactivated rplY and mexXY genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID521836Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA367 containing blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, aac(6')-1b genes by CLSI method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
AID524943Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID1127103Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS two-fold dilution method2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID285587Antimicrobial activity against Pseudomonas aeruginosa 65.36-2 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID520809Antimicrobial activity against CTX-M-59 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype C by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID521840Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA375 containing qnrA1, blaTEM-1, blaSHV-11genes by CLSI method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
AID565752Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID544282Antimicrobial activity against Enterococcus faecalis NKH12 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID562812Antimicrobial activity against Escherichia coli DH5[alpha]2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID554391Antimicrobial activity against Pseudomonas aeruginosa isolate 615R obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID532390Antibacterial activity against VIM-1 producing Pseudomonas putida isolate RM-11X-11 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID395392Antibacterial activity against Mycobacterium smegmatis CCM 2067 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID522932Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a N196D mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID94291Minimum inhibitory concentration was measured against Klebsiella pneumoniae 760070702 producing AAC-(3)-I modifying enzyme; Value expressed as 16/641991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID411996Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides.
AID283547Antibacterial activity against Pseudomonas aeruginosa FE60 containing inactivated mexXY gene by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID528734Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID542773Antimicrobial activity against Escherichia coli J53 transformed with pHNPA1 carrying qnrB6 gene by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID424833Ratio of MIC for kanamycin-resistant Staphylococcus aureus harboring mutations in FusA gene to MIC for wild type kanamycin-susceptible Staphylococcus aureus AH0012007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID774226Antibacterial activity against Staphylococcus aureus expressing aminoglycoside-6'-N-acetyltransferase/2''-O-phosphoryltransferase after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID1241215Ratio of Kd for 5'-FAM-pre-miR-372 (unknown origin) in presence of 100-fold excess of 15-mer DNA to Kd for 5'-FAM-pre-miR-372 (unknown origin)2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID348096Antibacterial activity against aminoglycosides-resistant Pseudomonas aeruginosa ATCC 27853 expressing APH(3')-2b after 12 to 18 hrs2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
AID533343Antibacterial activity against non-gentamicin-resistant Staphylococcus aureus clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID285627Antimicrobial activity against Pseudomonas aeruginosa 9A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID395403Antibacterial activity against Staphylococcus aureus MTCC 737 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID250296Susceptibility testing against Pseudomonas aeruginosa PAE_NUH21; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID577207Antimicrobial activity against Escherichia coli C600::H19B in stationary phase encoding Stx-1 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID567568Antimicrobial activity against Staphylococcus aureus RN4220 harboring pBS-01multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
AID423915Bactericidal activity against high inoculum density stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc assessed as effect on viability at 100 ug/mL after 4 hrs by time kill study2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
AID565279Antibacterial activity against mexB and mexY expressing Pseudomonas aeruginosa PA-A1 harboring GyrA T83I, ParC S87L and IS1001 insertion at position 629 in OprD gene by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
AID577210Antimicrobial activity against Escherichia coli C600::933W in stationary phase encoding Stx-2 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID533337Antibacterial activity against non-gentamicin-resistant Proteus rettgeri clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID571059Drug uptake in Wistar rat kidney collecting duct cells obtained after tissue digestion with 0.04% protease digestion for 15 mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID577649Antimicrobial activity against Escherichia coli isolate 329 expressing beta-lactamase KPC2, CTX-M-2, TEM and PFGE cluster 2 isolated from blood of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID396001Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
AID470151Antimicrobial activity against Escherichia coli ATCC 10536 by disk diffusion method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents.
AID571060Drug uptake in cytoplasm of Wistar rat kidney distal tubule cells obtained after tissue digestion with 0.04% protease digestion for 15 mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID567465Antimicrobial activity against xtended-spectrum-beta-lactamase-producing Escherichia coli obtained from urinary tract infection patient assessed as percent susceptible isolates by Etest2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
AID530330Antimicrobial activity against Escherichia coli XL1-Blue by Etest method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID583238Antibacterial activity against indole positive Proteae by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID548527Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID1553776Antibacterial activity against Salmonella typhimurium C7731 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID531777Antimicrobial activity against Pseudomonas aeruginosa urine isolate 4663 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID562386Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID586048Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U1 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID394683Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID670954Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 10 ug/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID1230243Antibacterial activity against Staphylococcus epidermidis CIP 53124 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID561235Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID564813Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285187Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by time-kill methodology2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
AID533350Antibacterial activity against non-gentamicin-resistant Proteus mirabilis clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID533580Antibacterial activity against gentamicin-resistant Serratia marcescens clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID565008Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID531736Induction of mexY in Pseudomonas aeruginosa EryR clinical isolate harboring pNF225 at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID774215Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID523510Antimicrobial activity against Pseudomonas aeruginosa isolate 16008 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID766178Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID201379Minimum inhibitory concentration was measured against Salmonella Typhimurium ATCC 140281991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID587243Antimicrobial activity against Klebsiella pneumoniae DSM 681 at 1 ug/ul after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID528828Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID351919Suppression of CFTR W1282X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID479299Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID522930Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase R92H/D268N mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID546621Antimicrobial activity against Escherichia coli harboring plasmid pPCRScript by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID561476Antibacterial activity against Serratia marcescens assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID162932Minimum inhibitory concentration (MIC) against Pseudomonas aeruginosa2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents.
AID518811Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 15 degC and measured at 15 degC by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID564834Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1056857Antibacterial activity against Clostridium perfringens FNSST 4999 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID445287Antibacterial activity against Mycobacterium avium SmO by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID523488Antimicrobial activity against Pseudomonas aeruginosa R70 Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID533568Antimicrobial activity against Pseudomonas aeruginosa isolate PA469 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID574435Antimicrobial activity against Escherichia coli isolate 547 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from blood of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID497691Antimicrobial activity against colistin-resistant Klebsiella pneumoniae isolated from bacteremia patient by broth microdilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
AID1242646Antifungal activity against Candida albicans after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID533615Bactericidal activity against Klebsiella pneumoniae isolate 01-21 assessed as log reduction in viable-cell count at 0.5 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID285647Antimicrobial activity against Pseudomonas aeruginosa 19B1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID599619Antibacterial activity against Streptococcus faecalis isolate 292122011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID1230228Antibacterial activity against Enterococcus gallinarum N492 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID670947Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 10 ug/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID774225Antibacterial activity against Staphylococcus aureus expressing aminoglycoside-3'-O-phosphoryltransferase after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID1553829Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of CaCl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID206208Minimum inhibitory concentration was measured against Staphylococcus epidermidis ATCC 12228.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID534169Antimicrobial activity against armB positive Escherichia coli COP producing beta lactamase CTX-M-14 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID373771Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh29 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID452745Antibacterial activity against Escherichia coli M152010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
AID564830Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID533566Antimicrobial activity against Pseudomonas aeruginosa isolate PA462 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID533617Bactericidal activity against Staphylococcus epidermidis isolate 01-55 assessed as log reduction in viable-cell count at 0.5 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID564816Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID558040Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S3 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID560975Antimicrobial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID609061Antibacterial activity against Staphylococcus aureus ATCC 9144 at 4 ug/ml after 24 hrs by agar-well diffusion technique2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID535837Antimicrobial activity against Pseudomonas aeruginosa GP20KT21 harboring oprD gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID64897Minimum inhibitory concentration was measured against Escherichia coli 001574-1 producing APH-(3'') modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID532903Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 531 ST 376 expressing beta-lactamase SHV-1 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID251742Zone of inhibition of Pseudomonas aeruginosa after treatment with 10 ug of the compound2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones.
AID581667Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level after 24 hrs in presence of thymidine2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID289774Antibacterial activity against Pseudomonas aeruginosa MTCCB 741 at 30 ug/disc after 48 hrs by disc diffusion method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID637094Antibacterial activity against Bacillus cereus ATCC 11778 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID338272Antimicrobial activity against Pseudomonas aeruginosa DSM 1117 after 18 hrs by twofold serial dilution method1994Journal of natural products, Dec, Volume: 57, Issue:12
Biological effects of prenylated hydroquinones: structure-activity relationship studies in antimicrobial, brine shrimp, and fish lethality assays.
AID533575Antibacterial activity against gentamicin-resistant Klebsiella pneumoniae clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1250082Inhibition of transcription-translation process in Escherichia coli2015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID548523Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID554421Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2804 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1188546Antimicrobial activity against Pseudomonas aeruginosa assessed as inhibition zone at 200 ug/disk after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID285658Antimicrobial activity against Pseudomonas aeruginosa 19E12 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID373031Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU4A22 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID609057Antibacterial activity against Escherichia coli ATCC 8739 at 4 ug/ml after 24 hrs by agar-well diffusion technique2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID533585Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID460802Antibacterial activity against Acinetobacter baumannii AB0043 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID599622Antibacterial activity against Vibrio parahaemolyticus isolate 720162011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID623613Antibacterial activity against 10'8 CFU/mL Staphylococcus aureus MTCC 96 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID373754Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab8 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID472623Antibacterial activity against Bacillus subtilis at 200 ug/disk after 24 hrs by disk diffusion method2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID560509Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b4k6307 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID583239Antibacterial activity against Serratia spp. by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID356400Antibacterial activity against vancomycin-resistant Enterococcus CKU-172003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID373982Antimicrobial activity Enterobacter cloacae 641 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID400528Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID573527Antibacterial activity against Serratia marcescens isolate Sm265 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID558043Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S6 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID585877Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID1127104Antibacterial activity against gentamicin-resistant Staphylococcus aureus ATCC 33592 by NCCLS two-fold dilution method2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID535841Antimicrobial activity against wild-type Pseudomonas aeruginosa GP4 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID564018Antibacterial activity against Pseudomonas aeruginosa isolated from wound infection of patient by Etest2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
AID308344Antibacterial activity against Escherichia coli MTCCB 16102007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID208067Minimum inhibitory concentration towards T. tumefaciens; NR denotes not reported2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents.
AID208067Minimum inhibitory concentration towards T. tumefaciens; NR denotes not reported2004Bioorganic & medicinal chemistry letters, Jun-07, Volume: 14, Issue:11
Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents.
AID564808Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID534192Antimicrobial activity against Enterobacter cloacae expressing beta-lactamase KPC-2 and SHV-12 obtained from criticall ill liver transplant recipient by broth microdilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
AID423064Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID573548Antibacterial activity against Escherichia coli Ec158 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID373024Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU4A1 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID423069Antibacterial activity against 53_F11 allele containing Pseudomonas aeruginosa PAO1 H1124 mutant strain with PA5279::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID521584Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 at <= 30 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID1056864Antibacterial activity against Aeromonas hydrophila FNSST 014 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID533594Antibacterial activity against gentamicin-resistant Citrobacter diversus clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID428271Antimicrobial activity against Klebsiella sp. assessed as resistant isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID311874Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID581658Cmax in human plasma2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID535864Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae GZ47T harboring qnrB gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID529482Antimicrobial activity against Enterobacter cloacae isolate 140 containing PFGE genetic clone A expressing beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID520962Antimicrobial activity against Corynebacterium xerosis isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID533616Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as log reduction in viable-cell count at 0.5 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID583249Antibacterial activity against aminoglycoside-resistant Klebsiella pneumoniae expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID542064Antibacterial activity against Klebsiella pneumoniae C expressing CTX-M group 1 beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID445210Antituberculosis activity against Mycobacterium tuberculosis H37Rv by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID529495Antimicrobial activity against Enterobacter cloacae isolate 4469 containing PFGE genetic clone C expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID529741Drug uptake in human at 15 mg/kg2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID561318Antimicrobial activity against Enterobacter cloacae isolate 153 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID544278Antimicrobial activity against Enterococcus faecalis NKH8 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID583208Antibacterial activity against Klebsiella pneumoniae ATCC 10031 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID637154Antibacterial activity against Bacillus megaterium NRRL 1353895 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID295085Antibacterial activity against Proteus vulgaris ATCC 8427 by after 24 hrs dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID528919Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-14 and CTX-M-27 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID750274Antifungal activity against Aspergillus niger MTCC 282 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID488044Inhibition of ribosomal activity in Escherichia coli strain B assessed as inhibition of translation after 60 mins by coupled transcription/translation assay2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
AID577203Antimicrobial activity against Escherichia coli O157:H7 PT-40 in logarithmic phase encoding Stx-2 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID488046Antibacterial activity against Escherichia coli R477-100 by double-microdilution method2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
AID523405Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 after 3 days by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID573333Antibacterial activity against Enterobacter cloacae isolate El3280 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID486416Antibacterial activity against Proteus vulgaris NCIM 2813 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID529484Antimicrobial activity against Enterobacter cloacae isolate 185 containing PFGE genetic clone A expressing qnrB2 aac(6')-Ib-cr and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID520957Antimicrobial activity against Corynebacterium jeikeium isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID555556Antimicrobial activity against Pseudomonas aeruginosa isolate 22843 expressing VIM-2 beta lactamase gene by Etest2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
AID575279Antimicrobial activity against Serratia marcescens by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID521282Antimicrobial activity against CTX-M-2 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype F by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID564685Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates by microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
AID564806Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID495514Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4668 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID763673Antibacterial activity against Staphylococcus aureus at 200 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID533584Antibacterial activity against gentamicin-resistant Acinetobacter calcoaceticus clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID520961Antimicrobial activity against Corynebacterium urealyticum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID573332Antibacterial activity against Klebsiella pneumoniae isolate Kp2730 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 and dfrA12-orfF-aadA2 arrays by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID571057Drug uptake in Wistar rat kidney proximal tubule S1 obtained after tissue digestion with 0.04% protease digestion for 2 hrs mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID531757Antibacterial activity against Pseudomonas aeruginosa 1956 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID1235639Antibacterial activity against Staphylococcus aureus DSM 799 incubated for 24 hrs by disk diffusion method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Endophytic Diaporthe sp. LG23 Produces a Potent Antibacterial Tetracyclic Triterpenoid.
AID477750Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives.
AID564829Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID486252Antibacterial activity against Bacillus subtilis NCIM 2546 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID1230216Antibacterial activity against Enterococcus faecalis CIP 104676 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID535842Antimicrobial activity against Pseudomonas aeruginosa PAO1 SO20 harboring mexAB-oprM gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID1170143Antimicrobial activity against Escherichia coli DSM 1116 incubated for 24 hrs by disk diffusion method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antibacterial secondary metabolites from an endophytic fungus, Eupenicillium sp. LG41.
AID351934Inhibition of protein translation in Escherichia coli by coupled transcription/translation assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID1245991Antimicrobial activity against Pseudomonas syringae pv. actinidiae 16027 after 24 hrs by spectrophotometry2015Journal of medicinal chemistry, Jan-22, Volume: 58, Issue:2
Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
AID533338Antibacterial activity against non-gentamicin-resistant Acinetobacter calcoaceticus clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID554385Antimicrobial activity against Pseudomonas aeruginosa mutGR1 overexpressing mexXY mutant by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID574436Antimicrobial activity against Escherichia coli isolate 547T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from blood of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID577192Decrease in shiga toxin production in Escherichia coli C600::H19B encoding Stx-1 gene at 0.5 X MIC by luciferase assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID564690Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates assessed as susceptible isolates by microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
AID1553819Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of NH4Cl2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID573509Antibacterial activity against Citrobacter amalonaticus isolate Ca1614 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID428274Antimicrobial activity against carbapenemase producing Enterobacter sp. assessed as resistant isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID770907Antibacterial activity against Pseudomonas aeruginosa IFO 3448 after 24 hrs by two fold dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID533596Antibacterial activity against gentamicin-resistant Serratia marcescens clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1230230Antibacterial activity against Listeria innocua E044 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID1553773Antibacterial activity against Escherichia coli K88 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID424861Antimicrobial activity against Escherichia coli XL1-Blue harboring pGTAAC-32 with cloned aac(6)'-32 by E-test2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID560599Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid expressing aac(6')-Iaf wild type gene by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID735363Antimicrobial activity against Staphylococcus aureus by microdilution method2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Nudibaccatumone, a trimer comprising a phenylpropanoid and two sesquiterpene moieties from Piper nudibaccatum.
AID530173Antimicrobial activity against glycopeptide-intermediate Staphylococcus aureus ATCC 700788 by microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
AID534297Antimicrobial activity against Pseudomonas aeruginosa isolate PA481 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID522928Antibacterial activity against Escherichia coli JM83 producing aminoglycoside 2''-2a phosphotransferase by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID561322Antimicrobial activity against Escherichia coli isolate 48 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID571069Drug uptake in nuclei of Wistar rat kidney distal tubule cells obtained after tissue digestion with 0.04% protease digestion for 15 mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID424338Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH196 harboring Pro406Leu mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID481906Antimicrobial activity against Klebsiella pneumoniae ATCC 33495 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID532898Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 523 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID535682Antibacterial activity against 16S rRNA methylase and beta-lactamase producing Enterobacteriaceae by CLSI method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Plasmid-mediated 16S rRNA methylases in aminoglycoside-resistant Enterobacteriaceae isolates in Shanghai, China.
AID564691Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates assessed as susceptible isolates by microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID597595Antibacterial activity against Staphylococcus aureus CIP 103428 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID144372Inhibitory activity against Bacillus subtilis NAD synthetase2003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Tethered dimers as NAD synthetase inhibitors with antibacterial activity.
AID428625Antimicrobial activity against Staphylococcus aureus after 24 hrs by agar well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
AID534175Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid BEH by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID677142Antimicrobial activity against Escherichia coli by broth microdilution assay2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Indole alkaloids from two cultured cyanobacteria, Westiellopsis sp. and Fischerella muscicola.
AID285671Antimicrobial activity against Pseudomonas aeruginosa 24E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID519178Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrZ mutant and MexZ mutant gene selected after 1 ug/ml of tobramycin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID565073Antibacterial activity against CTX-M-14 ESBL producing Morganella morganii assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID597593Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID533345Antibacterial activity against non-gentamicin-resistant Escherichia coli clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID510163Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 by spectrophotometry2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
AID564815Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID446133Antibacterial activity against MexCD expressing Pseudomonas aeruginosa PA01 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID774220Antibacterial activity against Acinetobacter lwoffii AI.88-483 expressing APH3'-6A after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID285648Antimicrobial activity against Pseudomonas aeruginosa 19B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID283530Antibacterial activity against Pseudomonas aeruginosa FE10 with inactivated nuoG gene by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID373753Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab4 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID520292Antimicrobial activity against Staphylococcus aureus 2549 small colony variants2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID1076980Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as growth inhibition after 48 hrs by two-fold serial dilution assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Bifunctional ethyl 2-amino-4-methylthiazole-5-carboxylate derivatives: synthesis and in vitro biological evaluation as antimicrobial and anticancer agents.
AID644240Antibacterial activity against Escherichia coli clinical isolate after 16 to 20 hrs by two fold agar dilution method2012European journal of medicinal chemistry, Mar, Volume: 49Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
AID571068Drug uptake in cytoplasm of Wistar rat kidney distal tubule cells obtained after tissue digestion with 0.04% protease digestion for 2 hrs at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID519120Antibacterial activity against Proteus mirabilis M 12 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID533588Antibacterial activity against gentamicin-resistant Staphylococcus epidermidis clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID554442Ratio of MIC for Pseudomonas aeruginosa 3066 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID599614Antibacterial activity against Staphylococcus aureus ATCC 259232011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID529303Antimicrobial activity against Acinetobacter genospecies 3 isolate Ac057 expressing beta-lactamase Oxa-58 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
AID510506Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate M3AC9-6 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID531766Antimicrobial activity against Pseudomonas aeruginosa blood isolate 4677 containing PFGE clone A expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID308346Antibacterial activity against Bacillus subtilis NCIM 20632007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID548472Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID564820Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285644Antimicrobial activity against Pseudomonas aeruginosa 15H5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID295087Antibacterial activity against Mycobacterium smegmatis CCM 2067 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID554418Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2716 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID583241Antibacterial activity against Acinetobacter spp. by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID523492Antimicrobial activity against Pseudomonas aeruginosa 2779-con by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID528816Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID533587Antibacterial activity against gentamicin-resistant Staphylococcus aureus clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID548522Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID1133314Antibacterial activity against Staphylococcus aureus ATCC 12600 assessed as lowest concentration required for total inhibition by broth microdilution assay1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles.
AID519179Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrZ mutant and MexZ mutant gene selected after 4ug/ml of gentamycin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID577205Antimicrobial activity against Escherichia coli O157:H7 PT-32 in logarithmic phase encoding Stx-1 and Stx-2 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID295082Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID1056871Antibacterial activity against Bacillus cereus ATCC 11778 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID285185Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus Panton-Valentine leukocidin negative by time-kill methodology2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
AID561466Antibacterial activity against Proteus mirabilis assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID603661Antimicrobial activity against Salmonella Typhimurium CCM 5445 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID1230245Antibacterial activity against Staphylococcus intermedius N987 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID563890Antimicrobial activity against Enterococcus faecalis HH22 infected in CD-1 ICR mouse using 1.8 X 10'8 inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID531974Antibacterial activity against Escherichia coli DH10B by agar dilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
AID573340Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID274308Cytotoxicity against CEM T cells after 72 hrs by proliferation assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
AID528715Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID285640Antimicrobial activity against Pseudomonas aeruginosa 13D11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID554416Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 3020R obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID423750Antibacterial activity against aacC-expressing Salmonella enterica subsp. enterica serovar Newport isolated from food animals2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Antimicrobial resistance genes associated with Salmonella enterica serovar newport isolates from food animals.
AID599371Antibacterial activity against Staphylococcus aureus2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines.
AID584558Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID394682Antibacterial activity against Pseudomonas aeruginosa clinical isolates assessed as resistant rate by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID531744Induction of mexY in Pseudomonas aeruginosa 1956 clinical isolate harboring pNF225 at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID481447Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID550184Antimicrobial activity against Candida albicans2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID163784Minimum inhibitory concentration towards Pseudomonas aeruginosa2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents.
AID163784Minimum inhibitory concentration towards Pseudomonas aeruginosa2004Bioorganic & medicinal chemistry letters, Jun-07, Volume: 14, Issue:11
Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents.
AID583266Antibacterial activity against aminoglycoside-resistant Staphylococcus epidermidis expressing ANT(4',4'')-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID637156Antibacterial activity against Bacillus cereus ATCC 11778 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID432094Antibacterial activity against Shigella dysenteriae at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID583253Antibacterial activity against aminoglycoside-resistant Citrobacter freundii expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID429839Antibacterial activity against Staphylococcus aureus by microdilution assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Pyrrolidinoindoline alkaloids from Selaginella moellendorfii.
AID573376Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID486251Cytotoxicity against human CCK8 cells at 10 uM2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.
AID1241205Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID533601Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID561486Antibacterial activity against Stenotrophomonas maltophilia by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID575278Antimicrobial activity against ESBL-production Klebsiella pneumoniae by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID447241Antibacterial activity against Mycobacterium smegmatis CCM 2067 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID532400Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone D2 isolate VA-06X-17 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID554398Antimicrobial activity against Pseudomonas aeruginosa isolate 2804 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285916Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 292132007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
AID583273Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa expressing ANT(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID560591Antimicrobial activity against Pseudomonas aeruginosa isolate IMCJ799 by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID565743Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID586056Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 6 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID201744Minimum inhibitory concentration was measured against Serratia marcescens 75012711 producing AAD-(2'')+AAC(6'') modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID562473Antimicrobial activity against rifampicin-resistant Escherichia coli A15 transconjugant expressing beta-lactamase KPC-2/TEM-1 by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID573371Antibacterial activity against ceftazidime-susceptible Serratia marcescens assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID297186Antibacterial activity against multidrug resistant Staphylococcus aureus 495892007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
AID563876Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 using 1.5 X 10'5 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID575281Antimicrobial activity against Acinetobacter baumannii by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID678717Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID394702Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(6')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID424343Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH206 harboring Arg464Ser mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID577445Antimicrobial activity against Staphylococcus aureus USA300 isolate harboring pSK41 plasmid expressing aac'-aph'''' gene assessed resistant isolates2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.
AID351918Suppression of CFTR G542X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID283544Antibacterial activity against Pseudomonas aeruginosa FE57GZ with inactivated rplY, nuoG and mexZ genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID528918Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-14 and CTX-M-27 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID583229Antibacterial activity against Pseudomonas aeruginosa expressing mexXY operon by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID395838Antimicrobial activity against Trichophyton mentagrophytes after 96 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID533612Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as log reduction in viable-cell count at 0.25 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID529199Antibacterial activity against AmpC-producing Escherichia coli assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
AID394703Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing ANT(2'')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID446128Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID565005Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID548474Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID647790Antibacterial activity Bacillus subtilis at 40 ug/disc after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Apr, Volume: 50Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
AID1056840Antibacterial activity against CTX-15 expressing Aeromonas caviae isolate 258 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID276383Antibacterial activity against Streptococcus faecalis by broth microdilution technique2006Bioorganic & medicinal chemistry letters, Nov-15, Volume: 16, Issue:22
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
AID533592Antibacterial activity against gentamicin-resistant Enterobacter cloacae clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID163271Minimum inhibitory concentration required against Pseudomonas aeruginosa ATCC 278532003Journal of medicinal chemistry, Jul-17, Volume: 46, Issue:15
Tethered dimers as NAD synthetase inhibitors with antibacterial activity.
AID1553833Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of NH4Cl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID584123Antimicrobial activity against Staphylococcus aureus RN4220 carrying pAFS11-apmA, erm(B), tet(L), dfrK, aadD resistance genes by CLSI M31-A3 method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.
AID338383Antimicrobial activity against Escherichia coli at 10 ug
AID573496Antibacterial activity against Enterobacter cloacae isolate El1573 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID766179Antibacterial activity against Klebsiella pneumoniae NCIB 8805 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID571684Antimicrobial activity against ESBL producing Escherichia coli isolated from patient bloodstream assessed as resistant isolate by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
AID573506Antibacterial activity against Klebsiella pneumoniae isolate Kp3799 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID585433Antimicrobial activity against Escherichia coli DH5[alpha] by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID394700Antibacterial activity against MexXY-OprM pump-independent aminoglycoside-resistant Pseudomonas aeruginosa isolate by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID557797Antimicrobial activity against Escherichia coli J53 transconjugated with Proteus mirabilis pHS10 carrying qnrC gene by CLSI agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
AID528733Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID285605Antimicrobial activity against Pseudomonas aeruginosa 2F6 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID533567Antimicrobial activity against Pseudomonas aeruginosa isolate PA465 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID528822Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient urine assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID544275Antimicrobial activity against Enterococcus faecalis NKH5 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID561496Antibacterial activity against Moraxella catarrhalis by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1553808Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as ratio of MBC after and before 30 serial passages at sub-MBC2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID573535Antibacterial activity against Enterobacter cloacae El1573 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1553768Antibacterial activity against Escherichia coli UB1005 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1242651Antifungal activity against Candida parapsilosis ATCC 22019 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID561666Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring plasmid MexXY expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID444056Fraction escaping gut-wall elimination in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID586044Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID554433Ratio of MIC for Pseudomonas aeruginosa 3020R to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID557788Antimicrobial activity against Pseudomonas aeruginosa CAN-ICU 62308 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID572136Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 35 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID535845Antimicrobial activity against Pseudomonas aeruginosa PAO1 KTL1 harboring oprD, mexAB-oprM gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID285679Antimicrobial activity against Pseudomonas aeruginosa 29G7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID338246Antimicrobial activity against Bacillus subtilis Bs1091-1 at 1 ug/disk1994Journal of natural products, Nov, Volume: 57, Issue:11
Vibrindole A, a metabolite of the marine bacterium, Vibrio parahaemolyticus, isolated from the toxic mucus of the boxfish Ostracion cubicus.
AID535651Antimicrobial activity against aac(6')-Ib-cr-positive Escherichia coli FJ3T harboring wild-type GyrA, ParC, GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID295724Antibacterial activity against Escherichia coli ATCC 23556 by broth dilution method2007European journal of medicinal chemistry, Sep, Volume: 42, Issue:9
N- and S-alpha-l-arabinopyranosyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. First synthesis and biological evaluation.
AID545054Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ390 from patient secretion by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID563888Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 15 infected in CD-1 ICR mouse using 2.5 X 10'5 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID444057Fraction escaping hepatic elimination in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID520291Antimicrobial activity against Staphylococcus aureus 25482008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID571898Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 13 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID548529Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID583243Antibacterial activity against aminoglycoside-resistant Klebsiella pneumoniae expressing AAC(3)-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID637099Antibacterial activity against Escherichia coli ATCC 8739 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID1156856Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microbroth dilution method2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
AID534344Antimicrobial activity against Burkholderia pseudomallei Bp174 harboring mini-Tn7T-bpeR+ after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID565041Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID647791Antibacterial activity Escherichia coli at 40 ug/disc after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Apr, Volume: 50Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID528915Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID529488Antimicrobial activity against Enterobacter cloacae isolate 625 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID529159Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
AID558253Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in bacterial cfu in peritoneum at 10 mg/kg, sc administered 2 hrs after infection measured after 4 hrs2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID1242647Antifungal activity against Cryptococcus neoformans after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID424339Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH198 harboring Gly452Ser mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID521597Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 5.7 by bioluminescence assay2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID575767Inhibition of DNA polymerase assessed as reduction in PCR products at MIC for Pseudomonas aeruginosa PAO1 H103 by qPCR2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Short cationic antimicrobial peptides interact with ATP.
AID577225Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring yaaA::ISphoA/haha mutation by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID207419Minimum inhibitory concentration was measured against Staphylococcus aureus ATCC 259231991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID477411Antibacterial activity against MBX-1090-resistant Staphylococcus aureus isolate d20A1 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID490933Antibacterial activity against Klebsiella pneumoniae NCIM 5082 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents.
AID574429Antimicrobial activity against Escherichia coli isolate 386 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from wound of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID561488Antibacterial activity against Acinetobacter baumannii by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID573497Antibacterial activity against Serratia marcescens isolate Sm2723 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID285649Antimicrobial activity against Pseudomonas aeruginosa 19B6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID360838Antibacterial activity against Staphylococcus aureus ATCC 27853 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID422475Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biomass of 2 days established biofilm measured on day 4 using flow cell culture2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID465512Antibacterial activity against beta carbenicillin resistant Pseudomonas aeruginosa LMP 804 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID535660Antimicrobial activity against aac(6')-Ib-cr-positive Enterobacter cloacae FJ63 harboring GyrA S83I, GyrA D87A, ParC S80I mutant, wild-type GyrB and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID564814Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID554388Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY F29S mutant by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285673Antimicrobial activity against Pseudomonas aeruginosa 24E6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID529520Antibacterial activity against thymidine-dependent small-colony variant Staphylococcus aureus derived from cystic fibrosis patient assessed as resistant isolates at 37 degC after 24 hrs by disk diffusion method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
AID535835Antimicrobial activity against Pseudomonas aeruginosa GP37KT31 harboring oprD gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID521968Antibacterial activity against Campylobacter sp. assessed as resistance breakpoint by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID523002Cytotoxicity against human 5637 cells assessed as mild induction of cell death by LDH release assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID573391Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1235642Antibacterial activity against Pseudomonas aeruginosa DSM 22644 incubated for 24 hrs by disk diffusion method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Endophytic Diaporthe sp. LG23 Produces a Potent Antibacterial Tetracyclic Triterpenoid.
AID410026Antimicrobial activity against Salmonella typhosa after 24 hrs by well diffusion method2008Bioorganic & medicinal chemistry letters, Dec-01, Volume: 18, Issue:23
Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
AID575276Antimicrobial activity against Escherichia coli by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID287387Antibacterial activity against Klebsiella pneumoniae after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID542772Antimicrobial activity against Escherichia coli J53 transformed with pHNDU1 carrying qnrB6 gene by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID573347Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID522366Antimicrobial activity against wild type Proteus mirabilis N2 mutant after 16 to 18 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
AID562591Antimicrobial activity against Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID285631Antimicrobial activity against Pseudomonas aeruginosa 10A6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID520698Antimicrobial activity against Escherichia coli isolate DH10B by agar dilution CLSI method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
AID521595Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 7.0 by bioluminescence assay2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID766181Antibacterial activity against Bacillus cereus NCTC 7464 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID152320Minimum inhibitory concentration was measured against Providencia stuartii 00000164 producing AAC-(2'') modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1230232Antibacterial activity against Listeria monocytogenes N783 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID1159100Antimicrobial activity against Proteus vulgaris ATCC 33420 assessed as zone of inhibition at 10 mg by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID531745Antibacterial activity against Pseudomonas aeruginosa PAO1 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID428876Binding affinity to 16S rRNA G1494(N7) position in wild type Escherichia coli JM109 30S sunit at 100 uM by footprint assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID522929Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase N196D/D268N mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID518810Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 37 degC and measured at 37 degC by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID572151Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID549334Antimicrobial activity against Escherichia coli isolate 100 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID724495Antimicrobial activity against Staphylococcus aureus ATCC 29213 assessed as zone of inhibition after 24 hrs by agar well-diffusion method2013Bioorganic & medicinal chemistry letters, Jan-15, Volume: 23, Issue:2
Facile regioselective synthesis of novel bioactive thiazolyl-pyrazoline derivatives via a three-component reaction and their antimicrobial activity.
AID561279Antibacterial activity against Klebsiella pneumoniae assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID576110Antimicrobial activity against mecA-positive Staphylococcus sciuri assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID486971Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by micro broth dilution method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
AID528922Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-14 and CTX-M-27 gene and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID521590Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 5.7 by broth dilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID521601Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 infected in mouse J774A.1 macrophage assessed as log reduction in viable counts at 150 ug/ml after 1hr2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID562474Antimicrobial activity against rifampicin-resistant Escherichia coli A15 transconjugant expressing beta-lactamase SHV-12 by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID386864Antibacterial activity against clinical isolate resistant Pseudomonas aeruginosa after 16 hrs by microbroth dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID558753Antibacterial activity against homo-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus H14 harboring vraS S329L mutant gene by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID355390Antimicrobial activity against Pseudomonas aeruginosa Z61 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID533573Antibacterial activity against non-gentamicin-resistant Staphylococcus epidermidis clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID285610Antimicrobial activity against Pseudomonas aeruginosa 65.68-2 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID470146Antimicrobial activity against Enterococcus hirae ATCC 10541 after 24 hrs by microplate assay2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents.
AID545057Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate SZ009 from patient pus by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID585428Antimicrobial activity against oqxAB positive Escherichia coli C600 SW8-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID573352Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID573372Antibacterial activity against ceftazidime-susceptible Serratia marcescens assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID509853Antibacterial activity against Acinetobacter baumannii ATCC 17978 assessed as bacterial growth at 1.125 mg/L in presence of 150 mM NaCl2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID532196Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae WH42 harboring wild-type GyrA, ParC, GyrB and qnrA genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID533335Antibacterial activity against non-gentamicin-resistant Morganella morganii clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID94217Minimum inhibitory concentration towards Klebsiella pneumoniae2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents.
AID94217Minimum inhibitory concentration towards Klebsiella pneumoniae2004Bioorganic & medicinal chemistry letters, Jun-07, Volume: 14, Issue:11
Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents.
AID560507Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b2k3421 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID573354Antibacterial activity against ceftazidime-susceptible Escherichia coli assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID542062Antibacterial activity against Klebsiella pneumoniae D expressing CTX-M group 1 beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID557778Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID520638Antimicrobial activity against Escherichia coli MRY04-1060 expressing qepA gene by agar dilution CLSI method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
AID1240501Antibacterial activity against Pseudomonas aeruginosa DU14476 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID563882Antimicrobial activity against Escherichia coli 9612 infected in CD-1 ICR mouse using 3.7 X 10'4 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID528823Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient blood assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID285650Antimicrobial activity against Pseudomonas aeruginosa 19C2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID544288Antimicrobial activity against Enterococcus faecalis NKH18 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID743576Antimicrobial activity against Staphylococcus aureus after 24 hrs by micro-dilution susceptibility method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID509870Antibacterial activity against Acinetobacter baumannii isolate 5191 isolated from human urine2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID561452Antibacterial activity against Klebsiella oxytoca assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID586046Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID561460Antibacterial activity against Enterobacter cloacae assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID531748Antibacterial activity against Pseudomonas aeruginosa EryR harboring pNF225 carrying nfxB by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID586085Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID531742Induction of mexY in Pseudomonas aeruginosa 2126 clinical isolate harboring pNF225 at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID597600Antibacterial activity against Staphylococcus epidermidis CIP 81.55 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID396031Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID285584Antimicrobial activity against Pseudomonas aeruginosa 65.33-3 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1159104Antimicrobial activity against Bacillus thuringiensis assessed as zone of inhibition at 10 mg for 24 hrs at 30 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID581665Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level at up to 10'5 times MIC after 24 hrs2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID253026Antimicrobial activity of the compound against Bacillus subtilis was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.
AID557781Antimicrobial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID562380Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID565751Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1180405Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 16 to 20 hrs2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
AID274302Inhibition of protein synthesis in Escherichia coli S30 extracts by coupled transcription-translation assay2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
AID575283Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID336234Antimicrobial activity against Staphylococcus aureus at 10 ug/disk
AID1250083Antibacterial activity against Acinetobacter baumannii ARC 34952015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID564833Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID531734Induction of mexY in Pseudomonas aeruginosa PAO1 clinical isolate harboring nfxB gene at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID1241206Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID481454Antibacterial activity against Escherichia coli CAN-ICU 63074 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID1127107Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by spectrophotometric analysis2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID1230066Antibacterial activity against methicillin-resistant Staphylococcus aureus GRE2691 assessed as inhibition of bacterial growth2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
AID550185Antimicrobial activity against Cryptococcus neoformans2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID573337Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID428267Antimicrobial activity against carbapenemase producing Enterobacteriaceae assessed as susceptible isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1230234Antibacterial activity against Listeria monocytogenes N851 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID557786Antimicrobial activity against Escherichia coli CAN-ICU 63074 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID520799Antimicrobial activity against CTX-M-59 producing Klebsiella pneumoniae with PFGE pulsotype G by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID486395Antibacterial activity against Micrococcus luteus after 24 hrs by liquid growth inhibition assay2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Structures and antimicrobial activities of pyridoacridine alkaloids isolated from different chromotypes of the ascidian Cystodytes dellechiajei.
AID395833Antimicrobial activity against Pseudomonas aeruginosa ATCC BAA427 after 24 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID285629Antimicrobial activity against Pseudomonas aeruginosa 9B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID533577Antibacterial activity against gentamicin-resistant Enterobacter aerogenes clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID583264Antibacterial activity against aminoglycoside-resistant Serratia marcescens expressing AAC(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID523505Antimicrobial activity against Pseudomonas aeruginosa isolate 12142c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID510162Antimicrobial activity against trimethoprim-sulfamethoxazole and tazobactum-induced Pseudomonas aeruginosa by spectrophotometry2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
AID434368Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by broth microdilution method2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
AID1553818Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of FeCl32019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID423074Antibacterial activity against 75_F11 allele containing Pseudomonas aeruginosa PAO1 H1136 mutant strain with PA5455::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID535383Antibacterial activity against small-colony variant Staphylococcus aureus isolate A22616/5 harboring 55-63 nucleotide deletion in menB gene by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID523512Antimicrobial activity against Pseudomonas aeruginosa isolate 1240 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID584560Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID583261Antibacterial activity against aminoglycoside-resistant Klebsiella pneumoniae expressing AAC(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID766171Antibacterial activity against methicillin-resistant Staphylococcus aureus USA-300 after 20 to 24 hrs by two-fold broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID472636Antibacterial activity against Bacillus subtilis at 100 ug/disk after 24 hrs by disk diffusion method2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID521600Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 infected in mouse J774A.1 cells at 50 ug/ml after 1hr2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID561277Antibacterial activity against Klebsiella pneumoniae by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID561663Antimicrobial activity against Pseudomonas aeruginosa isolate OC14552 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID573364Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID564805Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID571058Drug uptake in Wistar rat kidney proximal tubule cells duct cells obtained after tissue digestion with 0.04% protease digestion for 15 mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID623614Antibacterial activity against 10'8 CFU/mL Salmonella typhi MTCC 98 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID521803Antimicrobial activity against Francisella tularensis subsp. holarctica after 48 hrs by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
AID519743Antibacterial activity against Klebsiella pneumoniae INSRA1229 harboring SHV-72 Ile8Phe, Ala146Val, and Lys234Arg mutations by agar dilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID770908Antibacterial activity against Pseudomonas aeruginosa IFO 3448 assessed as growth inhibition at 100 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID533342Antibacterial activity against non-gentamicin-resistant Haemophilus parainfluenzae clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID573351Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1202787Antibacterial activity against Bacillus subtilis TISTR 008 by 2-fold serial dilution method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
AID743584Antimicrobial activity against Bacillus subtilis at 100 ug after 24 hrs by agar disc diffusion method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID743575Antimicrobial activity against Bacillus subtilis after 24 hrs by micro-dilution susceptibility method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID519991Antimicrobial activity against vancomycin-resistant Enterococcus faecalis nosocomial isolate2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID533578Antibacterial activity against gentamicin-resistant Citrobacter diversus clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID581655Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in presence of thymidine2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID533331Antibacterial activity against non-gentamicin-resistant Enterobacter aerogenes clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID564828Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID567290Clearance iv dosed in critically ill patient with acute kidney injury2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID1256338Antibacterial activity against Escherichia coli ATCC 25922 by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID528980Antimicrobial activity against Haemophilus influenzae assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID424616Antibacterial activity against Enterococcus avium AIS2007004 isolated from patients rectum by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID534342Antimicrobial activity against Burkholderia pseudomallei Bp58 harboring deleted bpeR::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID535836Antimicrobial activity against wild-type Pseudomonas aeruginosa GP37 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID563880Antimicrobial activity against Enterococcus faecalis HH22 using 1.8 X 10'8 by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID750277Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID583233Antibacterial activity against Citrobacter spp. by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID520777Antibacterial activity against beta-lactamase KPC-2 producing Klebsiella pneumoniae isolate K10 by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
AID498872Antimicrobial activity against Acinetobacter baumannii B9 containing carbapenemase blaOXA-23 gene assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
AID561470Antibacterial activity against Serratia marcescens by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID549012Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID533604Antibacterial activity against gentamicin-resistant Staphylococcus epidermidis clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID533340Antibacterial activity against non-gentamicin-resistant Pseudomonas spp. clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID535885Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae JN41 harboring GyrA S83I, ParC S80I mutant, wild-type GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID573721Antibacterial activity against Escherichia coli Ec221 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID573512Antibacterial activity against Klebsiella pneumoniae isolate Kp46142008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID561456Antibacterial activity against Enterobacter cloacae assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID521580Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 assessed as log reduction in viable counts at 150 ug/ml after 1hr2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID558255Antibacterial activity against Staphylococcus aureus E19977 infected in NMRI mouse assessed as log reduction in extracellular bacterial cfu in peritoneum at 10 mg/kg, sc administered 2 hrs after infection measured after 4 hrs2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID577195Decrease in shiga toxin production in Escherichia coli C600::933W encoding Stx-2 gene at 0.5 X MIC by luciferase assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID535855Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae GZ40 harboring GyrA S83I, ParC S80I mutant, wild-type GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID561269Antibacterial activity against Escherichia coli by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1143925Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 48 hrs by broth microdilution method2014European journal of medicinal chemistry, Jun-10, Volume: 80Unraveling the structure-activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus.
AID565337Antibacterial activity against Enterobacter hormaechei isolate UCN63 after 3 weeks of treatment2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
AID447243Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID523517Antimicrobial activity against Pseudomonas aeruginosa isolate 1665 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID573343Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID529734Induction of apoptosis in pig LLC-PK1 cells at 2 mM by DAPI staining2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID479301Antimicrobial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID1553827Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of NaCl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID529196Antibacterial activity against ESBL-producing Escherichia coli isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
AID1553781Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1159098Antimicrobial activity against Klebsiella pneumoniae ATCC 13882 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID201751Minimum inhibitory concentration was measured against Serratia marcescens S69.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID285691Antimicrobial susceptibility of Citrobacter freundii CF6010 isolate expressing carbapenemase KPC22007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
AID278806Antimicrobial activity against Stenotrophomonas maltophilia K279a (aph FS) mutant2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
AID528824Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID560519Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID548738Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID528786Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae assessed as resistant isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID565011Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID561458Antibacterial activity against Enterobacter cloacae assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID528738Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID528735Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID558051Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S14 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID373766Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh14 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID1224525Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 4 after 7 days by micromethod2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID584316Antimicrobial activity against beta-lactamase AmpC producing meropenem-resistant Serratia marcescens by agar dilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
AID533336Antibacterial activity against non-gentamicin-resistant Citrobacter freundii clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID445288Antibacterial activity against Mycobacterium smegmatis by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID1188551Antimicrobial activity against Pseudomonas aeruginosa assessed as inhibition of visible growth after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID486970Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution method2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
AID1230221Antibacterial activity against Enterococcus faecium CIP 107387 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID348889Antibacterial activity against Escherichia coli ATCC 25922 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID283529Antibacterial activity against Pseudomonas aeruginosa PAO1 by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID1240503Antibacterial activity against Pseudomonas aeruginosa DR4877 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID479300Antimicrobial activity against Bacillus cereus ATCC 7064 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID206851Minimum bacterial concentration (MBC) against Staphylococcus aureus2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents.
AID1230064Antibacterial activity against methicillin-resistant Staphylococcus aureus GRE2272 assessed as inhibition of bacterial growth2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
AID564017Antibacterial activity against Pseudomonas aeruginosa PAO1 by Etest2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
AID1553823Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of MgCl22019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID597609Antibacterial activity against Klebsiella pneumoniae ATCC 35657 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID495513Antibacterial activity against Acinetobacter baumannii BM4467 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID572138Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 36 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID561670Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 harboring plasmid MexZ expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID285654Antimicrobial activity against Pseudomonas aeruginosa 19D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID351924Toxicity against african green monkey COS7 cells2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID533341Antibacterial activity against non-gentamicin-resistant Haemophilus influenzae clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID548253Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID554395Antimicrobial activity against Pseudomonas aeruginosa isolate 2716 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID326502Antibacterial activity against vancomycin-susceptible Enterococcus faecalis 1209 after 24 hrs by broth macrodilution method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
AID400530Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID533829Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by modified broth macrodilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID355394Antimicrobial activity against Candida albicans UBC54 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID348886Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID308347Antibacterial activity against Escherichia coli2007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID565034Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID575147Antimicrobial activity against vancomycin-resistant Staphylococcus aureus VRS1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID540930Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor 92G harboring rpsL gene with inserted glycine at position 92 after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID1553783Antifungal activity against Candida tropicalis cgmcc2.1975 measured after 48 hrs by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID395840Antimicrobial activity against Candida parapsilosis after 48 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID373033Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ3-23 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID528834Antimicrobial activity against CTX-M ESBL producing Escherichia coli assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID532897Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 523 ST 340 expressing beta-lactamase TEM-1, SHV-11 and OXA-2 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID571062Drug uptake in Wistar rat Kidney endothelium cells obtained after tissue digestion with 0.04% protease digestion for 15 mins to 60 mins at 4 or 16 mg/kg, iv after 1 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID738389Antifungal activity against Monilia albican ATCC 10231 after 24 to 72 hrs by NCCLS method2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Efficient synthesis and antimicrobial activity of some novel S-β-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.
AID295086Antibacterial activity against Bacillus cereus ATCC 7064 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID561669Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 harboring plasmid MexXY expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID278860Antiproliferative effect against HeLa cells after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID750279Antibacterial activity against Escherichia coli MTCC 443 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID535873Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii JN1 harboring GyrA T83I, ParC S80I mutant, wild-type GyrB and qnrA genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID544274Antimicrobial activity against Enterococcus faecalis NKH4 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID554402Antimicrobial activity against Pseudomonas aeruginosa isolate 3066 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID585424Antimicrobial activity against oqxAB positive Escherichia coli C600 G062-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID533582Antibacterial activity against gentamicin-resistant Citrobacter freundii clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID573356Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID774214Antibacterial activity against Escherichia coli PAZ505H8101 expressing AAC6'-1B after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID573358Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID647787Antibacterial activity Klebsiella pneumoniae at 40 ug/disc after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Apr, Volume: 50Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
AID1056836Antibacterial activity against CTX-15 expressing Escherichia coli isolate 235 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID554386Antimicrobial activity against mexXY deficient ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID212744Inhibition of telomerase before assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID717369Antibacterial activity against Pseudomonas aeruginosa MTCC 2453 at 10 ug per disk after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach.
AID573513Antibacterial activity against Escherichia coli isolate Ec158 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID278065Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from deployed military patient2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
AID583246Antibacterial activity against aminoglycoside-resistant Enterobacter cloacae expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID565281Antibacterial activity against mexB and mexY expressing Pseudomonas aeruginosa PA-A2 harboring GyrA T83I, ParC S87L and IS1001 insertion at position 629 in OprD gene by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
AID278066Antimicrobial activity against Acinetobacter baumannii-calcoaceticus complex isolated from nondeployed military patient2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
AID563502Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 71 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID529887Induction of apoptosis in pig LLC-PK1 cells at 0.1mM after 24 hrs electoporated in presence of compound2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID411993Antibacterial activity against Streptococcus faecalis after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides.
AID670959Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID731204Antibacterial activity against Streptococcus pneumoniae MTCC 1936 after 24 hrs by broth microdilution method2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
AID1076974Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition after 48 hrs by two-fold serial dilution assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Bifunctional ethyl 2-amino-4-methylthiazole-5-carboxylate derivatives: synthesis and in vitro biological evaluation as antimicrobial and anticancer agents.
AID529519Antibacterial activity against normal-colony variant Staphylococcus aureus derived from cystic fibrosis patient assessed as resistant isolates at 37 degC after 24 hrs by disk diffusion method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
AID548524Antimicrobial activity against Oxacillin-resistant Staphylococcus aureus assessed as percent resistant isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID583220Antibacterial activity against aminoglycoside-resistant Staphylococcus aureus expressing APH(3')-3 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID283542Antibacterial activity against Pseudomonas aeruginosa FE57GU with inactivated rplY, nuoG and galU genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID599613Antibacterial activity against Klebsiella pneumoniae isolate J/1/42011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID445290Antibacterial activity against Escherichia coli by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID289779Antibacterial activity against Escherichia coli MTCCB 1652 after 18-20 hrs by broth dilution method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID558042Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S5 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID395401Antibacterial activity against Escherichia coli MTCC 443 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID422457Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD by Edisk assay2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID425653Renal clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID1224543Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID584566Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID510507Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate M3AC9-7 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID562809Antimicrobial activity against Escherichia coli J532009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID529160Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay in presence of 250 ug/ml polyethylenimine2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
AID425003Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution technique2009Journal of natural products, May-22, Volume: 72, Issue:5
Alkaloids from the roots of Stemona aphylla.
AID460796Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID560503Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 6zjsau7 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID355393Antimicrobial activity against Bacillus subtilis UBC221 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID534345Antimicrobial activity against Burkholderia pseudomallei Bp175 harboring mini-Tn7T-P1-bpeR+ after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID562593Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID520964Antimicrobial activity against Rhodococcus equi isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID446129Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID395772Antibacterial activity against Klebsiella pneumoniae isolate containing extended spectrum beta lactamase after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID586052Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 2 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID582763Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID373764Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh11 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID542737Antimicrobial activity against Klebsiella pneumoniae D24 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID533348Antibacterial activity against non-gentamicin-resistant Enterobacter aerogenes clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID523514Antimicrobial activity against Pseudomonas aeruginosa isolate 12102 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID549013Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID573369Antibacterial activity against ceftazidime-susceptible Proteus mirabilis assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID373767Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh17 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID523507Antimicrobial activity against Pseudomonas aeruginosa isolate 1495c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID519115Antibacterial activity against Proteus mirabilis NP37 after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID637161Antibacterial activity against Escherichia coli ATCC 8739 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID373040Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ58 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID565069Antibacterial activity against SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID520775Antibacterial activity against beta-lactamase KPC-2 producing Klebsiella pneumoniae isolate K1 to K9 by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
AID495518Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4676 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID1242650Antifungal activity against Aspergillus fumigatus after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID520294Antimicrobial activity against extracellular Staphylococcus aureus 2546 after 4 hrs in MH-II broth2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID599618Antibacterial activity against Shigella dysenteriae isolate 32011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID1141051Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as diameter of growth inhibition zone at 10 ug/disk after 24 hrs by disk diffusion assay2014Bioorganic & medicinal chemistry letters, May-15, Volume: 24, Issue:10
The antibacterial properties of sulfur containing flavonoids.
AID597664Antibacterial activity against Serratia marcescens CIP 103551 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID597594Antibacterial activity against Staphylococcus aureus CIP 65.6 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID587242Antimicrobial activity against Staphylococcus aureus DSM 799 at 1 ug/ul after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID285188Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by time-kill methodology2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
AID449253Antibacterial activity against Pseudomonas aeruginosa RITCC 1547 at 10 ug after overnight incubation by agar well diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, spectroscopic characterization and antibacterial activity of new cobalt(II) complexes of unsymmetrical tetradentate (OSN2) Schiff base ligands.
AID1256331Antibacterial activity against clinical isolate Enterococcus faecalis by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID518812Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 15 degC and measured at 37 degC by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID531754Antibacterial activity against Pseudomonas aeruginosa 2439 harboring pNF225 carrying nfxB by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID575145Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS71 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID567319Antimicrobial activity against Escherichia coli TUM4672 by broth dilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
AID745592Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 24 hrs by CLSI microdilution method2013Journal of natural products, May-24, Volume: 76, Issue:5
Antifungal agents from Pseudallescheria boydii SNB-CN73 isolated from a Nasutitermes sp. termite.
AID565014Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID573373Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID285674Antimicrobial activity against Pseudomonas aeruginosa 23C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID401032Antimicrobial activity against Escherichia coli DC2 after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID567292AUC (0 to 24 hrs) in critically ill patient with acute kidney injury at 4 mg/kg, iv administered as 30 mins infusion2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID425600Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as reduction in intracellular bacterial viability at 18 ug/2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID481451Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID643383Induction of phospholipidosis in bovine corneal fibroblasts assessed as lamellar inclusion bodies after 72 hrs by light microscopy2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
AID510513Antibacterial activity against Escherichia coli ATCC 25922 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID496399Antibacterial activity against azide-resistant Escherichia coli J53 TET2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID472624Antibacterial activity against Bacillus subtilis after 24 hrs by microdilution susceptibility method2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID523007Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in CBA/J mouse assessed as decrease in bacterial load in bladder at 200 ug/kg, sc administered on day 3 postinfection daily for 3 days measured on day 9 post-inoculation2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID637097Antibacterial activity against Sarcina lutea ATCC 9341 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID285184Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus Panton-Valentine leukocidin positive by time-kill methodology2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
AID560522Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz07030 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID717204Antimicrobial activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs by microtiter broth dilution method2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja.
AID564831Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID575169Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID294966Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID490932Antibacterial activity against Staphylococcus aureus NCIM 2120 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents.
AID513832Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as classical-state occupancy by tRNA (Rvb= 62.4+/-1.1%)2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID338385Antimicrobial activity against Pseudomonas aeruginosa at 10 ug
AID545050Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ250 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID94288Minimum inhibitory concentration was measured against Klebsiella pneumoniae 75012101 producing AAD-(2'')-modifying enzyme; Value expressed as 64/321991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1173799Antimicrobial activity against Pseudomonas aeruginosa NCIMB 8295 by agar well diffusion method2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones.
AID296130Antibacterial activity against Salmonella typhi at 50 to 100 uM after 24 hrs by well diffusion method2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
AID571886Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 7 expressing ampC, ompA, adeB, adeM, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID373987Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS4 transconjugant from Enterobacter cloacae 91 by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID285338Antimicrobial activity against streptomycin-resistant Escherichia coli J53 transconjugant with qnrA1 producing urinary specimen isolate 13.52 by agar dilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
AID276385Antibacterial activity against Escherichia coli by broth microdilution technique2006Bioorganic & medicinal chemistry letters, Nov-15, Volume: 16, Issue:22
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
AID519407Antibacterial activity against 16S rRNA methylase rmtB and CTX-M-65 ESBL producing rifampin resistant Escherichia coli isolate ECRB1 by Etest2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
AID573365Antibacterial activity against ceftazidime-susceptible Morganella morganii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID561163Half life in in vitro pharmacokinetic/pharmacodynamic model at 5 mg/kg for every 24 hrs2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID1553814Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of KCl2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID536082Antimicrobial activity against Escherichia coli IFO 3301 at 100 ug/8 mm disk after 24 hrs by agar disk diffusion method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID573547Antibacterial activity against Klebsiella oxytoca Ko1156 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID586055Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type U3 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID1225311Antibacterial activity against Bacillus subtilis ATCC 6051 at 20 ug/disk by agar disk diffusion method2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Hypocoprins A-C: new sesquiterpenoids from the coprophilous fungus Hypocopra rostrata.
AID609157Antibacterial activity against Bacillus cereus ATCC 11778 at 4 ug/ml after 24 hrs by agar-well diffusion technique2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID564819Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID535843Antimicrobial activity against Pseudomonas aeruginosa PAO1 IPM46 harboring oprD gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID533833Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as maximum population size by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID534167Antimicrobial activity against Escherichia coli TOP10 harboring plasmid VOG1 expressing RmtB, TEM-1, and QepA gene by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID151666Minimum inhibitory concentration was measured against Pseudomonas aeruginosa ATCC 278531991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID561472Antibacterial activity against Serratia marcescens assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID565228Antimicrobial activity against Mycobacterium chelonae ATCC 35752 by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID540932Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP2 harboring rpsL K88E mutant gene and inserted glycine at position 92 of the gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID198327In vitro testing for minimum inhibitory concentration against Salmonella Typhimurium SL 11021987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Design and synthesis of peptide derivatives of a 3-deoxy-D-manno-2-octulosonic acid (KDO) analogue as novel antibacterial agents acting upon lipopolysaccharide biosynthesis.
AID565419Antimicrobial activity against Salmonella enterica serotype Virchow isolate AM23818 expressing rmtC rRNA methyltransferase gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Identification of the aminoglycoside resistance determinants armA and rmtC among non-Typhi Salmonella isolates from humans in the United States.
AID534337Antimicrobial activity against Burkholderia pseudomallei Bp216 harboring mini-Tn7T after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID360850Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID510963Antimicrobial activity against ESBL producing Escherichia coli assessed as nonsusceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
AID532405Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone G isolate NA-14X-13 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID424420Antibacterial activity against vancomycin-resistant Staphylococcus aureus HIP14300 isolated from patients foot wound by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID386861Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 after 16 hrs by microbroth dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID701871Antibacterial activity against multidrug resistant KPC producing Klebsiella pneumoniae isolate after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID1256336Antibacterial activity against clinical isolate Pseudomonas aeruginosa by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID623616Antibacterial activity against 10'8 CFU/mL Escherichia coli MTCC 443 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID373044Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate CY6 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID575284Antimicrobial activity against Burkholderia cepacia by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
AID203310Minimum inhibitory concentration was measured against Serratia marcescens ATCC 81001991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID637098Antibacterial activity against Micrococcus luteus ATCC 9631 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID533609Antibacterial activity against Staphylococcus epidermidis isolate 01-55 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID664535Antibacterial activity against Escherichia coli TISTR 780 by broth dilution method2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bioactive carbazole alkaloids from Clausena wallichii roots.
AID531772Antimicrobial activity against Pseudomonas aeruginosa pleural fluid isolate 4679 containing PFGE clone A1 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID572126Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 30 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID295081Antibacterial activity against Escherichia coli ATCC 11230 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID285621Antimicrobial activity against Pseudomonas aeruginosa 8A2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID560973Antimicrobial activity against methicillin-resistant Staphylococcus aureus 494 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID424857Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring pV2GY3 with blaVIM-2 and aac(6)'-32 by E-test2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID528075Antibacterial activity against Bacillus subtilis by broth microdilution method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Stereocontrolled facile synthesis and antimicrobial activity of oximes and oxime ethers of diversely substituted bispidines.
AID535848Antimicrobial activity against Pseudomonas aeruginosa GP61KT51 harboring oprD,mexAB-oprM gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID452744Antibacterial activity against Escherichia coli MG16552010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
AID528736Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID534305Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA5072010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID534341Antimicrobial activity against Burkholderia pseudomallei Bp227 harboring deleted (bpeAB-oprA)::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID560510Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3529 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID516166Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID536088Antimicrobial activity against Bacillus subtilis IFO 3007 after 24 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID573367Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID533607Antibacterial activity against Klebsiella pneumoniae isolate 01-21 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1240507Antibacterial activity against Escherichia coli DM17528 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID545043Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ068 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID585422Antimicrobial activity against oqxAB positive Escherichia coli C600 W245-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID285669Antimicrobial activity against Pseudomonas aeruginosa 24D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID583222Antibacterial activity against aminoglycoside-resistant Acinetobacter spp. expressing APH(3')-6 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID401031Antimicrobial activity against Escherichia coli UB1005 after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID479298Antimicrobial activity against Staphylococcus aureus ATCC 6538-P after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID583209Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing ANT(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1233485Antimicrobial activity against Proteus vulgaris MTCC 1771 assessed as inhibition of visual microbial growth incubated for 24 hrs at 37 degC2015Bioorganic & medicinal chemistry letters, Jul-15, Volume: 25, Issue:14
Thiophene and benzodioxole appended thiazolyl-pyrazoline compounds: Microwave assisted synthesis, antimicrobial and molecular docking studies.
AID373046Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZS5 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID576112Antimicrobial activity against mecA-positive Staphylococcus sciuri harboring staphylococcus aureus mecA gene assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID472619Inhibition of bovine DHFR after 2 mins2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID519185Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY and MexZ mutant gene selected after 0.25 ug/ml of ciprofloxacin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID597597Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID556760Antimicrobial activity against extended spectrum beta-lactamase CTX-M-2-producing Pseudomonas aeruginosa isolate P62082009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
AID1241204Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID521579Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 15 ug/ml after 40 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID548525Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID557783Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID532193Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii TJ15T harboring wild-type GyrA, ParC, GyrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID573536Antibacterial activity against Serratia marcescens Sm2723 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID65059Concentration required for half maximum rate of enhanced [3H]DHS uptake in Escherichia coli K121987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID287391Antibacterial activity against Mycobacterium smegmatis after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID447237Antibacterial activity against Klebsiella pneumoniae UC57 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID564821Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID529740Drug level in human at 4 mg/kg2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID520290Antimicrobial activity against Staphylococcus aureus 2547 small colony variants2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID1230249Antibacterial activity against Staphylococcus sciuri N993 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID532402Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone D4 isolate VA-06X-47 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID283535Antibacterial activity against Pseudomonas aeruginosa FE10U with inactivated nuoG and galU genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID1127109Antibacterial activity against Escherichia coli by NCCLS two-fold dilution method2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID452742Antibacterial activity against Escherichia coli M15 containing pQE30 expression vector2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
AID285677Antimicrobial activity against Pseudomonas aeruginosa 29F6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID774217Antibacterial activity against Pseudomonas aeruginosa PA22 (PT629) expressing MexXY after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID557782Antimicrobial activity against Enterococcus faecium ATCC 27270 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID599617Antibacterial activity against Bacillus subtilis UC5642011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID1141055Antibacterial activity against Escherichia coli ATCC 25922 assessed as diameter of growth inhibition zone at 10 ug/disk after 24 hrs by disk diffusion assay2014Bioorganic & medicinal chemistry letters, May-15, Volume: 24, Issue:10
The antibacterial properties of sulfur containing flavonoids.
AID470182Antibacterial activity against Bacillus subtilis KCTC 1021 at 5 ug/disk after 48 hrs by disk diffusion method2009Journal of natural products, Nov, Volume: 72, Issue:11
Alternaramide, a cyclic depsipeptide from the marine-derived fungus Alternaria sp. SF-5016.
AID535381Antibacterial activity against small-colony variant Staphylococcus aureus isolate OM299/1 harboring -1 frame shift mutation in 687 nucleotide of menB gene by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID542065Antibacterial activity against Klebsiella pneumoniae A expressing CTX-M group 1 beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID563886Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 infected in CD-1 ICR mouse using 1.5 X 10'5 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID428869Antibacterial activity against Escherichia coli isolate ARS3 carrying pARS3 by agar dilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID509867Antibacterial activity against Acinetobacter baumannii isolate 2824 isolated from human urine2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID563501Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens 01 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID425598Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 18 ug/ml after 3 hr2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID1056866Antibacterial activity against Klebsiella pneumoniae FNSST 011 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID285614Antimicrobial activity against Pseudomonas aeruginosa 3D1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1064811Antibacterial activity against methicillin-sensitive Staphylococcus aureus L819/ATCC 19636 after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID423068Antibacterial activity against 6_G1 allele containing Pseudomonas aeruginosa PAO1 H1121 mutant strain with PA4961::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID373985Antimicrobial activity Citrobacter freundii 64 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID283543Antibacterial activity against Pseudomonas aeruginosa FE57UZ with inactivated rplY, galU and mexZ genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID348884Antibacterial activity against Bacillus pumilus PTCC 1114 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID559415Antimicrobial activity against Acinetobacter baumannii 3208 expressing multiple-antibiotic resistance gene AbaR5 by Viek 2 system2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AbaR5, a large multiple-antibiotic resistance region found in Acinetobacter baumannii.
AID554417Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2715 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID373765Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh13 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID535903Antimicrobial activity against aac(6')-Ib-cr-negative Escherichia coli PU12 harboring GyrA S83L mutant, wild-type GyrB, ParC and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID766183Antibacterial activity against penicillin-resistant Staphylococcus aureus 1H assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID355389Antimicrobial activity against Pseudomonas aeruginosa K799 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID583255Antibacterial activity against aminoglycoside-resistant Enterobacter cloacae expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID285661Antimicrobial activity against Pseudomonas aeruginosa 19F2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID521594Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 5.7 by bioluminescence assay2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID1256332Antibacterial activity against Staphylococcus aureus ATCC 29213 by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID477749Antimicrobial activity against Escherichia coli after 24 hrs2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives.
AID535876Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii JN1T by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID533600Antibacterial activity against gentamicin-resistant Acinetobacter calcoaceticus clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID545046Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ085 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID736478Antibacterial activity against Streptococcus pyogenes RCMB 010015 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID395778Antibacterial activity against ceftriaxone-resistant Bacillus subtilis isolate after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID373049Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate JN45 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID1242639Antibacterial activity against Escherichia coli ATCC 9637 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID283537Antibacterial activity against Pseudomonas aeruginosa FE57U with inactivated rplY and galU genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID533356Antibacterial activity against non-gentamicin-resistant Pseudomonas aeruginosa clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID529890Induction of apoptosis in pig LLC-PK1 cells measured at 0 to 3 mM after 2 days by DAPI staining2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID532905Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 525 ST 376 expressing beta-lactamase SHV-1 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID562383Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID524942Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
AID564818Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1230238Antibacterial activity against Staphylococcus aureus CIP 53154 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID585427Antimicrobial activity against oqxAB positive Escherichia coli C600 XT11-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID285583Antimicrobial activity against Pseudomonas aeruginosa 65.33-2 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1224517Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 234/2005 after 7 days by micromethod2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID395834Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID561450Antibacterial activity against Klebsiella oxytoca assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID531769Antimicrobial activity against Pseudomonas aeruginosa urine isolate 4698 containing PFGE clone A expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID528737Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID597592Antibacterial activity against Staphylococcus aureus ATCC 9144 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID1188544Antimicrobial activity against Bacillus subtilis assessed as inhibition zone at 200 ug/disk after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID554414Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 615R obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1225310Antibacterial activity against Staphylococcus aureus ATCC 29213 at 20 ug/disk by agar disk diffusion method2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Hypocoprins A-C: new sesquiterpenoids from the coprophilous fungus Hypocopra rostrata.
AID576111Antimicrobial activity against mecA-deficient Staphylococcus sciuri harboring staphylococcus aureus mecA gene assessed as resistant isolates2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
AID423751Antibacterial activity against susceptible Salmonella enterica subsp. enterica serovar Newport isolated from food animals2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Antimicrobial resistance genes associated with Salmonella enterica serovar newport isolates from food animals.
AID533328Antibacterial activity against non-gentamicin-resistant Escherichia coli clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID558052Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S15 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID561245Antibacterial activity against methicillin-resistant Staphylococcus epidermidis by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID523503Antimicrobial activity against Pseudomonas aeruginosa isolate 1248c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID532181Antimicrobial activity against aac(6')-Ib-cr-negative Klebsiella pneumoniae SY22T harboring qnrS gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID274303Antibacterial activity against Escherichia coli ATCC 259222006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
AID1064809Antibacterial activity against Staphylococcus aureus GISA L3798 after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID1230235Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID554399Antimicrobial activity against Pseudomonas aeruginosa isolate 2858 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1056835Antibacterial activity against SIM-1 expressing Acinetobacter baumannii isolate 170 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID428871Antibacterial activity against Escherichia coli CSH-2 by agar dilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID746785Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 20 hrs by macrobroth dilution method2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
AID293688Antibacterial activity against Staphylococcus aureus at 50 to 100 uM after 24 hrs by well diffusion method2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Clubbed triazoles: a novel approach to antitubercular drugs.
AID572140Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 37 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1133318Antibacterial activity against Pasteurella multocida ATCC 19427 assessed as lowest concentration required for total inhibition by broth microdilution assay1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles.
AID432095Antibacterial activity against Bacillus subtilis at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID565282Antibacterial activity against mexB and mexY expressing Pseudomonas aeruginosa PA-A3 harboring GyrA T83I, ParC S87L and IS1001 insertion at position 629 in OprD gene by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
AID571908Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 18 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID519119Antibacterial activity against Proteus mirabilis NP43 after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID531756Antibacterial activity against Pseudomonas aeruginosa 2126 harboring pNF225 carrying nfxB by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID533606Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID587245Antimicrobial activity against Escherichia coli DSM 682 after 24 hrs by disk diffusion method2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.
AID577222Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring phoU::ISphoA/haha mutation by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID560501Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06040 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID374135Antimicrobial activity Enterobacter cloacae 63 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID519124Antibacterial activity against Proteus mirabilis M 40 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID577221Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gatA::ISphoA/haha mutation by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID285633Antimicrobial activity against Pseudomonas aeruginosa 10B1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID395780Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID283545Antibacterial activity against Pseudomonas aeruginosa FE57GUZ with inactivated rplY, nuoG, galU and mexZ genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID581666Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level after 24 hrs2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID562596Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID609040Antibacterial activity against Bacillus cereus ATCC 11778 after 24 hrs by broth microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID564019Antibacterial activity against Pseudomonas aeruginosa isolated from lung biopsy specimen of patient by Etest2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
AID1553778Antibacterial activity against Staphylococcus aureus ATCC 25923 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID278666Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57392007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID396027Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID487958Cytotoxicity against HEK293 cells after 48 hrs by XTT assay2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
AID1167356Antibacterial activity against Escherichia coli D21 IpxC101/tolC deletion mutant after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID522367Antimicrobial activity against PpmrI knockout mutant Proteus mirabilis dIpc complemented with PPmrI gene after 16 to 18 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
AID670958Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID257553Antibacterial activity against Pseudomonas aeruginosa2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
AID573522Antibacterial activity against Citrobacter koseri isolate Ck211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID481905Antimicrobial activity against Burkholderia cepacia ATCC 25608 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID520959Antimicrobial activity against Corynebacterium pseudodiphtheriticum isolates by CLSI M45-A protocol based microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
AID561668Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID561283Antibacterial activity against Klebsiella pneumoniae assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID701875Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID295723Antibacterial activity against Bacillus subtilis ATCC 6633 by broth dilution method2007European journal of medicinal chemistry, Sep, Volume: 42, Issue:9
N- and S-alpha-l-arabinopyranosyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. First synthesis and biological evaluation.
AID544280Antimicrobial activity against Enterococcus faecalis NKH10 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID519482Antibacterial activity against Staphylococcus aureus T2019 with G2576T mutation in 23S rRNA genes by Etest method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
AID509631Antimicrobial activity against Staphylococcus aureus RN4220 transformant carrying plasmid pKKS25 and expressing erm(T), dfrK and tet(L) genes by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID770910Antibacterial activity against Escherichia coli IFO 3301 after 24 hrs by two fold dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID564686Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates by microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
AID561468Antibacterial activity against Proteus mirabilis assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID529486Antimicrobial activity against Enterobacter cloacae isolate 533 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID338271Antimicrobial activity against Escherichia coli DSM 1103 after 18 hrs by twofold serial dilution method1994Journal of natural products, Dec, Volume: 57, Issue:12
Biological effects of prenylated hydroquinones: structure-activity relationship studies in antimicrobial, brine shrimp, and fish lethality assays.
AID770913Antibacterial activity against Micrococcus luteus IFO 3232 after 24 hrs by two fold dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID521838Antibacterial activity against Klebsiella pneumoniae isolate VA375 with blaKPC-3, qnrA1, blaTEM-1, blaSHV-11 genes by CLSI method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
AID395394Antibacterial activity against Micrococcus luteus La 2971 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID561492Antibacterial activity against Acinetobacter baumannii assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1230244Antibacterial activity against Staphylococcus haemolyticus CIP 8156 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID563518Antibacterial activity against Pseudomonas aeruginosa PAO1 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
AID561271Antibacterial activity against Escherichia coli assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID717371Antibacterial activity against Staphylococcus aureus MTCC 1430 at 10 ug per disk after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach.
AID207688Minimum inhibitory concentration (MIC) against Staphylococcus aureus2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents.
AID766176Antibacterial activity against Staphylococcus aureus NCTC 6571 after 20 to 24 hrs by two-fold broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID577208Antimicrobial activity against Escherichia coli C600::H19B in logarithmic phase encoding Stx-1 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID1230210Antibacterial activity against Corynebacterium striatum N840 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID429078Antibacterial activity against Escherichia coli J53 expressing Klebsiella pneumoniae Greece blaKPC-2 gene by E test method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
AID1177386Antibacterial activity against Bacillus subtilis2014Journal of natural products, Aug-22, Volume: 77, Issue:8
Structure and Stereochemical Determination of Hypogeamicins from a Cave-Derived Actinomycete.
AID519118Antibacterial activity against Proteus mirabilis M 31 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID583236Antibacterial activity against Klebsiella spp. by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID560600Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid expressing aac(6')-Iaf (TTG-ATG) mutant gene by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID529197Antibacterial activity against ESBL-producing Escherichia coli assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
AID490934Antibacterial activity against Proteus vulgaris NCIM 2813 after 24 hrs by disc diffusion method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents.
AID565039Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID452746Antibacterial activity against fabI-overexpressing Escherichia coli M152010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
AID496396Antibacterial activity against azide-resistant Escherichia coli J53 SXT1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID561675Antimicrobial activity against Pseudomonas aeruginosa isolate OC17355 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID554434Ratio of MIC for Pseudomonas aeruginosa 2715 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID550179Antimicrobial activity against Escherichia coli2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID534174Antimicrobial activity against armA positive Enterobacter cloacae BEH producing beta lactamase CTX-M-3 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID567320Antimicrobial activity against Escherichia coli ML4909 by broth dilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
AID1230217Antibacterial activity against Enterococcus faecalis N491 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID548795Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus assessed as percent resistant isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID519180Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 1 ug/ml of oflaxacin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID1553793Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 43300 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID356405Antibacterial activity against methicillin-resistant Staphylococcus aureus2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID519111Antibacterial activity against Proteus mirabilis NP14 after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID544271Antimicrobial activity against Enterococcus faecalis NKH1 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1064803Antibacterial activity against Enterococcus faecium L569 expressing VanA gene after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID565070Antibacterial activity against CTX-M-14 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID520697Antimicrobial activity against Escherichia coli DH10B harboring p05283 carrying qepA and rmtB gene by agar dilution CLSI method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
AID1230205Antibacterial activity against Bacillus cereus CIP 6624 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID542770Antimicrobial activity against Escherichia coli J53 transformed with pHND2 carrying qnrB6 and CTX-M-9G genes by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID444051Total clearance in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID520639Antimicrobial activity against Escherichia coli MRY05-3283 expressing qepA and rmtB gene by agar dilution CLSI method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
AID571920Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 24 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID274307Antibacterial activity against Pseudomonas aeruginosa ATCC 278532006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
AID597599Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID447239Antibacterial activity against Micrococcus luteus La 2971 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID529827Antimicrobial activity against Acinetobacter baumannii by microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.
AID535840Antimicrobial activity against Pseudomonas aeruginosa GP4KT111 harboring oprD gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID524824Antibacterial activity against erythromycin resistant Campylobacter sp. by agar plate dilution method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID533659Antimicrobial activity against Staphylococcus aureus RN42202008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID558243Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 2 mg/liter after 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID564810Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID533593Antibacterial activity against gentamicin-resistant Enterobacter aerogenes clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID535541Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 by broth microdilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
AID574437Antimicrobial activity against Escherichia coli isolate 1679 expressing beta-lactamase KPC2, SHV-12, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID465511Antibacterial activity against beta ampicillin resistant Klebsiella pneumoniae LMP 803 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID599621Antibacterial activity against Salmonella typhi DIRW2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID64065In vitro testing for minimum inhibitory concentration against Escherichia coli ATCC 11303.1987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Design and synthesis of peptide derivatives of a 3-deoxy-D-manno-2-octulosonic acid (KDO) analogue as novel antibacterial agents acting upon lipopolysaccharide biosynthesis.
AID1553825Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of FeCl32019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID509630Antimicrobial activity against Staphylococcus aureus RN4220 by broth microdilution method2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
AID308345Antibacterial activity against Staphylococcus aureus MTCCB 962007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID400282Antimicrobial activity against Candida albicans CAND105 after 48 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID561667Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring plasmid MexZ expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID424422Antibacterial activity against vancomycin-resistant Staphylococcus aureus HIP15178 isolated from patients surgical wound by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID395774Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa isolate after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID519990Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis nosocomial isolate2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID717372Antibacterial activity against Bacillus subtilis MTCC 121 at 10 ug per disk after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach.
AID561323Antimicrobial activity against Klebsiella pneumoniae isolate 132 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID565017Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1064806Antibacterial activity against Enterococcus faecalis L559 expressing VanS gene after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID529491Antimicrobial activity against Enterobacter cloacae isolate 649 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID567302Cmin in critically ill patient with acute kidney injury at 3 mg/kg, iv infusion2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID572150Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID678627Antibacterial activity against Bacillus subtilis ATCC 6633 at 50 mg/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
Synthesis and biological evaluation of optically active conjugated γ- and δ-lactone derivatives.
AID562388Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID583231Antibacterial activity against Pseudomonas aeruginosa expressing AAC(3)-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID774218Antibacterial activity against Pseudomonas aeruginosa F03 expressing AAC6'-2A after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID565036Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID573544Antibacterial activity against Enterobacter cloacae El3799 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID360858Antibacterial activity against Klebsiella pneumoniae subsp. pneumoniae ATCC 13833 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID563885Antimicrobial activity against Klebsiella pneumoniae 967 infected in CD-1 ICR mouse using 2.6 X 10'5 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID546618Antimicrobial activity against Pseudomonas aeruginosa isolate 243-31C expressing beta-lactamase VIM-18 isolated from sputum of patient by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID572132Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 33 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID584563Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID495509Antibacterial activity against Acinetobacter baumannii BM4587 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID597596Antibacterial activity against methicillin-resistant Staphylococcus aureus CIP 65.25 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID607925Antibacterial activity against Klebsiella pneumoniae by broth dilution method2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Phytochemical studies on Stemona aphylla: isolation of a new stemofoline alkaloid and six new stemofurans.
AID285588Antimicrobial activity against Pseudomonas aeruginosa 65.36-3 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID625924Antibacterial activity against Klebsiella pneumoniae ATCC 27736 by micro-broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
AID396033Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID432093Antibacterial activity against Staphylococcus aureus at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID1241210Binding affinity to 5'-FAM-pre-miR-17 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1127101Antibacterial activity against Staphylococcus aureus ATCC 25923 by NCCLS two-fold dilution method2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID423072Antibacterial activity against 70_H3 allele containing Pseudomonas aeruginosa PAO1 H1129 mutant strain with rnt::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID558244Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 1.5 mg/liter after 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID565746Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID565040Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID395391Antibacterial activity against Bacillus cereus ATCC 7064 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID534299Antimicrobial activity against Pseudomonas aeruginosa isolate PA510 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID637096Antibacterial activity against Staphylococcus aureus NRRL B 313 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID470594Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
Design and synthesis of bile acid-based amino sterols as antimicrobial agents.
AID296561Antibacterial activity against Escherichia coli by micro dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis, characterization, cytotoxicity, antibacterial and antifungal evaluation of some new platinum (IV) and palladium (II) complexes of thiodiamines.
AID287389Antibacterial activity against Micrococcus luteus after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID573360Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID395390Antibacterial activity against Proteus vulgaris ATCC 8427 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID567295Cmax in critically ill patient with acute kidney injury at 5 mg/kg, iv administered as 1 hr infusion2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID549330Antimicrobial activity against Escherichia coli isolate 16 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID554396Antimicrobial activity against Pseudomonas aeruginosa isolate 2721 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID567317Antimicrobial activity against Proteus mirabilis TUM4660 by broth dilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
AID532912Antimicrobial activity against KPC-3 producing Klebsiella pneumoniae 557 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID562387Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID285615Antimicrobial activity against Pseudomonas aeruginosa 3D10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID567296AUC (0 to 24 hrs) in critically ill patient with acute kidney injury at 5 mg/kg, iv administered every 24 hrs2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID429077Antibacterial activity against Escherichia coli J53 by E test method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
AID532411Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B3 isolate PV-05X-02 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID560976Antimicrobial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID521286Antimicrobial activity against CTX-M-2 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype J by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID425002Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution technique2009Journal of natural products, May-22, Volume: 72, Issue:5
Alkaloids from the roots of Stemona aphylla.
AID534109Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm05272008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID560500Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate sh06024 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID583218Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1228186Antimicrobial activity against Pseudomonas aeruginosa DSM50071 assessed as inhibition of microbial growth incubated for 24 to 48 hrs by serial dilution assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Deconins A-E: Cuparenic and Mevalonic or Propionic Acid Conjugates from the Basidiomycete Deconica sp. 471.
AID373763Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh9 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID444055Fraction absorbed in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID597666Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID465513Antibacterial activity against chloramphenicol-resistant Salmonella typhi LMP 706 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID1241201Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID470595Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
Design and synthesis of bile acid-based amino sterols as antimicrobial agents.
AID396030Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID519405Antibacterial activity against 16S rRNA methylase RmtB and CTX-M-65 ESBL producing Escherichia coli isolate ECRB1 by Etest2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
AID1250086Antibacterial activity against Pseudomonas aeruginosa PAO12015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID1156857Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by microbroth dilution method2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
AID560514Antimicrobial activity against SCCmec type IV vancomycin-intermediate Staphylococcus aureus isolate 06b41 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID583258Antibacterial activity against aminoglycoside-resistant Klebsiella pneumoniae expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID411997Antibacterial activity against Staphylococcus aureus after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides.
AID1256339Antibacterial activity against clinical isolate Escherichia coli by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID348891Antibacterial activity against Pseudomonas aeruginosa ATCC 85327 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID395389Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID567297AUC (0 to 24 hrs) in critically ill patient with acute kidney injury at 6 mg/kg, iv administered every 48 hrs2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID536091Antimicrobial activity against Pseudomonas aeruginosa IFO 3448 after 24 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID535844Antimicrobial activity against Pseudomonas aeruginosa PAO1 KTS harboring mexAB-oprM gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID373768Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh18 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID571896Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 12 expressing ompA, adeB, adeM, aacA4, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID774227Antibacterial activity against 14- and 15-membered macrolide-resistant Staphylococcus aureus expressing MsrA efflux pump after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID585421Antimicrobial activity against oqxAB positive Escherichia coli C600 W322-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID518816Antibacterial activity against Acinetobacter genomosp. 3 isolates by broth micro dilution2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
AID423209Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution technique2009Journal of natural products, Apr, Volume: 72, Issue:4
Semisynthesis and biological activity of stemofoline alkaloids.
AID678712Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID535882Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae JN132T harboring qnrB gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID562813Antimicrobial activity against Escherichia coli DH5[alpha] harboring pEK516 plasmid encoding CTX-M extended-spectrum beta-lactamases2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID583240Antibacterial activity against Staphylococcus spp. by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID573503Antibacterial activity against Escherichia coli isolate Ec9381 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID532900Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 588 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID446140Antibacterial activity against R-methylase expressing Escherichia coli 06AB003 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID548471Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID425652Total body clearance in human2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Physicochemical determinants of human renal clearance.
AID534170Antimicrobial activity against armA positive Escherichia coli TOP10 harboring plasmid COP1 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID283656Increase in ROS levels in Escherichia coli K12 MG1655 assessed as ratio of ROS with antibiotic to ROS without antibiotic2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
AID573523Antibacterial activity against Enterobacter cloacae isolate El216 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID285657Antimicrobial activity against Pseudomonas aeruginosa 19E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID524826Antibacterial activity against erythromycin resistant Campylobacter sp. assessed as resistance breakpoint by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID564812Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID531740Induction of mexY in Pseudomonas aeruginosa 2439 clinical isolate harboring pNF225 at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID644960Displacement of ethidium bromide from human pre-hsa-mir-155 miRNA after 30 mins2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
AID542049Antibacterial activity against rifampicin resistant Escherichia coli J53-2 by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID488045Inhibition of ribosomal activity in Spodoptera frugiperda Sf21 cells assessed as inhibition of translation after 60 mins by fluorescence assay2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
AID536080Antimicrobial activity against Micrococcus luteus IFO 3232 at 100 ug/8 mm disk after 24 hrs by agar disk diffusion method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID584556Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID532397Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone D isolate VA-06X-69 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID533329Antibacterial activity against non-gentamicin-resistant Klebsiella pneumoniae clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID528785Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli assessed as resistant isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID583267Antibacterial activity against aminoglycoside-resistant Staphylococcus aureus expressing APH(2'') + AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID647792Antibacterial activity Pseudomonas aeruginosa at 40 ug/disc after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Apr, Volume: 50Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
AID423066Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID567569Antimicrobial activity against Staphylococcus aureus RN42202010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
AID1064804Antibacterial activity against Enterococcus faecium L568 expressing VanS gene after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID763665Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by microdilution susceptibility method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID530348Antimicrobial activity against azide-resistant Escherichia coli J53 by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID1553774Antibacterial activity against Escherichia coli K99 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID564807Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565230Antimicrobial activity against Mycobacterium chelonae 9917 by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID528983Antimicrobial activity against Haemophilus influenzae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID563883Antimicrobial activity against Escherichia coli 1515 infected in CD-1 ICR mouse using 2.4 X 10'6 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID278808Antibacterial activity against Pseudomonas aeruginosa ATCC 278532007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID373038Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate NJ59 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID285592Antimicrobial activity against Pseudomonas aeruginosa 65.38-3 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID285641Antimicrobial activity against Pseudomonas aeruginosa 13E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID528790Antimicrobial activity against extended-spectrum beta lactamase producing Klebsiella pneumoniae expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID536086Antimicrobial activity against Candida albicans IFO 0583 at 100 ug/8 mm disk after 48 hrs by agar disk diffusion method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID1553832Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of FeCl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID625923Antibacterial activity against Staphylococcus aureus ATCC 25923 by micro-broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
AID1202790Antibacterial activity against Salmonella typhimurium TISTR 292 by 2-fold serial dilution method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
AID533602Antibacterial activity against gentamicin-resistant Pseudomonas spp. clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID548256Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID530328Antimicrobial activity against Escherichia coli XL1-Blue harboring pGEM-T carrying aacA4 gene by Etest method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID373041Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ36 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID548743Antimicrobial activity against Vancomycin-susceptible Enterococcus faecium assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID577647Antimicrobial activity against Escherichia coli isolate 157 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 3 isolated from urine of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID439600Antifungal activity against Aspergillus fumigatus ATCC 36607 after 48 hrs by twofold dilution technique2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study.
AID283548Antibacterial activity against Pseudomonas aeruginosa FE63 containing inactivated rplY and PA5471 genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID770917Antibacterial activity against Bacillus subtilis IFO 3007 assessed as growth inhibition at 100 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID681777TP_TRANSPORTER: inhibition of PAH uptake (PAH: 2 uM, Gentamicin: 2000 uM) in Xenopus laevis oocytes1999The Journal of pharmacology and experimental therapeutics, Aug, Volume: 290, Issue:2
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
AID285638Antimicrobial activity against Pseudomonas aeruginosa 13D3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID534177Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid DU by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID519992Antimicrobial activity against vancomycin-susceptible Enterococcus faecium nosocomial isolate by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
AID561287Antibacterial activity against Klebsiella oxytoca assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1553769Antibacterial activity against Salmonella typhimurium ATCC 14028 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1245992Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by spectrophotometry2015Journal of medicinal chemistry, Jan-22, Volume: 58, Issue:2
Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
AID532029Antimicrobial activity against Escherichia coli TOP10F' transformant harboring beta-lactamase CTX-M-78 by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
AID561234Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID510504Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate M3AC9-2 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID1242640Antibacterial activity against Pseudomonas aeruginosa ATCC BAA-427 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID584559Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID373984Antimicrobial activity Escherichia coli 650 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID1240510Antibacterial activity against Klebsiella pneumoniae DU31158 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID1056841Antibacterial activity against TEM-1/SHV-12 expressing Aeromonas hydrophila isolate 268 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID434367Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
AID1250088Antibacterial activity against mexABCDXY-deficient Pseudomonas aeruginosa PAO12015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID574428Antimicrobial activity against Escherichia coli isolate 360T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from urine of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID554439Ratio of MIC for Pseudomonas aeruginosa 2858 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID567300Cmin in critically ill patient with acute kidney injury at 5 mg/kg, iv administered every 24 hrs2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID563874Antimicrobial activity against Klebsiella pneumoniae 935 using 3 X 10'5 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID1235641Antibacterial activity against Bacillus subtilis DSM 1088 incubated for 24 hrs by disk diffusion method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Endophytic Diaporthe sp. LG23 Produces a Potent Antibacterial Tetracyclic Triterpenoid.
AID529739Induction of apoptosis in pig LLC-PK1 cells assessed as caspase 3 activity at 2 mM after 1 day by DAPI staining2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
AID1230246Antibacterial activity against Staphylococcus lugdunensis ATCC 43809 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID529516Antibacterial activity against Pseudomonas aeruginosa 1750J expressing beta-lactamase IMP-15 by Etest2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.
AID562389Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID544273Antimicrobial activity against Enterococcus faecalis NKH3 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID546619Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-18 by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID548475Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID1553775Antibacterial activity against Escherichia coli 078 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID560592Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolate IMCJ2S1 by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID597591Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID534302Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA4792010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID573528Antibacterial activity against Acinetobacter isolate A74510 harboring blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID69197Minimum inhibitory concentration (MIC) against Escherichia coli2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents.
AID513836Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as tRNA translocation rate (Rvb= 1.57+/-0.05 /sec)2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID542759Antimicrobial activity against Escherichia coli Du19 expressing qnrB6 and CTX-M-9G genes by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID561243Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID607928Antibacterial activity against Streptococcus pyogenes by broth dilution method2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Phytochemical studies on Stemona aphylla: isolation of a new stemofoline alkaloid and six new stemofurans.
AID64896Minimum inhibitory concentration was measured against Escherichia coli 0000JR66 producing AAD-(2'')-modifying enzyme; Value expressed as 32/1281991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID736476Antibacterial activity against Enterococcus faecalis RCMB 010068 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID608938Antibacterial activity against Escherichia coli ATCC 8739 after 24 hrs by broth microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID586042Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type U3 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID250260Susceptibility testing against Pseudomonas aeruginosa PAE_NUH04; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID573335Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID519114Antibacterial activity against Proteus mirabilis M 23 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID424425Antibacterial activity against Enterococcus faecalis AIS2007003 isolated from patients rectum by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID571904Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 16 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID444052Hepatic clearance in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID533357Antibacterial activity against non-gentamicin-resistant Pseudomonas spp. clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID395776Antibacterial activity against Escherichia coli isolate containing extended spectrum beta lactamase after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID743572Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by micro-dilution susceptibility method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID637095Antibacterial activity against Acinetobacter johnsonii ATCC 17909 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID1553791Bactericidal activity against Escherichia coli 078 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID285636Antimicrobial activity against Pseudomonas aeruginosa 12A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID575144Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID447240Antibacterial activity against Proteus vulgaris ATCC 8427 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID558015Antibacterial activity against Staphylococcus aureus E19977 by Etest2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID400535Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID583216Antibacterial activity against aminoglycoside-resistant Providencia stuartii expressing ANT(2')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID583228Antibacterial activity against efflux pump deficient Pseudomonas aeruginosa by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID532895Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 469 ST 277 expressing beta-lactamase SHV-27, CTX-M-15 and OXA-4 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID536087Antimicrobial activity against Staphylococcus aureus IFO 3060 after 24 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID533330Antibacterial activity against non-gentamicin-resistant Enterobacter cloacae clinical isolate after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1553785Bactericidal activity against Escherichia coli UB1005 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1060494Antibacterial activity against Klebsiella pneumoniae MTCC 109 by agar streak dilution method2014European journal of medicinal chemistry, Jan, Volume: 71Access to a new class of biologically active quinoline based 1,2,4-triazoles.
AID573350Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID558039Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S2 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID584562Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID736474Antibacterial activity against Klebsiella pneumoniae RCMB 010093 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID285611Antimicrobial activity against Pseudomonas aeruginosa 65.68-3 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID495516Antibacterial activity against multidrug-resistant Acinetobacter baumannii AYE by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID516160Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID573529Antibacterial activity against Acinetobacter baumannii isolate AbN450 harboring IblaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID373037Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate DL34 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID521842Antibacterial activity against Escherichia coli J53 by CLSI method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
AID424340Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH201 harboring Gly452Cys mutation in fusA after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID424832Ratio of MIC for kanamycin-resistant Staphylococcus aureus harboring mutations in FusE gene to MIC for wild type kanamycin-susceptible Staphylococcus aureus AH0012007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID531770Antimicrobial activity against Pseudomonas aeruginosa urine isolate 4706 containing PFGE clone A expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID283546Antibacterial activity against Pseudomonas aeruginosa KJ7106 with inactivated PA5471 gene by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID244899In-vitro minimum inhibitory concentration against the growth of Klebsiella pneumoniae2005Bioorganic & medicinal chemistry letters, Jul-01, Volume: 15, Issue:13
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
AID561490Antibacterial activity against Acinetobacter baumannii assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID586040Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID731206Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hrs by broth microdilution method2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
AID581671Antibacterial activity against normal phenotype Staphylococcus aureus in cation-adjusted MH 2 broth at pH 5.5 after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID545044Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ078 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID532893Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 475 ST 277 expressing beta-lactamase SHV-27, CTX-M-15 and OXA-4 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID1173798Antimicrobial activity against Escherichia coli ATCC 8739 by agar well diffusion method2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones.
AID536084Antimicrobial activity against Pseudomonas aeruginosa IFO 3448 at 100 ug/8 mm disk after 24 hrs by agar disk diffusion method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID251696Zone of inhibition of Escherichia coli after treatment with 10 ug of the compound2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones.
AID1245993Antimicrobial activity against Staphylococcus aureus after 24 hrs by spectrophotometry2015Journal of medicinal chemistry, Jan-22, Volume: 58, Issue:2
Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
AID554415Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 3020S obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID577648Antimicrobial activity against Escherichia coli isolate 157T expressing beta-lactamase KPC2 and PFGE cluster 3 isolated from urine of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID521578Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 50 ug/ml within 5 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID533618Antibacterial activity against Escherichia coli ATCC 25922 at MIC up to 8 hrs by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID373030Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU78 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID623612Antibacterial activity against 10'8 CFU/mL Streptococcus pyogenes MTCC 442 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID1256335Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID520296Antimicrobial activity against extracellular Staphylococcus aureus 2549 small colony variants after 4 hrs in MH-II broth2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID522933Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a D268N mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID481910Antimicrobial activity against Enterobacter cloacae ATCC 13047 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID520797Antimicrobial activity against CTX-M-59 producing Klebsiella pneumoniae with PFGE pulsotype E by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID532409Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B2 isolate VA-06X-38 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID285624Antimicrobial activity against Pseudomonas aeruginosa 8B11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1241211Binding affinity to 5'-FAM-pre-miR-373 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID571061Drug uptake in Wistar rat Kidney endothelium cells obtained after tissue digestion with 0.04% protease digestion for 2 hrs mins at 4 or 16 mg/kg, iv after 1 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID1064808Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID1060497Antibacterial activity against Bacillus cereus MTCC 619 by agar streak dilution method2014European journal of medicinal chemistry, Jan, Volume: 71Access to a new class of biologically active quinoline based 1,2,4-triazoles.
AID1159101Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID535691Antimicrobial activity against beta-lactamase CTX-M-15-producing fluoroquinolone-resistant Escherichia coli FMV5825 expressing qnrB2 and aac(6')-Ib-cr and harboring gyrA Ser83Ile and Asp87Asn mutant gene and ParC Ser80Ile and Glu84Val mutant gene obtained2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
AID577206Antimicrobial activity against Escherichia coli O157:H7 PT-32 in stationary phase encoding Stx-1 and Stx-2 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID584555Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID534106Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID533660Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid VGA2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID560523Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID561326Antimicrobial activity against Klebsiella pneumoniae isolate 135 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID1553792Bactericidal activity against Salmonella typhimurium C7731 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID285339Antimicrobial activity against streptomycin-resistant Escherichia coli J53 by agar dilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
AID504047Antimicrobial activity against Escherichia coli MTCC 443 by broth microdilution technique2010Bioorganic & medicinal chemistry letters, Sep-15, Volume: 20, Issue:18
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
AID520807Antimicrobial activity against CTX-M-2 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype A by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID647788Antibacterial activity Staphylococcus aureus at 40 ug/disc after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Apr, Volume: 50Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
AID481452Antibacterial activity against gentamicin-resistant Escherichia coli ATCC 6174 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID244900In-vitro minimum inhibitory concentration against the growth of Staphylococcus aureus2005Bioorganic & medicinal chemistry letters, Jul-01, Volume: 15, Issue:13
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
AID573508Antibacterial activity against Klebsiella oxytoca isolate Ko1156 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID253033Antimicrobial activity against Staphylococcus epidermidis was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.
AID1156860Antimicrobial activity against Pseudomonas aeruginosa ATCC BAA-427 after 24 hrs by microbroth dilution method2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
AID531743Induction of mexY in Pseudomonas aeruginosa 1956 clinical isolate harboring nfxB C113T mutant gene at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID1139682Antimicrobial activity against Pseudomonas aeruginosa DSM 50071 by serial dilution method2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Indothiazinone, an indolyl thiazolyl ketone from a novel myxobacterium belonging to the Sorangiineae.
AID514831Binding affinity to Escherichia coli 23S rRNA G2553C mutant assessed as increase in classical-state occupancy by tRNA at 20 uM by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID374111Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS5 transconjugant from Enterobacter cloacae 641 by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID561247Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID531969Antibacterial activity against Klebsiella pneumoniae blood isolate A28008 PFGE pattern A expressing KPC-2, TEM-1, SHV-11, CTX-M-2 beta-lactamase by agar dilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
AID533840Ratio of Cmax to MIC for Pseudomonas aeruginosa ATCC 27853 in PK/PD model at 1500 mg administered every 12 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID520696Antimicrobial activity against Escherichia coli DH10B harboring p041060 carrying qepA gene by agar dilution CLSI method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
AID558026Half life in human at 240 mg, im2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID1245990Antimicrobial activity against Escherichia coli after 24 hrs by spectrophotometry2015Journal of medicinal chemistry, Jan-22, Volume: 58, Issue:2
Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
AID1129349Antibacterial activity against multidrug-resistant Acinetobacter baumannii clinical isolate E2-1228625 after 18 hrs by microdilution broth method2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
AID1230236Antibacterial activity against Staphylococcus aureus ATCC 9144 oxford after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID531750Antibacterial activity against Pseudomonas aeruginosa FK06 harboring pNF225 carrying nfxB by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID1230224Antibacterial activity against Enterococcus faecium N733 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID523398Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 5 days by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID533349Antibacterial activity against non-gentamicin-resistant Citrobacter diversus clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID532896Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 469 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID518808Antimicrobial activity against Staphylococcus aureus BD1 harboring aphA-3 insertion in cspB gene by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID1056842Antibacterial activity against TEM-1/SHV-12/CTX-15 expressing Enterobacter intermedius isolate 243 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID613193Antibacterial activity against Haemophilus influenzae ATCC 10211 after 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
AID1143927Antimicrobial activity against hemB-deficient Staphylococcus aureus Newbould after 48 hrs by broth microdilution method2014European journal of medicinal chemistry, Jun-10, Volume: 80Unraveling the structure-activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus.
AID532911Antimicrobial activity against KPC-3 producing Klebsiella pneumoniae 557 ST 327 expressing beta-lactamase TEM-1 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID571914Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 21 expressing ampC, ompA, adeB, adeM, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1156858Antimicrobial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by microbroth dilution method2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
AID554387Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY operon by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID564697Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates assessed as resistance isolates by microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
AID285639Antimicrobial activity against Pseudomonas aeruginosa 13D6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID373042Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZJ49 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID424336Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH207 harboring Thr385Asn mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID573510Antibacterial activity against Citrobacter freundii isolate Cf1614 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID584317Antimicrobial activity against azide-resistant Escherichia coli J53 by agar dilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
AID574426Antimicrobial activity against Escherichia coli isolate 339T expressing beta-lactamase KPC2 and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID535847Antimicrobial activity against Pseudomonas aeruginosa PAO1 KTL harboring oprD gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID531972Antibacterial activity against Klebsiella pneumoniae blood isolate A28006 PFGE pattern A expressing KPC-2, TEM-1, SHV-11, CTX-M-2 beta-lactamase by agar dilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
AID575146Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS123 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID250294Susceptibility testing against Pseudomonas aeruginosa PAE_NUH19; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID250258Susceptibility testing against Pseudomonas aeruginosa PAE_NUH02; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID1553807Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at sub-MBC measured after 17 serial passages2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID563878Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 15 using 2.5 X 10'5 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID518813Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate COL by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID545047Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ088 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID567301Cmin in critically ill patient with acute kidney injury at 6 mg/kg, iv administered every 48 hrs2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID561316Antimicrobial activity against Enterobacter cloacae isolate 101 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID520796Antimicrobial activity against SHV-5 producing Klebsiella pneumoniae with PFGE pulsotype D by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID572130Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 32 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID519183Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 4 ug/ml of cefepime exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID608940Antibacterial activity against Staphylococcus aureus ATCC 9144 after 24 hrs by broth microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID534346Antimicrobial activity against Burkholderia pseudomallei Bp207 harboring deleted (bpeAB-oprA)::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID561329Antimicrobial activity against azide-resistant Escherichia coli J532009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID531753Antibacterial activity against Pseudomonas aeruginosa 2439 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID571894Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 11 expressing ompA, adeB, adeM, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1230219Antibacterial activity against Enterococcus faecalis N520 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID565418Antimicrobial activity against Salmonella enterica serotype Stanley isolate AM04864 expressing armA rRNA methyltransferase gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Identification of the aminoglycoside resistance determinants armA and rmtC among non-Typhi Salmonella isolates from humans in the United States.
AID586038Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type U assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID678628Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 at 50 mg/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
Synthesis and biological evaluation of optically active conjugated γ- and δ-lactone derivatives.
AID753900Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 assessed as growth inhibition by broth dilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c][1,2,4]triazine derivatives from new 5-aminopyrazoles.
AID1242642Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID567294Cmax in critically ill patient with acute kidney injury at 4 mg/kg, iv administered as 30 mins infusion2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID607924Antibacterial activity against Escherichia coli by broth dilution method2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Phytochemical studies on Stemona aphylla: isolation of a new stemofoline alkaloid and six new stemofurans.
AID510964Antimicrobial activity against CTX-M15/CTX-M14 ESBL producing Escherichia coli ST131 clonal complex isolate assessed as nonsusceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
AID531749Antibacterial activity against Pseudomonas aeruginosa FK06 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID295722Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 by broth dilution method2007European journal of medicinal chemistry, Sep, Volume: 42, Issue:9
N- and S-alpha-l-arabinopyranosyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. First synthesis and biological evaluation.
AID548797Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis assessed as percent resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID573507Antibacterial activity against Klebsiella oxytoca isolate Ko0426 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID285670Antimicrobial activity against Pseudomonas aeruginosa 24E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID534171Antimicrobial activity against beta lactamase CTX-M-14 producing Escherichia coli TOP10 harboring plasmid COP2 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID599615Antibacterial activity against Pseudomonas aeruginosa ATCC 278532011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
AID698706Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 16 to 20 hrs2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Structure-based discovery of substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors.
AID519252Antibacterial activity against Proteus mirabilis M 26 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID287385Antibacterial activity against Escherichia coli after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID1230240Antibacterial activity against Staphylococcus aureus CIP 5710 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID736472Antibacterial activity against Pseudomonas aeruginosa RCMB 010043 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID522859Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in CBA/J mouse assessed as decrease in bacterial invasion into layers of urothelium at 200 ug/kg, sc administered on day 3 postinfection daily for 3 days measured on day 9 post-i2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID558752Antibacterial activity against hetero-Methicillin-resistant and tetracycline-resistant Staphylococcus aureus deltaIP by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID586043Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type U5 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID510508Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate MC1AC9-26 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID428268Antimicrobial activity against carbapenemase producing Enterobacteriaceae assessed as resistant isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID554394Antimicrobial activity against Pseudomonas aeruginosa isolate 2715 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1241213Ratio of Kd for 5'-FAM-pre-miR-372 (unknown origin) in presence of 100-fold excess of Escherichia coli tRNA to Kd for 5'-FAM-pre-miR-372 (unknown origin)2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID395773Antibacterial activity against Klebsiella pneumoniae RSHM 574 after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID533572Antibacterial activity against non-gentamicin-resistant Staphylococcus aureus clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID395777Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID360834Antibacterial activity against Bacillus cereus ATCC 11778 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID1553771Antibacterial activity against Salmonella pullorum ATCC 7913 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1129350Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 hrs by microdilution broth method2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
AID1240502Antibacterial activity against Pseudomonas aeruginosa DR5790 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID533608Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID422474Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in maximal thickness of biofilm at 0.25 ug/mL after 4 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID428879Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit at 1000 uM by footprint assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID285617Antimicrobial activity against Pseudomonas aeruginosa 5F2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID533570Antibacterial activity against non-gentamicin-resistant Haemophilus influenzae clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID529480Antimicrobial activity against Enterobacter cloacae isolate 1 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID637158Antibacterial activity against Staphylococcus aureus NRRL B 313 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID533837Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as concentration to achieve 50% of the maximal kill rate for the bacterial population by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID278664Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 5952007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID571910Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 19 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1244382Antimycobacterial activity against Mycobacterium abscessus ATCC 19977 after 7 days by serial dilution method2015European journal of medicinal chemistry, Aug-28, Volume: 101Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
AID735362Antimicrobial activity against Escherichia coli by microdilution method2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Nudibaccatumone, a trimer comprising a phenylpropanoid and two sesquiterpene moieties from Piper nudibaccatum.
AID545048Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ210 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID558047Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S10 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID573392Antibacterial activity against ceftazidime-susceptible Providencia sp. assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID644241Antibacterial activity against Streptococcus pneumoniae clinical isolate after 16 to 20 hrs by two fold agar dilution method2012European journal of medicinal chemistry, Mar, Volume: 49Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
AID285680Antimicrobial activity against Pseudomonas aeruginosa 29G8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID560518Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 15b52 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID528830Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID521596Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 7.0 by bioluminescence assay2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID1167360Antibacterial activity against wild type Staphylococcus epidermidis ATCC 35984 after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID684947Antibacterial activity against Escherichia coli ATCC 9637 after 24 hrs by broth microdilution method2012European journal of medicinal chemistry, Oct, Volume: 56Micelles catalyzed chemo- and regio-selective one pot and one step synthesis of 2,3,5,6-tetrakis(alkyl and arylsulfanyl)-1,4-benzoquinones and 2,5-diaminosubstituted-1,4-benzoquinones "In-Water" and their biological evaluation as antibacterial and antifun
AID531752Antibacterial activity against Pseudomonas aeruginosa 3308 harboring pNF225 carrying nfxB by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID533354Antibacterial activity against non-gentamicin-resistant Proteus rettgeri clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID565071Antibacterial activity against CTX-M-15 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID293691Antibacterial activity against Salmonella typhi at 50 to 100 uM after 24 hrs by well diffusion method2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Clubbed triazoles: a novel approach to antitubercular drugs.
AID583219Antibacterial activity against aminoglycoside-resistant Staphylococcus aureus expressing ANT(4')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID355387Antimicrobial activity against Escherichia coli DC2 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID573353Antibacterial activity against ceftazidime-susceptible Escherichia coli assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID520778Antibacterial activity against beta-lactamase KPC-2 producing Escherichia coli isolate E1 by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
AID372843Antibacterial activity against Acinetobacter baumannii isolate B expressing 16S rRNA methylase armA gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
AID558022Protein binding in human serum at 240 mg, im2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID548739Antimicrobial activity against Oxacillin-susceptible coagulase-negative Staphylococcus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID529493Antimicrobial activity against Enterobacter cloacae isolate 781 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID564826Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1172970Antibacterial activity against Staphylococcus aureus SH10002014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Identification and characterization of an anti-pseudomonal dichlorocarbazol derivative displaying anti-biofilm activity.
AID198326In vitro testing for minimum inhibitory concentration against Salmonella Typhimurium LT2 1681987Journal of medicinal chemistry, Dec, Volume: 30, Issue:12
Design and synthesis of peptide derivatives of a 3-deoxy-D-manno-2-octulosonic acid (KDO) analogue as novel antibacterial agents acting upon lipopolysaccharide biosynthesis.
AID560508Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k5923 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID561315Antimicrobial activity against Enterobacter cloacae isolate 101 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID293690Antibacterial activity against Escherichia coli at 50 to 100 uM after 24 hrs by well diffusion method2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Clubbed triazoles: a novel approach to antitubercular drugs.
AID1064810Antibacterial activity against methicillin-resistant Staphylococcus aureus ND035208 after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID285586Antimicrobial activity against Pseudomonas aeruginosa 65.36-1 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1596894Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 16 to 18 hrs by broth microdilution assay
AID449249Antibacterial activity against Streptococcus pyogenes RITCC 1940 at 10 ug after overnight incubation by agar well diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, spectroscopic characterization and antibacterial activity of new cobalt(II) complexes of unsymmetrical tetradentate (OSN2) Schiff base ligands.
AID535727Antibacterial activity against Klebsiella pneumoniae urine isolate A28011 PFGE pattern A expressing KPC-2 CTX-M-2 beta-lactamase by agar dilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
AID561314Antimicrobial activity against Enterobacter cloacae isolate 37 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID446137Antibacterial activity against TriABC expressing MexAB, MexCD, MexEF, MexXY deleted Pseudomonas aeruginosa PA405 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID395831Antimicrobial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID583272Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa expressing AAC(6')-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID583254Antibacterial activity against aminoglycoside-resistant Enterobacter aerogenes expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID428877Binding affinity to 16S rRNA G1494(N7) position in wild type Escherichia coli JM109 30S sunit at 1000 uM by footprint assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID531773Antimicrobial activity against Pseudomonas aeruginosa secretion isolate 4688 containing PFGE clone A1 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID528793Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 and other bla gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID348094Antibacterial activity against multidrug-resistant Klebsiella pneumoniae ATCC 700603 isolate after 12 to 18 hrs2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
AID561934Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate RUH134 harboring plasmid ABVA01 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
AID394684Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID533835Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as maximal kill rate constant for the bacterial population by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID567567Antimicrobial activity against Bacillus sp. BS-01 expressing multiple resistance gene cfr and phenolic resistance gene fexA obtained from swine feces2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
AID1167677Antibacterial activity against Escherichia coli BW25113 expressing 2''-O-adenylyltransferase with aadB gene into pGDP4 vector2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones.
AID1240505Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID584561Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID1224541Antibacterial activity against extended spectrum beta-lactamase producing Klebsiella pneumoniae J 14368/08 after 24 hrs by broth microdilution method2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID534194Antimicrobial activity against Pseudomonas putida expressing beta-lactamase KPC-2 and SHV-12 obtained from criticall ill liver transplant recipient by broth microdilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
AID373986Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS3 transconjugant from Citrobacter freundii 64 by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID535833Antimicrobial activity against Pseudomonas aeruginosa GP62KT41 harboring oprD gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID278802Antimicrobial activity against recombinant Escherichia coli DH5-alpha expressing pBAD in the presence of arabinose2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
AID285613Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID476939Antibacterial activity against Proteus vulgaris ATCC 13315 after 24 hrs by browth microdilution assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents.
AID529653Antimicrobial activity against Escherichia coli DH5alpha by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID561659Antimicrobial activity against Pseudomonas aeruginosa isolate OC16827 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID544285Antimicrobial activity against Enterococcus faecalis NKH15 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID351925Toxicity against MDCK cells2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID400529Antibacterial activity against Staphylococcus aureus ATCC 6538p after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID574427Antimicrobial activity against Escherichia coli isolate 360 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from urine of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID285637Antimicrobial activity against Pseudomonas aeruginosa 12B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID530321Antimicrobial activity against Pseudomonas aeruginosa isolate PA-SD2 harboring blaVIM-1 gene by Etest method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID585419Antimicrobial activity against oqxAB positive Escherichia coli C600 W281-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID678713Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID1553790Bactericidal activity against Escherichia coli K99 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID479297Antimicrobial activity against Klebsiella pneumoniae CCM 2318 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID373026Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PUA1 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID561240Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID520794Antimicrobial activity against CTX-M-2 producing Klebsiella pneumoniae with PFGE pulsotype B by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID563889Antimicrobial activity against Enterococcus faecalis ATCC 29212 infected in CD-1 ICR mouse using 2.8 X 10'7 inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID567091Drug absorption in human assessed as human intestinal absorption rate2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
AID750276Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID586039Antimicrobial activity against Staphylococcus aureus clone 1-1 harboring staphylococcal cassette chromosome mec element type 4 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID510514Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID531735Induction of mexY in Pseudomonas aeruginosa EryR clinical isolate harboring nfxB C199T mutant gene at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID519184Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY and MexZ mutant gene selected after 8 ug/ml of amikacin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID717205Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 incubated for 24 hrs by microtiter broth dilution method2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja.
AID400533Antibacterial activity against Proteus vulgaris ATCC 3851 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID531767Antimicrobial activity against Pseudomonas aeruginosa secretion isolate 4682-1 containing PFGE clone A expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID562475Antimicrobial activity against rifampicin-resistant Escherichia coli A15 by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID1159095Antimicrobial activity against Micrococcus luteus ATCC 9341 assessed as zone of inhibition at 10 mg for 24 hrs at 30 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID528076Antibacterial activity against Staphylococcus aureus by broth microdilution method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Stereocontrolled facile synthesis and antimicrobial activity of oximes and oxime ethers of diversely substituted bispidines.
AID470181Antibacterial activity against Staphylococcus aureus KCTC 1928 at 50 ug/disk after 48 hrs by disk diffusion method2009Journal of natural products, Nov, Volume: 72, Issue:11
Alternaramide, a cyclic depsipeptide from the marine-derived fungus Alternaria sp. SF-5016.
AID736475Antibacterial activity against Neisseria gonorrhoeae RCMB 010076 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID549336Antimicrobial activity against Escherichia coli isolate 49 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID564827Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID436262Antimicrobial activity against Micrococcus luteus DMS 348 after 48 hrs by serial dilution method2008Journal of natural products, Nov, Volume: 71, Issue:11
Synthesis and biological activities of thio-avarol derivatives.
AID1167361Antibacterial activity against wild type Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID1056854Antibacterial activity against Pseudomonas aeruginosa FNSST 982 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID481448Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID395775Antibacterial activity against Pseudomonas aeruginosa ATCC 25853 after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID465509Antibacterial activity against beta lactamase positive Escherichia coli LMP 701 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID565033Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID465514Antibacterial activity against chloramphenicol-resistant Citrobacter freundii LMP 802 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID564696Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates assessed as resistance isolates by microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
AID564811Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285651Antimicrobial activity against Pseudomonas aeruginosa 19C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID70617Minimum inhibitory concentration was measured against Escherichia coli ATCC 25992.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID428873Antibacterial activity against Escherichia coli JM109 carrying pMCL210 by agar dilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID623611Antibacterial activity against 10'8 CFU/mL Bacillus subtilis MTCC 441 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID574439Antimicrobial activity against Escherichia coli DH10B by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID766173Antibacterial activity against methicillin-resistant Staphylococcus aureus MW2 after 20 to 24 hrs by two-fold broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID558018Cmax in human at 240 mg, im2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID528831Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient wound assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID1076978Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition after 48 hrs by two-fold serial dilution assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Bifunctional ethyl 2-amino-4-methylthiazole-5-carboxylate derivatives: synthesis and in vitro biological evaluation as antimicrobial and anticancer agents.
AID523508Antimicrobial activity against Pseudomonas aeruginosa isolate 1726 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID533841Ratio of Cmax to MIC for Pseudomonas aeruginosa ATCC 27853 in PK/PD model at 2000 mg administered every 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID684948Antibacterial activity against Pseudomonas aeruginosa ATCC BAA-427 after 24 hrs by broth microdilution method2012European journal of medicinal chemistry, Oct, Volume: 56Micelles catalyzed chemo- and regio-selective one pot and one step synthesis of 2,3,5,6-tetrakis(alkyl and arylsulfanyl)-1,4-benzoquinones and 2,5-diaminosubstituted-1,4-benzoquinones "In-Water" and their biological evaluation as antibacterial and antifun
AID1064807Antibacterial activity against Streptococcus pyogenes L49 after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID532187Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae SY26T harboring wild-type GyrA, ParC, GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID572124Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 29 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID373034Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ3-9 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID609059Antibacterial activity against Pseudomonas aeruginosa ATCC 25668 at 4 ug/ml after 24 hrs by agar-well diffusion technique2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
A regioselective synthesis of some new pyrazol-1'-ylpyrazolo[1,5-a]pyrimidines in aqueous medium and their evaluation as antimicrobial agents.
AID1202789Antibacterial activity against Escherichia coli TISTR 780 by 2-fold serial dilution method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
AID524003Antimicrobial activity against Acinetobacter baumannii ATCC 15151 harboring ISAba1-blaOXA-66 gene by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
AID549332Antimicrobial activity against Escherichia coli isolate 86 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID422883Antimicrobial activity against 8 ug/ml colistin-subcultured Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolated from diabetic patient with calcaneal osteomyelitis and bacteremia by broth microdilution assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
AID573549Antibacterial activity against Klebsiella pneumoniae Kp149 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1241209Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID481907Antimicrobial activity against Acinetobacter baumannii ATCC 19606 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID283541Antibacterial activity against Pseudomonas aeruginosa FE53GU with inactivated mexZ, nuoG and galU genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID1242648Antifungal activity against Sporothrix schenckii after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID519734Antibacterial activity against Escherichia coli DH5alpha with deltaampC by agar dilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
AID562588Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID422473Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in biomass of biofilm at 0.25 ug/mL after 4 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID544976Antimicrobial activity against Klebsiella pneumoniae 521452009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides.
AID395832Antimicrobial activity against Escherichia coli ATCC 9637 after 24 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID1553813Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of NaCl2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID563892Antimicrobial activity against Escherichia coli 9612 infected in new Zealand white rabbit with skin burn injury assessed as decrease in bacterial load in burn wound at 1 mg/ml after 24 hrs (Rvb = 8.57 +/- 0.35 log10CFU/g)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID1064805Antibacterial activity against Enterococcus faecalis L560 expressing VanA gene after 24 hrs by broth microdilution method2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Characterization of the congeners in the lantibiotic NAI-107 complex.
AID311876Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID532899Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 588 ST 340 expressing beta-lactamase TEM-1 and SHV-11 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID285622Antimicrobial activity against Pseudomonas aeruginosa 8A12 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1056858Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID335116Antibacterial activity against Escherichia coli at 10 ug/disk by disk diffusion assay1993Journal of natural products, Sep, Volume: 56, Issue:9
An antifungal bibenzyl from the New Zealand liverwort, Plagiochila stephensoniana. Bioactivity-directed isolation, synthesis, and analysis.
AID558755Antibacterial activity against methicillin-susceptible, tetracycline-resistant and chloramphenicol-resistant Staphylococcus aureus H14-KVR by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID444050Fraction unbound in human plasma2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID575143Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NRS70 by broth microdilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
AID1129346Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by microdilution broth method2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID1553822Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of CaCl22019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1056867Antibacterial activity against Escherichia coli FNSST 982 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID544281Antimicrobial activity against Enterococcus faecalis NKH11 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID348098Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 expressing vanB, ant(6)-1, aac(6')-aph(2') resistant gene after 12 to 18 hrs2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
AID460799Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID360842Antibacterial activity against Streptococcus agalactiae ATCC 13813 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID460800Antibacterial activity against Acinetobacter baumannii UH8407 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID1060498Antibacterial activity against Staphylococcus aureus MTCC 96 by agar streak dilution method2014European journal of medicinal chemistry, Jan, Volume: 71Access to a new class of biologically active quinoline based 1,2,4-triazoles.
AID766184Antibacterial activity against Staphylococcus aureus NCTC 6571 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID523500Antimicrobial activity against Pseudomonas aeruginosa isolate 1681c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID577204Antimicrobial activity against Escherichia coli O157:H7 PT-40 in stationary phase encoding Stx-2 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID533347Antibacterial activity against non-gentamicin-resistant Enterobacter cloacae clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID571056Drug uptake in Wistar rat kidney proximal tubule S2 obtained after tissue digestion with 0.04% protease digestion for 2 hrs mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID285917Antimicrobial activity against methicillin-resistant Staphylococcus aureus 81112007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
AID212903Inhibition of human telomerase before assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID285643Antimicrobial activity against Pseudomonas aeruginosa 15G10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID545049Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ249 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID567298Cmax in critically ill patient with acute kidney injury at 5 mg/kg, iv administered every 24 hrs2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID479296Antimicrobial activity against Salmonella Typhimurium CCM 5445 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID495510Antibacterial activity against Acinetobacter baumannii BM4454 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID535648Antimicrobial activity against aac(6')-Ib-cr-positive Escherichia coli FJ3 harboring GyrA S83L, ParC S80R mutant, wild-type GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID561325Antimicrobial activity against Klebsiella pneumoniae isolate 135 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID285645Antimicrobial activity against Pseudomonas aeruginosa 16D2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID528984Antimicrobial activity against Haemophilus influenzae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID532391Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone A1 isolate FG-17X-14 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID519481Antibacterial activity against Staphylococcus aureus T991 by Etest method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
AID424617Antibacterial activity against vancomycin-resistant Staphylococcus aureus AIS2006049 isolated from patients arm wound by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID535654Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae FJ61 harboring GyrA S83I, GyrA D87A, ParC S80I mutant, wild-type GyrB and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID1127105Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by spectrophotometric analysis2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID396032Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID573534Antibacterial activity against Citrobacter amalonaticus Ca3927 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID535861Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae GZ47 harboring qnrB and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID572144Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 39 expressing ampC, ompA, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID533603Antibacterial activity against gentamicin-resistant Staphylococcus aureus clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID574432Antimicrobial activity against Escherichia coli isolate 543 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID295088Antibacterial activity against Listeria monocytogenes ATCC 15313 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID533613Bactericidal activity against Staphylococcus epidermidis isolate 01-55 assessed as log reduction in viable-cell count at 0.25 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1175557Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Antibacterial ilicicolinic acids C and D and ilicicolinal from Neonectria discophora SNB-CN63 isolated from a termite nest.
AID1185244Antimicrobial activity against Klebsiella pneumoniae RCMB 010093 assessed as inhibition zone at 5 mg/ml after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
AID581670Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth at pH 5.5 after 48 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID447242Antibacterial activity against Listeria monocytogenes ATCC 15313 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID373036Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ52 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID518809Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 37 degC and measured at 15 degC by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID532163Antimicrobial activity against aac(6')-Ib-cr-negative Escherichia coli PU12T harboring wild-type GyrA, GyrB, ParC and qnrS genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID446130Antibacterial activity against AAC6'-2b expressing Escherichia coli PAZ505H8101 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID550180Antimicrobial activity against Klebsiella pneumoniae2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID554419Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2721 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID560506Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k2345 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID250263Susceptibility testing against Pseudomonas aeruginosa PAE_NUH07; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID583211Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing ANT(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID476937Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by browth microdilution assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents.
AID519314Antimicrobial activity against mexXY-OprM-overproducing Pseudomonas aeruginosa PAO12008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID558046Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S9 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID554384Antimicrobial activity against Pseudomonas aeruginosa PAO1 by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1167352Antibacterial activity against wild type Escherichia coli D21 after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID509865Antibacterial activity against Acinetobacter baumannii ATCC 17978 isolated from human CSF2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID519189Antimicrobial activity against mexXY-OprM-overproducing Pseudomonas aeruginosa isolate PA/XY assessed as zone of inhibition by disk diffusion method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID1257071Antibacterial activity against methicillin-resistant Staphylococcus aureus Mu50 ATCC 700699 after 20 hrs by CLSI broth microdilution method2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis of biscoumarin and dihydropyran derivatives with promising antitumor and antibacterial activities.
AID519125Antibacterial activity against Proteus mirabilis M 42 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID497693Antimicrobial activity against colistin-susceptible Klebsiella pneumoniae isolated from bacteremia patient assessed as percentage of resistant isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
AID428870Antibacterial activity against Escherichia coli CSH-2 carrying Escherichia coli ARS3 pARS3 by agar dilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID472635Antibacterial activity against Staphylococcus aureus at 100 ug/disk after 24 hrs by disk diffusion method2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID529490Antimicrobial activity against Enterobacter cloacae isolate 354 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID533591Antibacterial activity against gentamicin-resistant Klebsiella pneumoniae clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID523515Antimicrobial activity against Pseudomonas aeruginosa isolate 1253 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID533661Antimicrobial activity against Staphylococcus aureus RN4220 harboring plasmid CU12008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID278804Antimicrobial activity against recombinant Escherichia coli DH5-alpha expressing pBAD [aph(3')-2] in the presence of arabinose2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
AID395387Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID373756Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab20 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID583250Antibacterial activity against aminoglycoside-resistant Serratia liquefaciens expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID283534Antibacterial activity against Pseudomonas aeruginosa FE57 containing inactivated rplY gene with pARAL25 by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID542106Antibacterial activity against Escherichia coli TrC C expressing Klebsiella pneumoniae C blaCTX-M beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID519408Antibacterial activity against 16S rRNA methylase RmtB and CTX-M-65 ESBL producing Escherichia coli DH10B by Etest2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
AID401033Antimicrobial activity against Pseudomonas aeruginosa K799 after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID678714Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID533621Bactericidal activity against Staphylococcus epidermidis isolate 01-55 at >=1 MIC up to 8 hrs by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID583234Antibacterial activity against Escherichia coli by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID520780Antibacterial activity against Escherichia coli EC600 transconjugant harboring beta-lactamase KPC-2 by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
AID278667Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 25132007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID1129347Antibacterial activity against extended-spectrum beta-lactamase producing multidrug-resistant and colistin-susceptible Escherichia coli CTX-M-15 clinical isolate Aar 11 after 18 hrs by microdilution broth method2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
AID336236Antimicrobial activity against Escherichia coli at 10 ug/disk
AID1241202Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID528829Antimicrobial activity against ESBL producing Klebsiella pneumoniae assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID535386Antibacterial activity against small-colony variant Staphylococcus aureus isolate OM1b harboring menB G698T Gly233Val mutant gene by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID561281Antibacterial activity against Klebsiella pneumoniae assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1230206Antibacterial activity against Bacillus cereus N190 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID530322Antimicrobial activity against Pseudomonas aeruginosa isolate PA-SL2 harboring blaVIM-13 gene by Etest method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
AID1256333Antibacterial activity against clinical isolate Staphylococcus aureus by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID544283Antimicrobial activity against Enterococcus faecalis NKH13 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1056859Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID289775Antibacterial activity against Escherichia coli MTCCB 1652 at 30 ug/disc after 48 hrs by disc diffusion method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID573720Antibacterial activity against Citrobacter koseri Ck211 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID583223Antibacterial activity against aminoglycoside-susceptible Acinetobacter baumannii by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID586041Antimicrobial activity against Staphylococcus aureus clone 2-2 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID1224527Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis Praha 131 after 7 days by micromethod2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID504048Antimicrobial activity against Pseudomonas aeruginosa MTCC 1688 by broth microdilution technique2010Bioorganic & medicinal chemistry letters, Sep-15, Volume: 20, Issue:18
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
AID481455Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID529649Antimicrobial activity against Escherichia coli DH5alpha harboring beta-lactamase VIM-16 by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID564825Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID766182Antibacterial activity against Enterococcus faecalis NCTC 775 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID1056834Antibacterial activity against GIM-1 expressing Pseudomonas aeruginosa isolate 197 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID542769Antimicrobial activity against Escherichia coli J53 transformed with pHND1 carrying DHA-1 gene by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID750275Antifungal activity against Candida albicans MTCC 227 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID373029Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PUA7 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID561324Antimicrobial activity against Klebsiella pneumoniae isolate 132 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID573498Antibacterial activity against Klebsiella pneumoniae isolate Kp7564 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID701869Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID571912Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 20 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID542735Antimicrobial activity against Klebsiella pneumoniae D10 expressing aac(6')-Ib-cr, qnrB4, CTX-M-1G and DHA-1 genes by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID530347Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M carrying blaCTX-M-15 and pQep plasmid carrying qepA2 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID1056844Antibacterial activity against TEM-1/CTX-M-15 expressing Enterobacter cloacae isolate 62 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1250085Antibacterial activity against Escherichia coli ATCC 259222015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID571666Inhibition of [3H]gentamicin binding to brush border membrane of renal cortex2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
AID532416Antibacterial activity against IMP-13 producing Pseudomonas aeruginosa clone C2 isolate NA-14X-11 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID563522Antibacterial activity against Pseudomonas aeruginosa NY219 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
AID544286Antimicrobial activity against Enterococcus faecalis NKH16 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID560590Antimicrobial activity against Pseudomonas aeruginosa isolate IMCJ798 by microdilution method2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
AID559645Antimicrobial activity against Extended-spectrum beta-lactamase producing Escherichia coli clinical isolate assessed as resistant isolate2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
AID561327Antimicrobial activity against Klebsiella pneumoniae isolate 202 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID571688Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 1 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1256334Antibacterial activity against clinical isolate Streptococcus pyogenes by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID285598Antimicrobial activity against Pseudomonas aeruginosa 2C1 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID396026Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID521834Antibacterial activity against Klebsiella pneumoniae isolate VA367 with blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, blaSHV-12, aac(6')-1b genes by CLSI method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
AID573725Antibacterial activity against Citrobacter youngae CyB38 transconjugant harboring blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID561480Antibacterial activity against Pseudomonas aeruginosa assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID571696Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 5 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID563884Antimicrobial activity against Klebsiella pneumoniae 935 infected in CD-1 ICR mouse using 3 X 10'5 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID523001Cytotoxicity against human 5637 cells assessed as mild induction of cell death by trypan blue exclusion assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID558759Antibacterial activity against hetero-vancomycin-intermediate Staphylococcus aureus Mu3 by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID561236Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID562472Antimicrobial activity against Klebsiella pneumoniae isolate 2641/08 obtained from urine of patient with ischemic cardiomyopathy and several comorbidities by Etest2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
AID565063Antibacterial activity against CTX-M-15 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID717207Antimicrobial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by microtiter broth dilution method2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja.
AID283540Antibacterial activity against Pseudomonas aeruginosa FE57Z with inactivated rplY and mexZ genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID522863Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in CBA/J mouse assessed as decrease in bacterial invasion into layers of urothelium at 200 ug/kg, sc administered on day 3 postinfection daily for 3 days measured on day 9 post-i2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID1159094Antimicrobial activity against Salmonella typhimurium ATCC 14028 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID581656Antibacterial activity against revertant Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID373770Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh26 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID529457Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone B expressing beta-lactamase Oxa-48, TEM-1, CTX-M-15 and Oxa-1 by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
AID1553787Bactericidal activity against Salmonella pullorum ATCC 7913 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID586051Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 1 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID766177Antibacterial activity against Salmonella typhimurium assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID496397Antibacterial activity against azide-resistant Escherichia coli J53 SXT2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID540237Phospholipidosis-positive literature compound observed in rat
AID766175Antibacterial activity against Staphylococcus aureus 1H after 20 to 24 hrs by two-fold broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID283648Susceptibility of Escherichia coli K12 MG1655 in presence of 10 mM glutathione by agar dilution method relative to control2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
AID561275Antibacterial activity against Escherichia coli assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1240508Antibacterial activity against Klebsiella pneumoniae DS07955 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID573525Antibacterial activity against Klebsiella oxytoca isolate Ko238 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID581664Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein after 24 hrs2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID410025Antimicrobial activity against Escherichia coli after 24 hrs by well diffusion method2008Bioorganic & medicinal chemistry letters, Dec-01, Volume: 18, Issue:23
Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
AID295721Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth dilution method2007European journal of medicinal chemistry, Sep, Volume: 42, Issue:9
N- and S-alpha-l-arabinopyranosyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. First synthesis and biological evaluation.
AID1235888Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by microdilution method2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Dirchromones: Cytotoxic Organic Sulfur Compounds Isolated from Dirca palustris.
AID1056850Antibacterial activity against TEM-1/SHV-12 expressing Klebsiella pneumoniae isolate 303 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID535385Antibacterial activity against Staphylococcus aureus isolate OM1a by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID585430Antimicrobial activity against oqxAB positive Escherichia coli C600 SP8-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID560511Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3578 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID532901Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 365 ST 376 expressing beta-lactamase SHV-27, CTX-M-15 and OXA-4 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID560502Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06051 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID545051Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ274 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1241212Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay in presence of 100-fold excess of Escherichia coli tRNA2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID519122Antibacterial activity against Proteus mirabilis NP55 after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID548742Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecalis assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID584122Antimicrobial activity against Staphylococcus aureus RN4220 by CLSI M31-A3 method2011Antimicrobial agents and chemotherapy, Jan, Volume: 55, Issue:1
Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.
AID432096Antibacterial activity against Bacillus cereus at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID522855Drug level in Escherichia coli UTI89-infected CBA/J mouse urine at 200 ug/kg, sc after 2 hrs2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID540236Phospholipidosis-positive literature compound observed in human
AID532396Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone A3 isolate FG-17X-08 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID487959Cytotoxicity against HDF after 72 hrs by XTT assay2010Bioorganic & medicinal chemistry, Jun-01, Volume: 18, Issue:11
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
AID583245Antibacterial activity against aminoglycoside-resistant Enterobacter aerogenes expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID567318Antimicrobial activity against Escherichia coli TUM4670 by broth dilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
AID1056868Antibacterial activity against Clostridium perfringens FNSST 4999 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID1188549Antimicrobial activity against Bacillus subtilis assessed as inhibition of visible growth after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID534304Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA4942010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID283646Susceptibility of Escherichia coli K12 MG1655 by agar dilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
AID577004Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as viable bacterial count by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID573342Antibacterial activity against ceftazidime-susceptible Citrobacter freundii assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID534301Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA4602010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID531976Antibacterial activity against Escherichia coli DH10B expressing KPC-2 CTX-M-2 by agar dilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
AID289772Antibacterial activity against Staphylococcus aureus MTCCB 737 at 30 ug/disc after 48 hrs by disc diffusion method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID535663Antimicrobial activity against aac(6')-Ib-cr-positive Enterobacter cloacae FJ63T harboring qnrS gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID258349MIC per disc against Streptomyces thermonitrificans by disc diffusion method2006Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
AID583252Antibacterial activity against aminoglycoside-resistant Klebsiella pneumoniae expressing AAC(3)-4 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID560512Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k1642 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID524005Antimicrobial activity against Acinetobacter sp. harboring aacA4 gene assessed as percent resistant isolates2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
AID557777Antimicrobial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID763667Antibacterial activity against Bacillus subtilis after 24 hrs by microdilution susceptibility method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID1133315Antibacterial activity against Streptococcus faecalis ATCC 14506 assessed as lowest concentration required for total inhibition by broth microdilution assay1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles.
AID446134Antibacterial activity against MexEF expressing Pseudomonas aeruginosa PA03 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID424344Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH190 harboring Arg464His mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID1240500Antibacterial activity against Pseudomonas aeruginosa DM23376 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID535900Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii JS33T harboring qnrA gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID529498Antimicrobial activity against Escherichia coli T-781 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID529645Antimicrobial activity against Pseudomonas aeruginosa 166301 expressing beta-lactamase VIM-16 obtained from urine of patient by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID336235Antimicrobial activity against Streptococcus pyogenes at 10 ug/disk
AID573501Antibacterial activity against Morganella morganii isolate Mm38009 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1230207Antibacterial activity against Bacillus cereus N258 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID1230233Antibacterial activity against Listeria monocytogenes N836 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID573344Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID535838Antimicrobial activity against wild-type Pseudomonas aeruginosa GP20 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID460803Antibacterial activity against multidrug-resistant Acinetobacter baumannii BAA-1605 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID575170Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID308343Antibacterial activity against Pseudomonas aeruginosa MTCCB 7412007Bioorganic & medicinal chemistry letters, Aug-01, Volume: 17, Issue:15
Antimicrobial activity of rationally designed amino terminal modified peptides.
AID465508Antibacterial activity against methicillin-resistant Staphylococcus aureus LMP 805 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID558049Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S12 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID581663Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein at up to 10'5 times MIC after 24 hrs2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID424424Antibacterial activity against vancomycin-resistant Staphylococcus aureus AIS2006032 isolated from patients foot wound by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID603662Antimicrobial activity against Klebsiella pneumoniae CCM 2318 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID519123Antibacterial activity against Proteus mirabilis M 35 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID424859Antimicrobial activity against Pseudomonas aeruginosa PAO1 by E-test2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID1185242Antimicrobial activity against Proteus vulgaris RCMB 010085 assessed as inhibition zone at 5 mg/ml after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
AID573366Antibacterial activity against ceftazidime-susceptible Morganella morganii assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID283531Antibacterial activity against Pseudomonas aeruginosa FE49 with inactivated galU gene by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID278673Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 57342007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID583247Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID644239Antibacterial activity against Staphylococcus aureus clinical isolate after 16 to 20 hrs by two fold agar dilution method2012European journal of medicinal chemistry, Mar, Volume: 49Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
AID1256330Antibacterial activity against Enterococcus faecalis ATCC 29212 by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID65071Estimated rate of [3H]DHS uptake in Escherichia coli K12 (ATCC 25868)1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID558756Antibacterial activity against hetero-Methicillin-resistant and tetracycline-resistant and rifampicin-resistant Staphylococcus aureus deltaIP-rifR harboring RpoB H481Y mutant gene by Etest method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
AID554443Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa PAO1 by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID510502Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate C1AC9-24 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID355388Antimicrobial activity against Escherichia coli UB1005 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID528827Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID678716Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID1230214Antibacterial activity against Enterococcus durans CIP 104999 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID562587Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID1159103Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as zone of inhibition at 10 mg by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID535388Antibacterial activity against wild type Staphylococcus aureus OM1b:F5 phenotypic revertant by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID561248Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID571064Drug uptake in Wistar rat Kidney glomeruli cells obtained after tissue digestion with 0.04% protease digestion for 15 mins to 2 hrs mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID529161FIC index, ratio of MIC for Pseudomonas aeruginosa 100609 in presence of 250 ug/ml polyethylenimine to MIC for Pseudomonas aeruginosa 1006092008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
AID373762Antibacterial activity against imipenem-resistant Acinetobacter baumannii ab1266 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID372847Antibacterial activity against Escherichia coli DH10B expressing Acinetobacter baumannii isolate B 16S rRNA methylase armA gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID528820Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID394706Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(3')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID750273Antifungal activity against Aspergillus clavatus MTCC 1323 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID65223Minimum inhibitory concentration was measured against Escherichia coli OLA 290R5 producing AAD-(2'')-modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID531741Induction of mexY in Pseudomonas aeruginosa 2126 clinical isolate harboring nfxB deltaC114-T130 mutant gene at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID561657Antimicrobial activity against Pseudomonas aeruginosa isolate OC14805 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID763668Antibacterial activity against Staphylococcus aureus after 24 hrs by microdilution susceptibility method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID531755Antibacterial activity against Pseudomonas aeruginosa 2126 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID533590Antibacterial activity against gentamicin-resistant Escherichia coli clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID510509Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate MC4AC9-30 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID567289Half life in iv dosed critically ill patient with acute kidney injury during extended daily diafiltration2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID152321Minimum inhibitory concentration was measured against Providencia stuartii 72052305 producing AAC-(2'') modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID481909Antimicrobial activity against Escherichia coli ATCC 11775 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID519181Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrZ mutant and MexZ mutant gene selected after 1 ug/ml of Norfloxacin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID548737Antimicrobial activity against Oxacillin-susceptible Staphylococcus aureus assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID558242Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 9 mg/liter after 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID554424Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2998 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID250292Susceptibility testing against Pseudomonas aeruginosa PAE_NUH17; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID535390Antibacterial activity against phenotypic revertant Staphylococcus aureus OM1b:F9 harboring G698T/Gly233Val and compensatory A776T/Lys259Ile mutant menB gene by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID446131Antibacterial activity against ANT2'-2a expressing Escherichia coli L58058.1 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID1553815Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of CaCl22019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID424341Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH197 harboring Leu456Phe mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID674909Antibacterial activity against Staphylococcus aureus MTCC 962012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
AID559860Antibacterial activity against Acinetobacter baumannii A9844 infected in Galleria mellonella caterpillar assessed as prolonged survival rate at 6 mg/kg administered as single dose2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
AID285607Antimicrobial activity against Pseudomonas aeruginosa 2A9 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1171199Antimicrobial activity against Pseudomonas aeruginosa 50071 after 24 to 48 hrs by serial dilution method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Nannozinones and sorazinones, unprecedented pyrazinones from myxobacteria.
AID532172Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae SH39 harboring GyrA S83I, ParC S80I mutant, wild-type GyrB and qnrA genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID293689Antibacterial activity against Pseudomonas aeruginosa at 50 to 100 uM after 24 hrs by well diffusion method2007European journal of medicinal chemistry, Jun, Volume: 42, Issue:6
Clubbed triazoles: a novel approach to antitubercular drugs.
AID561678Antimicrobial activity against Pseudomonas aeruginosa isolate OC14551 harboring plasmid MexZ expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID1230215Antibacterial activity against Enterococcus faecalis CIP 103214 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID561161Cmax in in vitro pharmacokinetic/pharmacodynamic model at 5 mg/kg for every 24 hrs2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID424342Antibacterial activity against fusidic acid-resistant Staphylococcus aureus AH187 harboring His457Tyr mutation in fusA gene after 18 to 24 hrs by Etest strip assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.
AID201258Minimum inhibitory concentration was measured against Staphylococcus aureus 76080401 producing AAD-(4')) modifying enzyme; Value expressed as less than 0.25/0.51991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID423073Antibacterial activity against 63_H5 allele containing Pseudomonas aeruginosa PAO1 H1133 mutant strain with nfxB::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID763670Antifungal activity against Candida albicans at 200 ug/disc after 48 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID1553821Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of KCl2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID532412Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B3 isolate PV-05X-07 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID276384Antibacterial activity against Klebsiella pneumoniae by broth microdilution technique2006Bioorganic & medicinal chemistry letters, Nov-15, Volume: 16, Issue:22
Naphtho[2,3-b][1,4]-thiazine-5,10-diones and 3-substituted-1,4-dioxo-1,4-dihydronaphthalen-2-yl-thioalkanoate derivatives: synthesis and biological evaluation as potential antibacterial and antifungal agents.
AID583269Antibacterial activity against aminoglycoside-resistant Acinetobacter baumannii expressing AAC(3')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID338245Antimicrobial activity against Staphylococcus aureus Sau1091-5 at 1 ug/disk1994Journal of natural products, Nov, Volume: 57, Issue:11
Vibrindole A, a metabolite of the marine bacterium, Vibrio parahaemolyticus, isolated from the toxic mucus of the boxfish Ostracion cubicus.
AID1202791Antibacterial activity against Pseudomonas aeruginosa TISTR 884 by 2-fold serial dilution method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
AID533569Antimicrobial activity against Pseudomonas aeruginosa isolate PA475 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID557787Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID548744Antimicrobial activity against Vancomycin-nonsusceptible Enterococcus faecium assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID253031Antimicrobial activity of the compound against Staphylococcus aureus was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.
AID554392Antimicrobial activity against Pseudomonas aeruginosa isolate 3020S obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID432091Antibacterial activity against Micrococcus sp. at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID1553831Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of ZnCl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID565074Antibacterial activity against CTX-M-14 ESBL producing Proteus mirabilis assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID510511Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate N2AC9-19 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID561273Antibacterial activity against Escherichia coli assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID1170144Antimicrobial activity against Bacillus subtilis DSM 1088 incubated for 24 hrs by disk diffusion method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antibacterial secondary metabolites from an endophytic fungus, Eupenicillium sp. LG41.
AID481904Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID516161Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID428872Antibacterial activity against Escherichia coli JM109 carrying pMCL-BE by agar dilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID374113Antimicrobial activity against azide-resistant Escherichia coli J53 by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID571063Drug uptake in Wistar rat Kidney endothelium cells obtained after tissue digestion with 0.04% protease digestion for 15 mins to 2 hrs mins at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID285690Antimicrobial susceptibility of carbapenem-resistant Pseudomonas aeruginosa PA4036 isolate expressing carbapenemase KPC22007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
AID1170145Antimicrobial activity against Acinetobacter sp. BD4 DSM 586 incubated for 24 hrs by disk diffusion method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antibacterial secondary metabolites from an endophytic fungus, Eupenicillium sp. LG41.
AID577224Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring mmsA::ISphoA/haha mutation by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID1180406Antimicrobial activity against Enterococcus faecalis ATCC 29212 after 16 to 20 hrs2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
AID285635Antimicrobial activity against Pseudomonas aeruginosa 12A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID422472Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in maximal thickness of biofilm at 0.25 ug/mL after 2 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID250284Susceptibility testing against Pseudomonas aeruginosa ATCC 27853; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID607926Antibacterial activity against Staphylococcus aureus by broth dilution method2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Phytochemical studies on Stemona aphylla: isolation of a new stemofoline alkaloid and six new stemofurans.
AID1553779Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID395835Antimicrobial activity against Candida albicans after 48 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID573724Antibacterial activity against Serratia marcescens Sm265 transconjugant harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID562811Antimicrobial activity against Escherichia coli J53 harboring pEK204 plasmid encoding CTX-M extended-spectrum beta-lactamases2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
AID1230220Antibacterial activity against Enterococcus faecium CIP 103014 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID311877Antibacterial activity against Escherichia coli ATCC 8739 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID586054Antimicrobial activity against Staphylococcus aureus clone 4-4 harboring staphylococcal cassette chromosome mec element type 5 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID400534Antibacterial activity against Salmonella typhimurium ATCC 14028 after 24 hrs by twofold microtiter broth dilution method2004Journal of natural products, Mar, Volume: 67, Issue:3
Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity.
AID522931Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase R92H mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID528979Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID411995Antibacterial activity against Escherichia coli after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides.
AID425599Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 18 ug/ml after 6 hr2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID94284Minimum inhibitory concentration was measured against Klebsiella pneumoniae 00GT3020 producing AAD-(2'')-modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID554401Antimicrobial activity against Pseudomonas aeruginosa isolate 2998 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID561674Antimicrobial activity against Pseudomonas aeruginosa isolate OC14812 harboring plasmid MexZ expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID532909Antimicrobial activity against KPC-3 producing Klebsiella pneumoniae 549 ST 327 expressing beta-lactamase TEM-1 and CTX-M-2 by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID523497Antimicrobial activity against Pseudomonas aeruginosa isolate 1529c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID558044Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S7 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID573533Antibacterial activity against Enterobacter cloacae El3518 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID351921Suppression of IDUA Q70X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID498362Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrR containing isogenic acrR knockout assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
AID534298Antimicrobial activity against Pseudomonas aeruginosa isolate PA500 expressing VIM-1 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID278669Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 25142007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID250261Susceptibility testing against Pseudomonas aeruginosa PAE_NUH05; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID701870Antibacterial activity against multidrug resistant NDM-1 producing Klebsiella pneumoniae isolate after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID581657Antibacterial activity against normal phenotype Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID348095Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 12 to 18 hrs2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
AID637091Antibacterial activity against Bacillus idosus B 241 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID701874Antibacterial activity against multidrug resistant ESBL producing Escherichia coli isolate after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID449250Antibacterial activity against Staphylococcus aureus RITCC 1885 at 10 ug after overnight incubation by agar well diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, spectroscopic characterization and antibacterial activity of new cobalt(II) complexes of unsymmetrical tetradentate (OSN2) Schiff base ligands.
AID285659Antimicrobial activity against Pseudomonas aeruginosa 19E9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID533665Antimicrobial activity against Staphylococcus aureus ATCC 292132008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
AID529518Antibacterial activity against normal-colony variant Staphylococcus aureus derived from non cystic fibrosis patient assessed as resistant isolates at 37 degC after 24 hrs by disk diffusion method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
AID534172Antimicrobial activity against armA positive Escherichia coli MEZ producing beta lactamase CTX-M-3 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID562592Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID528712Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID212902Inhibition of human telomerase after assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID674910Antibacterial activity against Streptococcus pyogenes MTCC 4422012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
AID1230247Antibacterial activity against Staphylococcus saprophyticus CIP 76125 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID647789Antibacterial activity Salmonella Typhimurium at 40 ug/disc after 24 hrs by agar disc diffusion method2012European journal of medicinal chemistry, Apr, Volume: 50Synthesis of new α aminophosphonate system bearing Indazole moiety and their biological activity.
AID540931Antimicrobial activity against paromomycin-resistant Streptomyces coelicolor SP1 harboring rpsL A262G and C271T mutant gene after 48 hrs2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
AID285681Antimicrobial activity against Pseudomonas aeruginosa 29H1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID560504Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate bd4768 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID287392Antibacterial activity against Listeria monocytogenes after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID564088Antimicrobial activity against Escherichia coli 9612 infected in CD-1 ICR mouse assessed as decrease in bacterial load in kidney at 24 mg/kg, sc after 72 hrs (Rvb = 4.45 +/- 0.37 log10CFU/g)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID701873Antibacterial activity against multidrug resistant NDM-1 producing Escherichia coli isolate after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID1241208Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID736473Antibacterial activity against Shigella flexneri RCMB 0100542 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID774229Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA efflux pump after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID770911Antibacterial activity against Escherichia coli IFO 3301 assessed as growth inhibition at 100 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID396002Antimicrobial activity against Mycoplasma putrefaciens KS1 after 24 hrs by twofold serial dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
AID583226Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID717368Antibacterial activity against Klebsiella pneumoniae MTCC 618 at 10 ug per disk after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Design, synthesis and antimicrobial evaluation of novel 1-benzyl 2-butyl-4-chloroimidazole embodied 4-azafluorenones via molecular hybridization approach.
AID250295Susceptibility testing against Pseudomonas aeruginosa PAE_NUH20; S=Susceptible2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID532404Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone F isolate RM-11X-09 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID774216Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID724496Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition after 24 hrs by agar well-diffusion method2013Bioorganic & medicinal chemistry letters, Jan-15, Volume: 23, Issue:2
Facile regioselective synthesis of novel bioactive thiazolyl-pyrazoline derivatives via a three-component reaction and their antimicrobial activity.
AID544276Antimicrobial activity against Enterococcus faecalis NKH6 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID549337Antimicrobial activity against Escherichia coli ATCC 25922 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID532910Antimicrobial activity against KPC-3 producing Klebsiella pneumoniae 549 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID583262Antibacterial activity against aminoglycoside-resistant Enterobacter cloacae expressing AAC(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID532394Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone A2 isolate NA-14X-32 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID583212Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing ANT(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID470593Antibacterial activity against Pseudomonas aeruginosa ATCC BAA-427 after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
Design and synthesis of bile acid-based amino sterols as antimicrobial agents.
AID532031Antimicrobial activity against Escherichia coli TOP10F' by disk diffusion method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
AID561676Antimicrobial activity against Pseudomonas aeruginosa isolate OC17355 harboring plasmid MexZ expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID558246Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 0.5 mg/liter after 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID373757Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab1308 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID534107Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID519110Antibacterial activity against Proteus mirabilis M 55 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1055949Antibacterial activity against Escherichia coli ATCC 25922 after 16 hrs2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
AID573499Antibacterial activity against Citrobacter amalonaticus isolate Ca38009 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1240498Antibacterial activity against Pseudomonas aeruginosa DM4150R after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID1242643Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID1240504Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID201745Minimum inhibitory concentration was measured against Serratia marcescens 75022704 producing AAC-(6'')-III modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID424421Antibacterial activity against Enterococcus faecalis HIP14333 isolated from patients rectum by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID529497Antimicrobial activity against Escherichia coli T-625 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID534339Antimicrobial activity against Burkholderia pseudomallei 1026b after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID534111Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID532392Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone A2 isolate NA-14X-21 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID348093Antibacterial activity against ampicillin-resistant and aminoglycosides-susceptible Klebsiella pneumoniae ATCC 13883 after 12 to 18 hrs2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
AID534166Antimicrobial activity against rmtB positive Escherichia coli VOG producing beta lactamase CTX-M-14 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID770914Antibacterial activity against Micrococcus luteus IFO 3232 assessed as growth inhibition at 100 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID1242645Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 16 hrs by microtiter broth dilution method2015ACS medicinal chemistry letters, Jul-09, Volume: 6, Issue:7
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
AID561664Antimicrobial activity against Pseudomonas aeruginosa isolate OC14551 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID429079Antibacterial activity against Klebsiella pneumoniae Greece producing KPC-2 beta-lactamase by E test method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
AID534176Antimicrobial activity against armA positive Klebsiella pneumoniae DU producing beta lactamase CTX-M-3 by Etest method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
AID1553830Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of MgCl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID573500Antibacterial activity against Klebsiella pneumoniae isolate Kp38009 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID295089Antibacterial activity against Micrococcus luteus La 2971 after 24 hrs by dilution method2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
AID637155Antibacterial activity against Bacillus mycoides DSMZ 274 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID689502Antibacterial activity against Salmonella typhimurium TISTR 292 by two-fold broth dilution method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Rearranged benzophenones and prenylated xanthones from Garcinia propinqua twigs.
AID560517Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID529487Antimicrobial activity against Enterobacter cloacae isolate 622 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID481456Antibacterial activity against Pseudomonas aeruginosa CAN-ICU 62308 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID521572Antibacterial activity against Salmonella infected in mouse RAW 264.7 cells expressing Nramp1 assessed as log reduction in viable count at 100 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID531966Antibacterial activity against Klebsiella pneumoniae urine isolate A28009 PFGE pattern A expressing KPC-2, TEM-1, SHV-11, CTX-M-2 beta-lactamase by agar dilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
AID1230065Antibacterial activity against methicillin-resistant Staphylococcus aureus GRE2372 assessed as inhibition of bacterial growth2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
AID481457Antibacterial activity against Stenotrophomonas maltophilia CAN-ICU 62585 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID533599Antibacterial activity against gentamicin-resistant Proteus rettgeri clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID678722Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID531771Antimicrobial activity against Pseudomonas aeruginosa secretion isolate 4658 containing PFGE clone A1 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID410024Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by well diffusion method2008Bioorganic & medicinal chemistry letters, Dec-01, Volume: 18, Issue:23
Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
AID441065Antibacterial activity against Escherichia coli by microdilution assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Sesquiterpenoids from Pilea cavaleriei subsp. crenata.
AID285676Antimicrobial activity against Pseudomonas aeruginosa 24G1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID424423Antibacterial activity against Enterococcus faecalis HIP15179 coisolated with vancomycin-resistant Staphylococcus aureus by broth microdilution method2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
AID535888Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae JN41T harboring qnrB gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID207254Minimum inhibitory concentration towards Staphylococcus aureus2004Bioorganic & medicinal chemistry letters, Mar-08, Volume: 14, Issue:5
Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents.
AID207254Minimum inhibitory concentration towards Staphylococcus aureus2004Bioorganic & medicinal chemistry letters, Jun-07, Volume: 14, Issue:11
Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID477748Antimicrobial activity against Klebsiella pneumoniae after 24 hrs2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives.
AID411994Antibacterial activity against Klebsiella pneumoniae after 24 hrs by NCCLS method2009Bioorganic & medicinal chemistry, Jan-01, Volume: 17, Issue:1
Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides.
AID567291Half life in iv dosed critically ill patient with acute kidney injury2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID583265Antibacterial activity against aminoglycoside-resistant Staphylococcus aureus expressing ANT(4',4'')-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID564091Antimicrobial activity against Escherichia coli 9612 infected in CD-1 ICR mouse assessed as decrease in bacterial load in kidney at 5.18 mg/kg, sc after 72 hrs (Rvb = 4.45 +/- 0.37 log10CFU/g)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID567321Antimicrobial activity against Escherichia coli ML4901 by broth dilution method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
AID532398Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone D1 isolate VA-06X-63 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID540239Phospholipidosis-positive literature compound observed in dog
AID584554Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID586049Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U6 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID386865Cytotoxicity against HEK cells assessed as cell viability at 0.73 to 1500 ug/mL after 48 hrs by MTT assay2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID573331Antibacterial activity against Klebsiella pneumoniae isolate Kp1945 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 and dfrA12-orfF-aadA2 arrays by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID523489Antimicrobial activity against Pseudomonas aeruginosa R20 Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID434366Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
AID562589Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID573338Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID774223Antibacterial activity against healthcare-acquired methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID429831Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 10 ug2009Journal of natural products, Jun, Volume: 72, Issue:6
Phenylphenalenones from the Australian plant Haemodorum simplex.
AID573542Antibacterial activity against Escherichia coli Ec9381 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID637092Antibacterial activity against Bacillus megaterium NRRL 1353895 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID422882Antimicrobial activity against Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolated from diabetic patient with calcaneal osteomyelitis by broth microdilution assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
AID654696Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 20 hrs2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.
AID529492Antimicrobial activity against Enterobacter cloacae isolate 658 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID528825Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID1240497Antibacterial activity against Pseudomonas aeruginosa DR18531 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID520808Antimicrobial activity against CTX-M-2 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype B by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID531774Antimicrobial activity against Pseudomonas aeruginosa secretion isolate 4703 containing PFGE clone A1 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID348885Antibacterial activity against Micrococcus luteus PTCC 1110 by microdilution method2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.
AID565332Antibacterial activity against Enterobacter hormaechei isolate UCN622009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
AID1056853Antibacterial activity against Aeromonas hydrophila FNSST 014 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID535891Antimicrobial activity against aac(6')-Ib-cr-negative Citrobacter freundii JN64 harboring GyrA T83I, wild-type ParC, GyrB and qnrA genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID532190Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii TJ15 harboring GyrA T83I, ParC S80I mutant, wild-type GyrB, qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID212740Inhibition of purified telomerase of Euplotes aediculatus at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID465515Antifungal activity against Candida albicans LMP 709U after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID481903Antimicrobial activity against Staphylococcus aureus ATCC 700787 at 15 ug in 6 mm disk after 10 hrs by disc-diffusion assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum.
AID561671Antimicrobial activity against Pseudomonas aeruginosa isolate OC16830 harboring plasmid JAK16 expressing mexXY gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID1230209Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID523397Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 3 days by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID554432Ratio of MIC for Pseudomonas aeruginosa 615R to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID278665Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57372007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID554413Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 615S obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID424867Antibacterial activity against bacterial sensory kinase PhoQ deficient Salmonella enterica serovar Typhimurium CS009 by modified twofold broth microdilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance.
AID523487Antimicrobial activity against Pseudomonas aeruginosa M1251 by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID522878Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in human 5637 cells assessed as decrease in intracellular bacterial level at 400 to 800 ug/ml after 12 hrs by serial dilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
AID521583Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 macrophage assessed as log reduction in viable counts at 150 ug/ml after 1hr2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID766174Antibacterial activity against Enterococcus faecalis NCTC 775 after 20 to 24 hrs by two-fold broth microdilution method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID535839Antimicrobial activity against Pseudomonas aeruginosa GP4KT111 harboring oprD,mexAB-oprM gene after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID544279Antimicrobial activity against Enterococcus faecalis NKH9 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID1224521Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 8666/2010 after 7 days by micromethod2014European journal of medicinal chemistry, Jul-23, Volume: 821-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
AID521577Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 50 ug/ml after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID532395Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone A3 isolate NA-14X-34 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID509869Antibacterial activity against Acinetobacter baumannii isolate 4860 isolated from human urine2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID1202786Antibacterial activity against Bacillus cereus TISTR 688 by 2-fold serial dilution method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
AID520801Antimicrobial activity against CTX-M-2 producing Klebsiella pneumoniae with PFGE pulsotype I by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID338268Antimicrobial activity against Bacillus subtilis DSM 347 after 18 hrs by twofold serial dilution method1994Journal of natural products, Dec, Volume: 57, Issue:12
Biological effects of prenylated hydroquinones: structure-activity relationship studies in antimicrobial, brine shrimp, and fish lethality assays.
AID573518Antibacterial activity against Klebsiella pneumoniae isolate Kp211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID356406Antibacterial activity against Enterococcus faecalis2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID561464Antibacterial activity against Proteus mirabilis assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID586086Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID326499Antibacterial activity against vancomycin-susceptible Enterococcus faecalis JH2-2 after 24 hrs by broth macrodilution method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
AID678721Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID521593Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 7.0 by broth dilution method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID557791Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID563873Antimicrobial activity against Escherichia coli 1515 using 2.4 X 10'6 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID373759Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab1316 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID401034Antimicrobial activity against Pseudomonas aeruginosa Z61 after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID285596Antimicrobial activity against Pseudomonas aeruginosa 1C9 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID564089Antimicrobial activity against Escherichia coli 9612 infected in CD-1 ICR mouse assessed as decrease in bacterial load in kidney at 14.4 mg/kg, sc after 72 hrs (Rvb = 4.45 +/- 0.37 log10CFU/g)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID423063Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 H103 after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID529499Antimicrobial activity against Escherichia coli GeneHogs by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID545056Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate DL010 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID563500Antimicrobial activity against Serratia marcescens ATCC 13880 by broth dilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
AID445286Antibacterial activity against Mycobacterium avium 724S by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID498361Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrB containing isogenic acrB knockout assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
AID425622Cmax in human2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
AID428270Antimicrobial activity against Klebsiella sp. assessed as susceptible isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID558038Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S1 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID593492Antimicrobial activity against pgm, pla deficient Yersinia pestis CO92 infected in human peripheral blood monocytes assessed as inhibition of intracellular bacterial growth at 10 uM after 16 hrs2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.
AID212743Inhibition of telomerase after assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID1056870Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as diameter of zone of inhibition at 15 ug/disc after 24 hrs by disc diffusion method2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID564015Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring Pseudomonas aeruginosa plasmid DNA lung biopsy specimen of patient by Etest2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
AID743574Antimicrobial activity against Micrococcus luteus after 24 hrs by micro-dilution susceptibility method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID285628Antimicrobial activity against Pseudomonas aeruginosa 9A10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID289776Antibacterial activity against Staphylococcus aureus MTCCB 737 after 18-20 hrs by broth dilution method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID532913Antimicrobial activity against Escherichia coli Genehogs by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID623617Antibacterial activity against 10'8 CFU/mL Pseudomonas aeruginosa MTCC 1688 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID557799Antimicrobial activity against Escherichia coli J53 by CLSI agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
AID373774Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh39 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID532414Antibacterial activity against IMP-13 producing Pseudomonas aeruginosa clone C2 isolate NA-14X-02 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID65067Percent killing of the total Escherichia coli K12 (ATCC 25868)cells at the C50 concentration was determined.1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID548796Antimicrobial activity against Oxacillin-resistant coagulase-negative Staphylococcus assessed as percent resistant isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID564016Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring Pseudomonas aeruginosa plasmid DNA isolated from wound infection of patient by Etest2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
AID763669Antibacterial activity against Pseudomonas aeruginosa at 200 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID664536Antibacterial activity against Salmonella typhimurium TISTR 292 by broth dilution method2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bioactive carbazole alkaloids from Clausena wallichii roots.
AID529304Antimicrobial activity against Acinetobacter baumannii isolate Ac058 expressing beta-lactamase Oxa-58 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
AID561494Antibacterial activity against Acinetobacter baumannii assessed as resistant isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID528713Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID351927Antibacterial activity against Escherichia coli R477-100 by double-microdilution method2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID701872Antibacterial activity against multidrug resistant Amp-C producing Escherichia coli isolate after 16 to 20 hrs by broth microdilution assay2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
AID750278Antibacterial activity against Pseudomonas aeruginosa MTCC 441 assessed as growth inhibition by broth microdilution method2013European journal of medicinal chemistry, Jun, Volume: 64Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
AID519182Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 0.25 ug/ml of ciprofloxacin exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID520293Antimicrobial activity against intracellular Staphylococcus aureus 2548 infected in human monocyte-derived macrophages after 48 hrs2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID470144Antimicrobial activity against Pseudomonas aeruginosa ATCC 15442 after 24 hrs by microplate assay2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents.
AID285667Antimicrobial activity against Pseudomonas aeruginosa 22C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID573339Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID532906Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 525 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID535382Antibacterial activity against Staphylococcus aureus isolate OM299/1 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID575762Antimicrobial activity against Pseudomonas aeruginosa PAO1 H1032010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Short cationic antimicrobial peptides interact with ATP.
AID285618Antimicrobial activity against Pseudomonas aeruginosa 5F8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID428273Antimicrobial activity against carbapenemase producing Enterobacter sp. assessed as susceptible isolates by CLSI breakpoint assay2008Antimicrobial agents and chemotherapy, Feb, Volume: 52, Issue:2
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
AID432097Antibacterial activity against Pseudomonas aeruginosa at 10 ug/ml for 24 hrs by disc diffusion method2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone.
AID534303Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA4832010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID528826Antimicrobial activity against ESBL producing Klebsiella pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID351923Toxicity against HEK293 cells2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID395402Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 at 20 ug after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID1055947Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 hrs2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
AID1230250Antibacterial activity against Streptococcus agalactiae CIP 103227 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID394704Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing AAC(6')-1, ANT(2'')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID678715Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID373043Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate CY7 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID519188Antimicrobial activity against mexXY-OprM-overproducing Pseudomonas aeruginosa clinical isolate2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID521967Antibacterial activity against Campylobacter coli assessed as resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID532393Antibacterial activity against VIM-1 producing Pseudomonas aeruginosa clone A2 isolate NA-14X-26 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID571698Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 6 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID356402Antibacterial activity against Staphylococcus aureus2003Journal of natural products, Sep, Volume: 66, Issue:9
Cytotoxic sesquiterpene lactones from the root of Saussurea lappa.
AID428878Binding affinity to 16S rRNA G1494(N7) position in A1408-methylated Escherichia coli JM109 30S sunit at 100 uM by footprint assay2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
AID724494Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition after 24 hrs by agar well-diffusion method2013Bioorganic & medicinal chemistry letters, Jan-15, Volume: 23, Issue:2
Facile regioselective synthesis of novel bioactive thiazolyl-pyrazoline derivatives via a three-component reaction and their antimicrobial activity.
AID573539Antibacterial activity against Klebsiella pneumoniae Kp38009 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID573519Antibacterial activity against Escherichia coli isolate Ec211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1245989Antimicrobial activity against streptomycin-resistant Erwinia amylovora after 24 hrs by spectrophotometry2015Journal of medicinal chemistry, Jan-22, Volume: 58, Issue:2
Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
AID533346Antibacterial activity against non-gentamicin-resistant Klebsiella pneumoniae clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID278805Antimicrobial activity against Stenotrophomonas maltophilia K279a mutant2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
AID545055Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate CC023 from patient sputum by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1170142Antimicrobial activity against Staphylococcus aureus subsp. aureus DSM 799 incubated for 24 hrs by disk diffusion method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antibacterial secondary metabolites from an endophytic fungus, Eupenicillium sp. LG41.
AID394707Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(6')-1, AAC(3')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID535867Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae GZ51 harboring qnrA gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID586050Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type U8 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID373045Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate ZS15 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID560974Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 1199 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID548254Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID560505Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate b2k4781 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID351926Acute toxicity in iv dosed BALB/c mouse assessed as mortality administered as single dose after 4 days2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID770920Antibacterial activity against Staphylococcus aureus IFO 3060 assessed as growth inhibition at 100 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID548257Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID535387Antibacterial activity against phenotypic revertant Staphylococcus aureus OM1b:F2 harboring G698C Val233Ala compensatory mutation in menB gene by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID554425Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 3066 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID274304Antibacterial activity against Staphylococcus aureus ATCC 259232006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
AID571695Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 4 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID374112Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS6 transconjugant from Escherichia coli 650 by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID558241Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 20 mg/liter upto 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID1553767Antibacterial activity against Escherichia coli ATCC 25922 measured after 24 hrs2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID581652Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU after 24 hrs2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
AID278810Antibacterial activity against Escherichia coli BL21(DE3) expressing Pseudomonas aeruginosa APH(3')-2b2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
AID597601Antibacterial activity against Staphylococcus epidermidis CIP 103627 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID372842Antibacterial activity against Acinetobacter baumannii isolate A expressing 16S rRNA methylase armA gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
AID296135Antibacterial activity against Escherichia coli ATCC 25922 after 20 hrs by broth microdilution method2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.
AID520795Antimicrobial activity against CTX-M-59 producing Klebsiella pneumoniae with PFGE pulsotype C by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID444054Oral bioavailability in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID574169Antibacterial activity against Escherichia coli MG1655 harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes grown as planktonic cells after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID531775Antimicrobial activity against Pseudomonas aeruginosa blood isolate 4659 containing PFGE clone A2 expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID583213Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing ANT(3')-1b by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID565068Antibacterial activity against CTX-M-15 and SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID574425Antimicrobial activity against Escherichia coli isolate 339 expressing beta-lactamase KPC2, TEM and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID285183Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by time-kill methodology2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
AID470154Antimicrobial activity against Enterococcus hirae ATCC 10541 by disk diffusion method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents.
AID528817Antimicrobial activity against carbapenem-resistant Enterobacter cloacae isolated from ICU patient urine assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID548473Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 48 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID533831Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth rate constant for the bacterial population by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.
AID479294Antimicrobial activity against Escherichia coli ATCC 23999 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID542768Antimicrobial activity against Escherichia coli J53 by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID530349Antimicrobial activity against Escherichia coli TOP10 harboring pQep plasmid carrying qepA2 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID1167354Antibacterial activity against Escherichia coli D21 tolC deletion mutant after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID285620Antimicrobial activity against Pseudomonas aeruginosa 5H6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID573330Antibacterial activity against Klebsiella pneumoniae isolate Kp1239 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID545052Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ363 from patient secretion by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID296560Antibacterial activity against Escherichia coli after 18 hrs by disk diffusion method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis, characterization, cytotoxicity, antibacterial and antifungal evaluation of some new platinum (IV) and palladium (II) complexes of thiodiamines.
AID565280Antibacterial activity against Pseudomonas aeruginosa PAO1 by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
AID323690Antibacterial activity against TEM92 ESBL-producing Acinetobacter baumannii by CLSI method2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
AID520776Antibacterial activity against beta-lactamase KPC-2 producing Serratia marcescens isolate S1 to S21 by agar dilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
AID534340Antimicrobial activity against Burkholderia pseudomallei Bp50 harboring deleted (amrRAB-oprA)::FRT gene after 24 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
AID520800Antimicrobial activity against CTX-M-2 producing Klebsiella pneumoniae with PFGE pulsotype H by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID250308Susceptibility testing against Pseudomonas aeruginosa PAE_NUH23; I=Intermediate2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID257554Antibacterial activity against Staphylococcus aureus2005Bioorganic & medicinal chemistry letters, Dec-01, Volume: 15, Issue:23
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
AID565037Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID574430Antimicrobial activity against Escherichia coli isolate 386T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from wound of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID523504Antimicrobial activity against Pseudomonas aeruginosa isolate 15110c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1056838Antibacterial activity against CTX-15 expressing Escherichia coli isolate 4024 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID571916Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 22 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID532894Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 475 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID373755Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab12 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID436261Antimicrobial activity against Bacillus subtilis subsp. spizizenii DMS 347 after 48 hrs by serial dilution method2008Journal of natural products, Nov, Volume: 71, Issue:11
Synthesis and biological activities of thio-avarol derivatives.
AID523499Antimicrobial activity against Pseudomonas aeruginosa isolate 1247c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID374137Antimicrobial activity Enterobacter cloacae 113 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID1156859Antimicrobial activity against Escherichia coli ATCC 9637 after 24 hrs by microbroth dilution method2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
AID531768Antimicrobial activity against Pseudomonas aeruginosa catheter isolate 4696 containing PFGE clone A expressing beta-lactamase IMP-15 by broth microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID285634Antimicrobial activity against Pseudomonas aeruginosa 10B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID285915Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 433002007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
AID355392Antimicrobial activity against methicillin-susceptible Staphylococcus aureus RN4220 by twofold serial microbroth dilution method1997Journal of natural products, Nov, Volume: 60, Issue:11
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant.
AID529195Antibacterial activity against ESBL-producing Escherichia coli assessed as sensitive isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
AID583214Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing ANT(3)-4a by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID535834Antimicrobial activity against wild-type Pseudomonas aeruginosa GP62 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID428626Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by agar well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
AID530346Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M plasmid carrying blaCTX-M-15 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID533595Antibacterial activity against gentamicin-resistant Proteus mirabilis clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID561319Antimicrobial activity against Escherichia coli isolate 17 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID736477Antibacterial activity against Bacillus subtilis RCMB 010063 assessed as growth inhibition after 24 hrs by twofold serial dilution method2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis of some new 2-(3-pyridyl)-4,5-disubstituted thiazoles as potent antimicrobial agents.
AID573526Antibacterial activity against Klebsiella pneumoniae isolate Kp204 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID530345Antimicrobial activity against Escherichia coli BicA expressing blaTEM-1, blaCTX-M-15 and qepA2 gene by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID519109Antibacterial activity against Proteus mirabilis M 48 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID1553795Bactericidal activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID560513Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k7974 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID400279Antimicrobial activity against Staphylococcus aureus SAP00017 after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID573359Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID465510Antibacterial activity against beta lactamase positive Shigella dysenteriae LMP 606 after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID285642Antimicrobial activity against Pseudomonas aeruginosa 15G2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID572120Antimicrobial activity against Acinetobacter baumannii lambda clonal group isolate 27 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID532417Antibacterial activity against IMP-13 producing Pseudomonas aeruginosa clone C2 isolate NA-14X-12 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID583248Antibacterial activity against aminoglycoside-resistant Klebsiella oxytoca expressing AAC(3)-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID599372Antibacterial activity against Escherichia coli2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines.
AID1230218Antibacterial activity against Enterococcus faecalis N518 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID571900Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 14 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID561931Antibacterial activity against blaOXA-24-positive Acinetobacter baumannii isolate VA-566/00 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
AID373773Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh37 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID558041Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S4 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID428627Antimicrobial activity against Escherichia coli after 24 hrs by agar well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
AID285602Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1230242Antibacterial activity against Staphylococcus aureus CRBIP 2121 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID565283Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring plasmid pA1 by Etest method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
AID509868Antibacterial activity against Acinetobacter baumannii isolate 2898 isolated from human ankle2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
AID528077Antibacterial activity against Klebsiella pneumoniae by broth microdilution method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Stereocontrolled facile synthesis and antimicrobial activity of oximes and oxime ethers of diversely substituted bispidines.
AID550183Antimicrobial activity against Streptococcus pyogenes2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID583259Antibacterial activity against aminoglycoside-resistant Serratia marcescens expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID253027Antimicrobial activity of the compound against Escherichia coli was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.
AID574434Antimicrobial activity against Escherichia coli isolate 544 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from abscess of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID544978Antimicrobial activity against Klebsiella pneumoniae 52OmpA22009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides.
AID283533Antibacterial activity against Pseudomonas aeruginosa FE57 with inactivated rplY gene by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID373047Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate FZ4A18 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID1256337Antibacterial activity against clinical isolate Klebsiella pneumoniae by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID518807Antimicrobial activity against Staphylococcus aureus BD2 harboring wild-type cspB gene by Etest2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Altered growth, pigmentation, and antimicrobial susceptibility properties of Staphylococcus aureus due to loss of the major cold shock gene cspB.
AID1250084Antibacterial activity against Klebsiella pneumoniae ATCC 7006032015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID561317Antimicrobial activity against Enterobacter cloacae isolate 153 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID548741Antimicrobial activity against Vancomycin-susceptible Enterococcus faecalis assessed as percent susceptible isolate by broth microdilution method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
AID564090Antimicrobial activity against Escherichia coli 9612 infected in CD-1 ICR mouse assessed as decrease in bacterial load in kidney at 8.64 mg/kg, sc after 72 hrs (Rvb = 4.45 +/- 0.37 log10CFU/g)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID460795Antibacterial activity against Staphylococcus aureus ATCC 29740 after 16 to 20 hrs by microdilution susceptibility test2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
AID555557Antimicrobial activity against Pseudomonas aeruginosa isolate 27135 expressing VIM-2 beta lactamase gene by Etest2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
AID446124Antibacterial activity against APH30-VIa expressing Acinetobacter lwoffii AI.88-483 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID446127Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PT629 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID495515Antibacterial activity against Acinetobacter baumannii CIP70-10 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID549333Antimicrobial activity against Escherichia coli isolate 36 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID572128Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 31 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID529483Antimicrobial activity against Enterobacter cloacae isolate 151 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID743577Antimicrobial activity against Pseudomonas aeruginosa at 100 ug after 24 hrs by agar disc diffusion method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID520798Antimicrobial activity against CTX-M-2 producing Klebsiella pneumoniae with PFGE pulsotype F by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID1167350Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID542720Antimicrobial activity against ESBL-producing Klebsiella pneumoniae clinical isolate assessed as susceptible isolates2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
AID542766Antimicrobial activity against Escherichia coli PA11 expressing aac(6')-Ib-cr, qnrS1 and qepA genes by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID395386Antibacterial activity against Escherichia coli ATCC 11230 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID245259Minimum inhibitory concentration gainst Streptococcus faecalis by broth microdilution technique2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents.
AID348097Antibacterial activity against vancomycin-susceptible and aminoglycosides-resistant Enterococcus faecalis ATCC 29212 after 12 to 18 hrs2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
AID285655Antimicrobial activity against Pseudomonas aeruginosa 19D10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID573524Antibacterial activity against Escherichia coli isolate Ec221 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID510512Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate W2AC8-S10 expressing OXA-512010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID373048Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate FZ84 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID773686Inhibition of hemozoin-like crystal formation at 1 to 1000 uM after 5 days2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Structural optimization of quinolon-4(1H)-imines as dual-stage antimalarials: toward increased potency and metabolic stability.
AID447236Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth micro dilution method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
AID528078Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Stereocontrolled facile synthesis and antimicrobial activity of oximes and oxime ethers of diversely substituted bispidines.
AID446135Antibacterial activity against MexAB expressing Pseudomonas aeruginosa PA21 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID520289Antimicrobial activity against Staphylococcus aureus 25462008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
AID296129Antibacterial activity against Pseudomonas aeruginosa at 50 to 100 uM after 24 hrs by well diffusion method2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
AID583260Antibacterial activity against aminoglycoside-resistant Enterobacter gergoviae expressing AAC(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID532184Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae SY26 harboring GyrA S83I, ParC S80I mutant, wild-type GyrB and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID637093Antibacterial activity against Bacillus mycoides DSMZ 274 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID510505Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate M3AC9-4 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID532408Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B2 isolate VA-06X-28 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID311368Antimicrobial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2007Journal of natural products, Sep, Volume: 70, Issue:9
Antimicrobial compounds from the Australian desert plant Eremophila neglecta.
AID446139Antibacterial activity against R-methylase expressing Citrobacter amalonaticus 06AB0010 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID523511Antimicrobial activity against Pseudomonas aeruginosa isolate 13167 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285619Antimicrobial activity against Pseudomonas aeruginosa 5G3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID289773Antibacterial activity against Staphylococcus epidermidis MTCCB 1824 at 30 ug/disc after 48 hrs by disc diffusion method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID1230223Antibacterial activity against Enterococcus faecium N507 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID561239Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID674908Antibacterial activity against Bacillus subtilis MTCC 4412012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
AID479295Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microdilution assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Antimicrobial triterpenoid glycosides from Cephalaria scoparia.
AID523493Antimicrobial activity against Pseudomonas aeruginosa 1405-con D2 by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID571892Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 10 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID449251Antibacterial activity against Bacillus anthracis RITCC 1036 at 10 ug after overnight incubation by agar well diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Synthesis, spectroscopic characterization and antibacterial activity of new cobalt(II) complexes of unsymmetrical tetradentate (OSN2) Schiff base ligands.
AID557779Antimicrobial activity against Staphylococcus epidermidis ATCC 14990 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID311880Antibacterial activity against Bacillus subtilis subsp. spizizenii ATCC 9027 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID583227Antibacterial activity against wild type Pseudomonas aeruginosa expressing efflux pump by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID386860Antibacterial activity against Shigella flexneri MTCC 1457 after 16 hrs by microbroth dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID1240509Antibacterial activity against Klebsiella pneumoniae DS16260 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID285337Antimicrobial activity against Escherichia coli qnrA1 producing urinary specimen isolate 13.52 by agar dilution method2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
AID531747Antibacterial activity against Pseudomonas aeruginosa EryR by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID294965Antibacterial activity against Escherichia coli ATCC 23556 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID544277Antimicrobial activity against Enterococcus faecalis NKH7 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID253025Antimicrobial activity against Bacillus cereus was determined2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones.
AID532175Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae SH39T harboring qnrA gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID40944Minimum inhibitory concentration was measured against Bacillus subtilis ATCC 6633.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID532415Antibacterial activity against IMP-13 producing Pseudomonas aeruginosa clone C2 isolate NA-14X-10 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID285666Antimicrobial activity against Pseudomonas aeruginosa 22E3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID573515Antibacterial activity against Serratia marcescens isolate Sm220 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID572134Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 34 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID508741Antibacterial activity against Pseudomonas aeruginosa assessed as percent nonsusceptible isolates by broth microdilution assay2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.
AID573541Antibacterial activity against Klebsiella pneumoniae Kp38045 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID445285Antibacterial activity against Mycobacterium bovis BCG str. Tokyo 172 by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID550181Antimicrobial activity against Staphylococcus aureus2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID557789Antimicrobial activity against Stenotrophomonas maltophilia CAN-ICU 62584 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID278672Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 57332007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
AID637160Antibacterial activity against Micrococcus luteus ATCC 9631 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID446138Antibacterial activity against MexAB, MexCD, MexEF, MexXY, TriABC deleted Pseudomonas aeruginosa PA406 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID557790Antimicrobial activity against Acinetobacter baumannii CAN-ICU 63169 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Antibacterial activity of ultrashort cationic lipo-beta-peptides.
AID558045Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S8 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID565030Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285591Antimicrobial activity against Pseudomonas aeruginosa 65.38-2 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID424858Antimicrobial activity against Pseudomonas aeruginosa GY3 producing blaVIM-2 by E-test2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID561328Antimicrobial activity against Klebsiella pneumoniae isolate 202 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID570782Antimicrobial activity against multidrug-resistant Acinetobacter baumannii assessed as resistant isolates by disk diffusion method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
AID585420Antimicrobial activity against oqxAB positive Escherichia coli C600 W191-T transconjugant by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID554437Ratio of MIC for Pseudomonas aeruginosa 2729 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID532169Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii PU55T harboring wild-type GyrA, ParC, GyrB and qnrA genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID571902Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 15 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID544977Antimicrobial activity against Klebsiella pneumoniae 52OmpA2Com2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides.
AID571924Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 26 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID573345Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID465552Antibacterial activity against Staphylococcus aureus by NCCLS broth microdilution method2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Stereospecific synthesis of oximes and oxime ethers of 3-azabicycles: A SAR study towards antimicrobial agents.
AID573530Antibacterial activity against Citrobacter youngae isolate CyB38 harboring blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID289777Antibacterial activity against Staphylococcus epidermidis MTCCB 1824 after 18-20 hrs by broth dilution method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID394714Antibacterial activity against Pseudomonas aeruginosa clinical isolates assessed as susceptible rate by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID563881Antimicrobial activity against Escherichia coli ATCC 25922 infected in CD-1 ICR mouse using 1 X 10'5 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID373772Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh36 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID1230212Antibacterial activity against Enterococcus casseliflavus N487 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID250257Susceptibility testing against Pseudomonas aeruginosa PAE_NUH01; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID544284Antimicrobial activity against Enterococcus faecalis NKH14 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID572142Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 38 expressing ampC, ompA, adeB, adeM by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID770919Antibacterial activity against Staphylococcus aureus IFO 3060 after 24 hrs by two fold dilution method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID573383Antibacterial activity against beta lactamase-positive Haemophilus influenzae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID514826Binding affinity to Escherichia coli 23S rRNA assessed as increase in classical-state occupancy by tRNA at 20 uM by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID563879Antimicrobial activity against Enterococcus faecalis ATCC 29212 using 2.8 X 10'7 by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID573368Antibacterial activity against ceftazidime-susceptible Proteus mirabilis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1240511Antibacterial activity against Klebsiella pneumoniae DB55301 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID283536Antibacterial activity against Pseudomonas aeruginosa FE53U with inactivated mexZ and galU genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID533610Bactericidal activity against Escherichia coli ATCC 25922 assessed as log reduction in viable-cell count at 0.25 MIC by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID571067Drug uptake in Wistar rat kidney collecting duct cells obtained after tissue digestion with 0.04% protease digestion for 2 hrs at 4 or 16 mg/kg, iv after 12 hrs post dose by light-microscopic immunocytochemistry2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.
AID603577Antimicrobial activity against Staphylococcus aureus 6538/P after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID1076976Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 48 hrs by two-fold serial dilution assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Bifunctional ethyl 2-amino-4-methylthiazole-5-carboxylate derivatives: synthesis and in vitro biological evaluation as antimicrobial and anticancer agents.
AID1188552Antimicrobial activity against Candida albicans assessed as inhibition of visible growth after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID523396Antimicrobial activity against amikacin-resistant Nocardia farcinica IFM 10580 after 3 days by broth microdilution method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
AID351936Suppression of PCDH15 R245X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID554389Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY F1018L mutant by twofold macrodilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID446141Antibacterial activity against R-methylase expressing Enterobacter aerogenes 06AB008 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID558050Antimicrobial activity against blaKPC-positive Klebsiella oxytoca S13 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID766158Antibacterial activity against methicillin-resistant Staphylococcus aureus USA-300 assessed as growth inhibition at 50 uM after 5 hrs by BacTiter-Glo microbial assay relative to control2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Psammaplysin F: a unique inhibitor of bacterial chromosomal partitioning.
AID394705Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(6')-1, ANT(2'')-1 by macrodilution technique2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
AID439601Antifungal activity against Candida albicans ATCC 10231 after 48 hrs by twofold dilution technique2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study.
AID311875Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth microdilution assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis.
AID532902Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 365 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID1553786Bactericidal activity against Salmonella typhimurium ATCC 14028 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID561238Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M100-S17 method2009Antimicrobial agents and chemotherapy, Aug, Volume: 53, Issue:8
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
AID563871Antimicrobial activity against Escherichia coli ATCC 25922 using 1 X 10'5 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID285595Antimicrobial activity against Pseudomonas aeruginosa 1B9 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID562382Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID529643Antimicrobial activity against Pseudomonas aeruginosa 9551 expressing beta-lactamase VIM-15 obtained from urine of patient by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
AID763671Antibacterial activity against Escherichia coli at 200 ug/disc after 24 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Aug, Volume: 66Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
AID519108Antibacterial activity against Proteus mirabilis M 44 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID395404Antibacterial activity against Escherichia coli MTCC 443 after 24 hrs by cup diffusion method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity.
AID623615Antibacterial activity against 10'8 CFU/mL Klebsiella pneumoniae MTCC 109 by broth microdilution method2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
AID523491Antimicrobial activity against Pseudomonas aeruginosa Z799/61 by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID746786Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 to 20 hrs by macrobroth dilution method2013Bioorganic & medicinal chemistry letters, May-15, Volume: 23, Issue:10
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
AID510962Antimicrobial activity against Escherichia coli assessed as nonsusceptible isolates by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
AID573357Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID296128Antibacterial activity against Escherichia coli at 50 to 100 uM after 24 hrs by well diffusion method2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
AID536076Antimicrobial activity against Staphylococcus aureus IFO 3060 at 100 ug/8 mm disk after 24 hrs by agar disk diffusion method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID573516Antibacterial activity against Serratia marcescens isolate Sm201 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID548255Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
AID573521Antibacterial activity against Serratia marcescens isolate Sm211 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID258346MIC per disc in Staphylococcus aureus by disc diffusion method2006Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
AID423070Antibacterial activity against 16_G12 allele containing Pseudomonas aeruginosa PAO1 H1125 mutant strain with recG::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID351938Suppression of PCDH15 R3X nonsense mutant cDNA translation in african green monkey COS7 cells at 0.25 mg/mL2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID372844Antibacterial activity against Acinetobacter baumannii isolate C expressing 16S rRNA methylase armA gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
AID424862Antimicrobial activity against carbapenem-susceptible Pseudomonas aeruginosa clinical isolate assessed as resistant isolates2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID519121Antibacterial activity against Proteus mirabilis M 17 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID574438Antimicrobial activity against Escherichia coli isolate 1679T expressing beta-lactamase KPC2, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID1188550Antimicrobial activity against Escherichia coli assessed as inhibition of visible growth after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID525125Suppression of drug resistance development in Staphylococcus aureus RN4220 assessed as assessed as prolonged length of subculture to develop Linezolid resistance at 0.25 times MIC2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
AID567288Clearance in iv dosed critically ill patient with acute kidney injury during extended daily diafiltration2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID497692Antimicrobial activity against Klebsiella pneumoniae isolated from bacteremia patient assessed as percentage of resistant isolates by broth microdilution method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
AID250259Susceptibility testing against Pseudomonas aeruginosa PAE_NUH03; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID373035Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate BJ55 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID510510Antibacterial activity against Acinetobacter calcoaceticus/baumannii complex isolate N2AC9-18 expressing KPC beta lactamase2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Detection of KPC in Acinetobacter spp. in Puerto Rico.
AID374670Antimicrobial activity against Escherichia coli isolate AMG1 24 hrs biofilms after 24 hrs relative to control2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
AID287393Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID534771Antimicrobial activity against Acinetobacter baumannii-calcoaceticus obtained from war-wounded patient assessed as susceptible isolates2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
AID565002Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID637157Antibacterial activity against Acinetobacter johnsonii ATCC 17909 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID496398Antibacterial activity against azide-resistant Escherichia coli J53 TET1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain2010Antimicrobial agents and chemotherapy, Feb, Volume: 54, Issue:2
Transferable quinolone resistance in Vibrio cholerae.
AID465516Antifungal activity against Microsporum audouinii LMP 725D after 30 mins by microbroth dilution method2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Pycnanthulignenes A-D, antimicrobial cyclolignene derivatives from the roots of Pycnanthus angolensis.
AID558048Antimicrobial activity against blaKPC-positive Klebsiella pneumoniae S11 by broth microdilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
AID528789Antimicrobial activity against extended-spectrum beta lactamase producing Escherichia coli expressing beta-lactamase CTX-M-3, CTX-M-15 and CTX-M-55 gene assessed as susceptible isolates by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
AID64893Minimum inhibitory concentration was measured against Escherichia coli 00000589 producing APH-(3'') modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID285589Antimicrobial activity against Pseudomonas aeruginosa 65.36-4 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID685140Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method2012European journal of medicinal chemistry, Oct, Volume: 56Micelles catalyzed chemo- and regio-selective one pot and one step synthesis of 2,3,5,6-tetrakis(alkyl and arylsulfanyl)-1,4-benzoquinones and 2,5-diaminosubstituted-1,4-benzoquinones "In-Water" and their biological evaluation as antibacterial and antifun
AID557795Antimicrobial activity against Proteus mirabilis 06-489 isolated from infected human urinary tract by CLSI agar dilution method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
AID534300Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA4592010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID685141Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by broth microdilution method2012European journal of medicinal chemistry, Oct, Volume: 56Micelles catalyzed chemo- and regio-selective one pot and one step synthesis of 2,3,5,6-tetrakis(alkyl and arylsulfanyl)-1,4-benzoquinones and 2,5-diaminosubstituted-1,4-benzoquinones "In-Water" and their biological evaluation as antibacterial and antifun
AID573377Antibacterial activity against imipenem-susceptible Acinetobacter assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID743586Inhibition of bovine DHFR after 2 mins by spectrophotometry2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID1055951Antibacterial activity against Acinetobacter baumannii ATCC BAA-747 after 16 hrs2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
AID546620Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-2 by Etest2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
AID285660Antimicrobial activity against Pseudomonas aeruginosa 19F1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID535694Antimicrobial activity against Azide-resistant Escherichia coli J53 transconjugant harboring Escherichia coli DH5alpha-5825 qnrB2 gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID774228Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID285590Antimicrobial activity against Pseudomonas aeruginosa 65.38-1 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1185241Antimicrobial activity against Escherichia coli RCMB 010052 assessed as absence of turbidity after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
AID439602Antifungal activity against Penicillium after 48 hrs by twofold dilution technique2009European journal of medicinal chemistry, Dec, Volume: 44, Issue:12
2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study.
AID743573Antimicrobial activity against Escherichia coli after 24 hrs by micro-dilution susceptibility method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID531739Induction of mexY in Pseudomonas aeruginosa 2439 clinical isolate harboring nfxB deltaG177-A178 mutant gene at 0.5 times MIC after 4 hrs relative to control2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID603660Antimicrobial activity against Escherichia coli ATCC 8739 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID1553824Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of ZnCl22019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID283532Antibacterial activity against Pseudomonas aeruginosa FE53 with inactivated mexZ gene by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID573495Antibacterial activity against Citrobacter amalonaticus isolate Ca3927 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID583256Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing AAC(6')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID423065Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID529489Antimicrobial activity against Enterobacter cloacae isolate 656 containing PFGE genetic clone A expressing beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID250309Susceptibility testing against Pseudomonas aeruginosa PAE_NUH24; I=Intermediate2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID529496Antimicrobial activity against Escherichia coli T-622 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID542047Antibacterial activity against Escherichia coli TrC A expressing Klebsiella pneumoniae A blaCTX-M beta-lactamase by Etest method2009Antimicrobial agents and chemotherapy, Jan, Volume: 53, Issue:1
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
AID561313Antimicrobial activity against Enterobacter cloacae isolate 37 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID561162Cmin in in vitro pharmacokinetic/pharmacodynamic model at 5 mg/kg for every 24 hrs2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID66097Minimum inhibitory concentration was measured against Enterobacter cloacae ATCC 233551991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID563872Antimicrobial activity against Escherichia coli 9612 using 3.7 X 10'4 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID1159102Antimicrobial activity against Bacillus cereus ATCC 11778 assessed as zone of inhibition at 10 mg for 24 hrs at 30 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID373983Antimicrobial activity Escherichia coli 633 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
AID1056855Antibacterial activity against Klebsiella pneumoniae FNSST 011 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID396029Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID523496Antimicrobial activity against Pseudomonas aeruginosa isolate 17145c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID654697Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16 to 20 hrs2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.
AID441066Antibacterial activity against Staphylococcus aureus by microdilution assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Sesquiterpenoids from Pilea cavaleriei subsp. crenata.
AID533571Antibacterial activity against non-gentamicin-resistant Haemophilus parainfluenzae clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID586047Antimicrobial activity against Staphylococcus aureus clone 3-3 harboring staphylococcal cassette chromosome mec element type 6 assessed as percent susceptible isolates by kirby-bauer method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
AID1250087Antibacterial activity against tolC-deficient Escherichia coli ATCC 259222015ACS medicinal chemistry letters, Aug-13, Volume: 6, Issue:8
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.
AID573375Antibacterial activity against multidrug-resistant Acinetobacter assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID583210Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID533565Antimicrobial activity against Pseudomonas aeruginosa isolate PA399 expressing VIM-2 beta-lactamase2010Antimicrobial agents and chemotherapy, Aug, Volume: 54, Issue:8
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
AID577194Decrease in shiga toxin production in Escherichia coli O157:H7 PT-40 encoding Stx-2 gene at 0.5 X MIC by luciferase assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID285604Antimicrobial activity against Pseudomonas aeruginosa 2A6 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID574170Antibacterial activity against Escherichia coli MG1655 grown as biofilms harboring plasmid pBR322 carrying blaTEM-1 and tetA(C) genes after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.
AID529485Antimicrobial activity against Enterobacter cloacae isolate 293 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
AID583270Antibacterial activity against aminoglycoside-resistant Acinetobacter baumannii expressing ANT(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID558245Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 20 mg/liter after 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID519186Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY and MexZ mutant gene selected after 4 ug/ml of cefepime exposure2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
AID565231Antimicrobial activity against Mycobacterium chelonae 9917 harboring pZS01 carrying mspA gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID1241214Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay in presence of 100-fold excess of 15-mer DNA2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID532208Antimicrobial activity against Escherichia coli J53 harboring wild-type GyrA, ParC, GyrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID472620Inhibition of human DHFR after 2 mins2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones.
AID285623Antimicrobial activity against Pseudomonas aeruginosa 8C4 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID1159093Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID573531Antibacterial activity against Klebsiella pneumoniae Kp1239 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1056860Antibacterial activity against Bacillus cereus ATCC 11778 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID575766Inhibition of DnaK assessed as reduction in ATP turnover at MIC for Pseudomonas aeruginosa PAO1 H103 by ATPase assay2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Short cationic antimicrobial peptides interact with ATP.
AID535846Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.
AID495512Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4666 by antimicrobial susceptibility assay2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
AID554420Antimicrobial activity against mexXY operon inactivated Pseudomonas aeruginosa isolate 2729 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID520811Antimicrobial activity against CTX-M-59 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype E by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID523513Antimicrobial activity against Pseudomonas aeruginosa isolate 3149 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID528833Antimicrobial activity against CTX-M ESBL producing Escherichia coli isolated from ICU patient blood assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID534110Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID528981Antimicrobial activity against Haemophilus influenzae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID565038Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID533351Antibacterial activity against non-gentamicin-resistant Serratia marcescens clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1230229Antibacterial activity against Enterococcus hirae CIP 5855 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID1185243Antimicrobial activity against Proteus vulgaris RCMB 010085 assessed as absence of turbidity after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
AID278858Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID278859Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
AID446132Antibacterial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by geometric microdilution method2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
AID584564Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID535657Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae FJ61T harboring qnrS gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID289778Antibacterial activity against Pseudomonas aeruginosa MTCCB 741 after 18-20 hrs by broth dilution method2007European journal of medicinal chemistry, Apr, Volume: 42, Issue:4
Synthesis, characterization and in vitro biological studies of novel cyano derivatives of N-alkyl and N-aryl piperazine.
AID521586Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 at > 30 ug/ml after 40 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID373027Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PUA6 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID481450Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 14990 after 24 hrs by macrobroth dilution method2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
AID597663Antibacterial activity against Enterobacter cloacae ATCC 13047 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID597590Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID1188543Antimicrobial activity against Staphylococcus aureus assessed as inhibition zone at 200 ug/disk after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID577650Antimicrobial activity against Escherichia coli isolate 329T expressing beta-lactamase KPC2 and PFGE cluster 2 isolated from blood of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID561658Antimicrobial activity against Pseudomonas aeruginosa isolate OC14812 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID1133317Antibacterial activity against Erysipelothrix insidiosa ATCC 19414 assessed as lowest concentration required for total inhibition by broth microdilution assay1978Journal of medicinal chemistry, Dec, Volume: 21, Issue:12
Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles.
AID1167357Antibacterial activity against wild type Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID529830Antimicrobial activity against Acinetobacter baumannii assessed as susceptible isolates by microdilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.
AID524593Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolate Kpn-DK2 by broth microdilution method2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
AID1553828Antifungal activity against Candida albicans cgmcc2.2086 measured after 48 hrs in presence of KCl by broth microdilution method2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1056839Antibacterial activity against TEM-1/CTX-M-15 expressing Aeromonas caviae isolate 260 after 18 to 24 hrs by two-fold broth microdilution assay2013Bioorganic & medicinal chemistry, Dec-01, Volume: 21, Issue:23
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
AID351922Suppression of PCDH15 R3X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID369576Antibacterial activity against multidrug-resistant Acinetobacter baumannii 06-74 isolate by CLSI microdilution test2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
AID373028Antimicrobial activity against imipenem and meropenem-resistant Acinetobacter baumannii isolate PU86 by CLSI agar dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
AID574431Antimicrobial activity against Escherichia coli isolate 540 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
AID1188547Antimicrobial activity against Candida albicans assessed as inhibition zone at 200 ug/disk after 24 hrs by disc-diffusion method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
AID424863Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa clinical isolate assessed as resistant isolates2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
AID360854Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID533352Antibacterial activity against non-gentamicin-resistant Morganella morganii clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID571693Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 2 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
AID1159096Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 10 mg for 24 hrs at 37 degC by disk diffusion test2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.
AID520793Antimicrobial activity against CTX-M-2 producing Klebsiella pneumoniae with PFGE pulsotype A by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID561321Antimicrobial activity against Escherichia coli isolate 48 expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID351937Suppression of IDUA W402X nonsense mutant cDNA translation in TNT rabbit reticulocyte lysate transcription translation system at 25 to 100 uM at 30 degC after 90 mins by luciferase reporter gene assay2009Journal of medicinal chemistry, May-14, Volume: 52, Issue:9
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.
AID533597Antibacterial activity against gentamicin-resistant Morganella morganii clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID565035Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID644242Antibacterial activity against pencillin-resistant Streptococcus pneumoniae after 16 to 20 hrs by two fold agar dilution method2012European journal of medicinal chemistry, Mar, Volume: 49Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
AID395388Antibacterial activity against Klebsiella pneumoniae UC57 after 24 hrs by twofold serial dilution method2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
AID422453Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as maximal doubling time at 0.25 ug/mL using flow cell culture after 24 hrs2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID283538Antibacterial activity against Pseudomonas aeruginosa FE53G with inactivated mexZ and nuoG genes by microdilution method2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
AID423071Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+c mutant strain with lon::lux/lon+ mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID559770Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy32 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID518817Antibacterial activity against Acinetobacter genomosp. 3 isolates assessed as percent of resistance isolates by broth micro dilution2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
AID521284Antimicrobial activity against CTX-M-2 and TEM-1 producing Klebsiella pneumoniae transconjugants/transformants with PFGE pulsotype H by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID532166Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii PU55 harboring GyrA T83I, ParC S80I mutant, wild-type GyrB, qnrA genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID524827Antibacterial activity against erythromycin susceptible Campylobacter sp. assessed as resistance breakpoint by CLSI method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID1173797Antimicrobial activity against Staphylococcus aureus ATCC 25923 by agar well diffusion method2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones.
AID528711Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID573502Antibacterial activity against Klebsiella pneumoniae isolate Kp38045 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1256340Antibacterial activity against clinical isolate Acinetobacter baumannii by microdilution method2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
AID637153Antibacterial activity against Bacillus idosus B 241 at 4 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID585432Antimicrobial activity against oqxAB positive Escherichia coli DH5[alpha] harboring pMD18-T::oqxAB by CLSI agar dilution method2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
AID528819Antimicrobial activity against carbapenem-resistant Enterobacter cloacae assessed as resistant isolates by broth microdilution method2008Antimicrobial agents and chemotherapy, Apr, Volume: 52, Issue:4
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
AID396028Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by Etest2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID523509Antimicrobial activity against Pseudomonas aeruginosa isolate 15107 from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID531746Antibacterial activity against Pseudomonas aeruginosa FE60 by twofold serial dilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
AID573543Antibacterial activity against Morganella morganii Mm1229 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID1553820Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 18 to 24 hrs in presence of NaCl2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID561320Antimicrobial activity against Escherichia coli isolate 17 transconjugant expressing aac(6')-Ib-cr gene2009Antimicrobial agents and chemotherapy, Jun, Volume: 53, Issue:6
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
AID386859Antibacterial activity against Klebsiella planticola MTCC 2272 after 16 hrs by microbroth dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands.
AID532205Antimicrobial activity against aac(6')-Ib-cr-positive Klebsiella pneumoniae WH99T harboring qnrB gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID534112Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm19802008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Characterization of TolC efflux pump proteins from Pasteurella multocida.
AID562594Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID423208Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution technique2009Journal of natural products, Apr, Volume: 72, Issue:4
Semisynthesis and biological activity of stemofoline alkaloids.
AID287388Antibacterial activity against Bacillus cereus after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID573546Antibacterial activity against Klebsiella oxytoca Ko0426 transconjugant harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID373752Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab3 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID64905Minimum inhibitory concentration was measured against Escherichia coli 71120101 producing AAD-(4')) modifying enzyme1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID743585Antimicrobial activity against Staphylococcus aureus at 100 ug after 24 hrs by agar disc diffusion method2013European journal of medicinal chemistry, May, Volume: 63Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
AID285630Antimicrobial activity against Pseudomonas aeruginosa 9B5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID530350Antimicrobial activity against Escherichia coli TOP10 by disk diffusion method2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
AID373761Antibacterial activity against imipenem-resistant Acinetobacter baumannii ab1265 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID424866Antibacterial activity against wild type Salmonella enterica serovar Typhimurium ATCC 14028 by modified twofold broth microdilution method2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance.
AID573505Antibacterial activity against Enterobacter cloacae isolate El3799 harboring IncL/M plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID577226Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISlacZ/haha mutation by Etest2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
AID516163Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID519113Antibacterial activity against Proteus mirabilis M 21 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID533355Antibacterial activity against non-gentamicin-resistant Acinetobacter calcoaceticus clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID637090Antibacterial activity against Bacillus subtilis ATCC 6633 at 20 mg/ml after 24 hrs by agar diffusion test2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID550182Antimicrobial activity against methicillin-resistant Staphylococcus aureus2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Phytochemical investigations of Stemona curtisii and synthetic studies on stemocurtisine alkaloids.
AID545045Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolate BJ082 from patient bile by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
AID1230213Antibacterial activity against Enterococcus casseliflavus CIP 103018 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID521581Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 15 ug/ml after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID285585Antimicrobial activity against Pseudomonas aeruginosa 65.33-4 tracheal isolates from mechanically ventilated tuberculosis patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID561662Antimicrobial activity against Pseudomonas aeruginosa isolate OC17355 by broth microdilution method2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
AID528492Antimicrobial activity against Pseudomonas aeruginosa clinical isolates assessed as resistant isolates by agar dilution method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
AID520802Antimicrobial activity against CTX-M-2 producing Klebsiella pneumoniae with PFGE pulsotype J by Etest2008Antimicrobial agents and chemotherapy, May, Volume: 52, Issue:5
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
AID395837Antimicrobial activity against Sporothrix schenckii after 72 hrs by standard microbroth dilution assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
AID564824Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID533353Antibacterial activity against non-gentamicin-resistant Citrobacter freundii clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID533598Antibacterial activity against gentamicin-resistant Citrobacter freundii clinical isolate assessed as susceptible isolates after 18 hrs by agar dilution method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID245442Minimum inhibitory concentration gainst Escherichia coli by broth microdilution technique Not reported activity type 2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents.
AID373769Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh20 by broth dilution method2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID573336Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae assessed as resistant isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID774222Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS2 after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID1167351Antibacterial activity against Pseudomonas aeruginosa PAO1 mexAB/mexCD/mexXY/mexHI/opmH deletion mutant after 18 to 24 hrs by two-fold broth microdilution method2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Design, synthesis, and antibacterial properties of dual-ligand inhibitors of acetyl-CoA carboxylase.
AID774224Antibacterial activity against Staphylococcus aureus expressing aminoglycoside-4'-O-phosphoryltransferase after 24 hrs by geometric microdilution method2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
AID583221Antibacterial activity against aminoglycoside-resistant Staphylococcus aureus expressing APH(2'') + AAC(6') by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID258347MIC per disc against Salmonella typhi by disc diffusion method2006Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
AID285665Antimicrobial activity against Pseudomonas aeruginosa 22E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID245248Minimum inhibitory concentration gainst Pseudomonas aeruginosa by broth microdilution technique2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents.
AID565067Antibacterial activity against CTX-M-15 and SHV-27 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID577209Antimicrobial activity against Escherichia coli C600::933W in logarithmic phase encoding Stx-2 gene by broth macrodilution assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID245247Minimum inhibitory concentration gainst Klebsiella pneumoniae by broth microdilution technique2005Bioorganic & medicinal chemistry letters, Jul-15, Volume: 15, Issue:14
Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents.
AID603580Antimicrobial activity against Micrococcus luteus ATCC 9341 after 18 hrs by microdilution method2011European journal of medicinal chemistry, Jul, Volume: 46, Issue:7
Synthesis and antimicrobial activities of hexahydroimidazo[1,5-a]pyridinium bromides with varying benzyl substituents.
AID519117Antibacterial activity against Proteus mirabilis M 29 mutant after 18 hrs by Etest method2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Reduced Susceptibility of Proteus mirabilis to triclosan.
AID523506Antimicrobial activity against Pseudomonas aeruginosa isolate 1712c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID1202788Antibacterial activity against Staphylococcus aureus TISTR 1466 by 2-fold serial dilution method2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Bioactive prenylated xanthones from the young fruits and flowers of Garcinia cowa.
AID521585Reduction in light emission by Salmonella enterica serovars virchow isolate 101591 at < 50 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID1553816Antibacterial activity against Escherichia coli ATCC 25922 measured after 18 to 24 hrs in presence of MgCl22019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1240499Antibacterial activity against Pseudomonas aeruginosa DM23257 after 24 hrs by broth microdilution method2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
AID573362Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID294964Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID444053Renal clearance in human2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
AID528716Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate assessed as susceptibility level by broth microdilution method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
In vitro activity of telavancin against resistant gram-positive bacteria.
AID554397Antimicrobial activity against Pseudomonas aeruginosa isolate 2729 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID498360Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52145R assessed as growth inhibition by Etest method2010Antimicrobial agents and chemotherapy, Jan, Volume: 54, Issue:1
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
AID597667Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method2011Bioorganic & medicinal chemistry, May-15, Volume: 19, Issue:10
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID521589Reduction in light emission by Salmonella enterica serovars Typhimurium ATCC 14028 after 5 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID562385Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
AID536090Antimicrobial activity against Escherichia coli IFO 3301 after 24 hrs2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID565066Antibacterial activity against CTX-M-15 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method2009Antimicrobial agents and chemotherapy, Nov, Volume: 53, Issue:11
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
AID516168Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method2010Antimicrobial agents and chemotherapy, Jun, Volume: 54, Issue:6
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
AID554440Ratio of MIC for Pseudomonas aeruginosa 2933 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID285688Antimicrobial susceptibility of carbapenem-resistant Pseudomonas aeruginosa PA2404 isolate expressing carbapenemase KPC22007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID294963Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by serial dilution method2007European journal of medicinal chemistry, Oct, Volume: 42, Issue:10
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
AID535384Antibacterial activity against Staphylococcus aureus isolate A22616/5 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
AID582764Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
AID1143926FIC index, ratio of gentamicin MIC for Staphylococcus aureus ATCC 29213 to gentamicin MIC for Staphylococcus aureus ATCC 29213 in presence of compound2014European journal of medicinal chemistry, Jun-10, Volume: 80Unraveling the structure-activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus.
AID565009Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID395781Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by twofold serial dilution technique2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
AID536078Antimicrobial activity against Bacillus subtilis IFO 3007 at 100 ug/8 mm disk after 24 hrs by agar disk diffusion method2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.
AID1553794Bactericidal activity against Staphylococcus epidermidis ATCC 12228 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID1553796Bactericidal activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID558237Bactericidal activity against Staphylococcus aureus E19977 assessed as log reduction in cfu at 9 mg/liter upto 24 hrs by time-kill study2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
AID296134Antibacterial activity against Staphylococcus aureus ATCC 25923 after 20 hrs by broth microdilution method2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.
AID250262Susceptibility testing against Pseudomonas aeruginosa PAE_NUH06; R=Resistant2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID565229Antimicrobial activity against Mycobacterium chelonae ATCC 35752 harboring pZS01 carrying mspA gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
AID250305Susceptibility testing against Pseudomonas aeruginosa PAE_NUH18; I=Intermediate2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
AID423067Antibacterial activity against 69_C12 allele containing Pseudomonas aeruginosa PAO1 H1109 mutant strain with recA::lux mutation after 24 hrs by broth microdilution technique2007Antimicrobial agents and chemotherapy, Dec, Volume: 51, Issue:12
Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
AID554400Antimicrobial activity against Pseudomonas aeruginosa isolate 2933 obtained from cystic fibrosis patient by disk diffusion method2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID555555Antimicrobial activity against Pseudomonas aeruginosa isolate 26285 expressing IMP-13 beta lactamase gene by Etest2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
AID1241203Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID360844Antibacterial activity against Escherichia coli ATCC 25922 at 10 ug/disk after overnight incubation by agar diffusion test2002Journal of natural products, Jul, Volume: 65, Issue:7
Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.
AID258348MIC per disc against Pseudomonas aeruginosa by disc diffusion method2006Bioorganic & medicinal chemistry letters, Jan-15, Volume: 16, Issue:2
Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
AID575765Inhibition of Photinus pyralis fire fly luciferase assessed as reduction in light production at 10 times MIC for Pseudomonas aeruginosa PAO1 H103 by ATP bioluminescence assay2010Antimicrobial agents and chemotherapy, Oct, Volume: 54, Issue:10
Short cationic antimicrobial peptides interact with ATP.
AID770905Antifungal activity against Candida albicans IFO 0583 assessed as growth inhibition at 100 ug/disc after 48 hrs by agar disc-diffusion method2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones.
AID400280Antimicrobial activity against Staphylococcus aureus RN4220 after 24 hrs by twofold serial microbroth dilution assay1996Journal of natural products, Jan, Volume: 59, Issue:1
Chlorochimaphilin: a new antibiotic from Moneses uniflora.
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID1228710Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 24 hrs by microdilution method2015Journal of natural products, May-22, Volume: 78, Issue:5
Antibacterial Balsacones J-M, Hydroxycinnamoylated Dihydrochalcones from Populus balsamifera Buds.
AID689501Antibacterial activity against Escherichia coli TISTR 780 by two-fold broth dilution method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Rearranged benzophenones and prenylated xanthones from Garcinia propinqua twigs.
AID1156861Antimicrobial activity against vancomycin-resistant Staphylococcus aureus after 24 hrs by microbroth dilution method2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
AID521582Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 50 ug/ml after 1hr2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
AID426076Antimicrobial activity against Salmonella typhosa after 24 hrs by agar well diffusion assay2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
AID476938Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by browth microdilution assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents.
AID549335Antimicrobial activity against Escherichia coli isolate Z1 harboring bla CTX-M-3a gene by broth microdilution method2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
AID65062Lethal dose required to kill 90% of the Escherichia coli K12 (ATCC 25868) cell population1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID565013Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565032Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vitro activities of panduratin A against clinical Staphylococcus strains.
AID285652Antimicrobial activity against Pseudomonas aeruginosa 19C7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID523501Antimicrobial activity against Pseudomonas aeruginosa isolate 1352c from fibrosis patient by Etest2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID532908Antimicrobial activity against carbapenem-resistant KPC-2 producing Klebsiella pneumoniae 526 transformant by agar dilution method2010Antimicrobial agents and chemotherapy, Jul, Volume: 54, Issue:7
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
AID554441Ratio of MIC for Pseudomonas aeruginosa 2998 to MIC for Pseudomonas aeruginosa PAO12009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
AID522364Antimicrobial activity against PpmrI knockout mutant Proteus mirabilis dIp after 16 to 18 hrs by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
AID1055941Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16 hrs2013Journal of natural products, Nov-22, Volume: 76, Issue:11
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
AID1127102Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 by NCCLS two-fold dilution method2014European journal of medicinal chemistry, May-06, Volume: 78Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis.
AID583232Antibacterial activity against Pseudomonas aeruginosa expressing AAC(6')-2 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID1230211Antibacterial activity against Enterococcus avium CIP 104053 after 18 hrs by agar dilution method2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Antibacterial Labdane Diterpenoids from Vitex vestita.
AID535870Antimicrobial activity against aac(6')-Ib-cr-negative Enterobacter cloacae GZ51T harboring qnrA gene by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID563887Antimicrobial activity against methicillin-resistant Staphylococcus aureus 9344 infected in CD-1 ICR mouse using 2.5 X 10'5 CFU inoculum2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID372845Antibacterial activity against Acinetobacter baumannii isolate D expressing 16S rRNA methylase armA gene2007Antimicrobial agents and chemotherapy, Nov, Volume: 51, Issue:11
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
AID560521Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by agar dilution method2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
AID573520Antibacterial activity against Klebsiella pneumoniae isolate Kp266 harboring IncA/C plasmid and blaIMP-4-qacG2-aacA4-catB3 array by Etest method2008Antimicrobial agents and chemotherapy, Aug, Volume: 52, Issue:8
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
AID476936Antibacterial activity against Enterobacter cloacae ATCC 13047 after 24 hrs by browth microdilution assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents.
AID535897Antimicrobial activity against aac(6')-Ib-cr-positive Citrobacter freundii JS33 harboring GyrA T83I mutant, wild-type ParC, GyrB, qnrA and qnrB genes by agar dilution method2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
AID1129348Antibacterial activity against NDM-1 producing Escherichia coli clinical isolate 74859898 after 18 hrs by microdilution broth method2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
AID285664Antimicrobial activity against Pseudomonas aeruginosa 22D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
AID287386Antibacterial activity against Staphylococcus aureus after 24 hrs by dilution method2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
AID567299Cmax in critically ill patient with acute kidney injury at 6 mg/kg, iv administered every 48 hrs2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
AID544287Antimicrobial activity against Enterococcus faecalis NKH17 harboring pMG2200-like plasmid after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID544272Antimicrobial activity against Enterococcus faecalis NKH2 harboring pMG2200-like and pMG2201-like plasmids after 24 hrs by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
AID445289Antibacterial activity against Staphylococcus aureus by broth dilution method2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
AID1185245Antimicrobial activity against Klebsiella pneumoniae RCMB 010093 assessed as absence of turbidity after 24 hrs2014European journal of medicinal chemistry, Sep-12, Volume: 84Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
AID533619Antibacterial activity against Klebsiella pneumoniae isolate 01-21 at 1 MIC up to 8 hrs by time-kill study2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
AID1553784Bactericidal activity against Escherichia coli ATCC 25922 incubated for 24 hrs followed by replating on agar plate and measured after overnight incubation2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens.
AID521966Antibacterial activity against Campylobacter jejuni assessed as resistant isolates by disk diffusion method2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
AID564087Antimicrobial activity against Escherichia coli 9612 infected in CD-1 ICR mouse assessed as decrease in bacterial load in kidney at 40 mg/kg, sc after 72 hrs (Rvb = 4.45 +/- 0.37 log10CFU/g)2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID625925Antibacterial activity against Pseudomonas aeruginosa by micro-broth dilution method2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
AID698705Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 16 to 20 hrs2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
Structure-based discovery of substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors.
AID577193Decrease in shiga toxin production in Escherichia coli O157:H7 PT-32 encoding Stx-1 and Stx-2 gene at 0.5 X MIC by luciferase assay2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Different classes of antibiotics differentially influence shiga toxin production.
AID1257070Antibacterial activity against methicillin-resistant Staphylococcus aureus XJ 75302 after 20 hrs by CLSI broth microdilution method2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Synthesis of biscoumarin and dihydropyran derivatives with promising antitumor and antibacterial activities.
AID542771Antimicrobial activity against Escherichia coli J53 transformed with pHND3 carrying qnrB6 gene by agar dilution method2009Antimicrobial agents and chemotherapy, Feb, Volume: 53, Issue:2
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
AID563875Antimicrobial activity against Klebsiella pneumoniae 967 using 2.6 X 10'5 CFU inoculum by agar dilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
AID584557Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
AID583263Antibacterial activity against aminoglycoside-resistant Escherichia coli expressing AAC(2'')-1 by broth microdilution method2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
Synthesis and spectrum of the neoglycoside ACHN-490.
AID561164AUC (0 to 24 hrs) in in vitro pharmacokinetic/pharmacodynamic model at 5 mg/kg for every 24 hrs2009Antimicrobial agents and chemotherapy, Jul, Volume: 53, Issue:7
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
AID532410Antibacterial activity against VIM-2 producing Pseudomonas aeruginosa clone B3 isolate CR-04X-14 by Etest method2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
AID422470Antimicrobial activity against nontypeable Haemophilus influenzae isolate 2019 expressing GFP isolated from patient with COPD assessed as decrease in maximal thickness of biofilm at 16 ug/mL after 2 days2008Antimicrobial agents and chemotherapy, Jan, Volume: 52, Issue:1
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
AID164233Minimum bacterial concentration (MBC) against Pseudomonas aeruginosa2003Bioorganic & medicinal chemistry letters, Sep-01, Volume: 13, Issue:17
Synthesis of N-alkylated derivatives of imidazole as antibacterial agents.
AID523009Antibacterial activity against uropathogenic Escherichia coli UTI89 isolated from urine samples of infected CBA/J mouse after 24 hrs by disk diffusion assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (397)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.01)18.7374
1990's9 (2.27)18.2507
2000's208 (52.39)29.6817
2010's176 (44.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials2 (0.52%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies7 (1.82%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
Other375 (97.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]